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Chapter 1

INTRODUCTION

Inorganic pyrophosphatase (EC 3.6.1.1), also known as IPPase, is a hydrolase
class metal dependent enzyme that catalyzes the hydrolysis of inorganic pyrophosphate
into two orthophosphate molecules, an exothermic reaction.

ΔGo’= -33 kJ/mol

IPPases are essential for life and growth in all domains of life [1-6]. These
enzymes are associated with several major metabolic reactions such as replication,
transcription, during translation, synthesis of glycogen, catabolism of fatty acids and
synthesis of flavin adenine dinucleotide (FAD), a cofactor. Cytosolic inorganic
pyrophosphate is highly subject to regulation by cytosolic soluble IPPase. Energy
released during hydrolysis of their high-energy phosphoanhydride bond is utilized to
drive corresponding endothermic reactions forward and thereby providing the required
thermodynamic pull. Hence, IPPases are vital for cellular bioenergetics [7-11]. Though
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the direct effect of IPPase on DNA polymerase during replication in vivo is not known
conclusively, thermostable IPPases can be used to enhance the efficiency of PCR in vitro
[12, 13].

1.1

Importance of pyrophosphate and phosphate in the cell
Concentration of both pyrophosphate and phosphate in cells are closely regulated,

and their relative concentration is involved in the regulation of several biochemical
pathways. For example, in mouse, apoptosis of growth plate chondrocytes and their
terminal differentiation are highly dependent on the regulation and balance of
pyrophosphate and phosphate [9]. Regulation of their concentration plays a major role in
the mineralization of bone, teeth and growth plate cartilage [10]. Also, concentration of
pyrophosphate in mouse cells has been linked to the regulation of calcification in tissues
and to increased risk of arthritis [11]. Increased levels of pyrophosphate, due to
inhibition of IPPase by calcium, were shown to regulate guanylyl cyclase in bovine
retinal photoreceptor cells [14]. Interestingly, inorganic pyrophosphate has been
demonstrated to be a central energy carrier in Caldicellulosiruptor saccharolyticus, a
hydrogen-producing thermophilic, strictly anaerobic bacterium that utilizes EmbdenMeyerhof pathway for glycolysis [15]. While these are not inclusive of all the roles of
pyrophosphate and phosphate in the cellular function, they underscore the importance of
their regulation in cells.

1.2

Types of IPPases
IPPases are primarily classified into three major classes – Family I IPPases,

Family II IPPases and Membrane IPPases. Family I and II IPPases are soluble proteins,
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whereas membrane IPPases are integral membrane proteins. These three classes of
IPPases do not share sequence or structural homology [16-18].
1.2.1 Family I IPPases
Family I IPPases are magnesium dependent, single domain proteins that are
present in all domains of life. They belong to Oligonucleotide/Oligosaccharide-Binding
(OB) fold superfamily with five β-strands forming a β-barrel at the core (Figure 1.1)
[19, 20]. They typically form homodimers in eukaryotes and homohexamers (dimer of
trimers) in prokaryotes, with their active site present within the domain (Figure 1.2)
[21-24]. Family I IPPases, primarily those from Escherichia coli and Saccharomyces
cerevisiae, have been well characterized. Though sequence identity of E. coli IPPase
(175 aa) and S. cerevisiae IPPase (286 aa) is rather low at just 27%, the core of their three
dimensional structures has high structural similarity. S. cerevisiae IPPase has extended
N-terminal (26 aa) and C-terminal (54 aa) residues in addition to three loops (8-13 aa)
that are longer than those in E. coli IPPase (Figure 1.2) [25, 26].

A

B

C

D

Figure 1.1. Conserved fold of Family I IPPases in three domains of life. A, B, C) Family I IPPases
have conserved OB-fold β-barrel – made of five β-strands – as shown in monomeric IPPase
subunits of Escherichia coli (green-colored, PDB ID: 2au6, bacterial), Thermococcus thioreducens
(red-colored, PDB ID: 3r5u, archaeal) and Saccharomyces cerevisiae (blue-colored, PDB id: 2ihp,
eukaryotic). D) Despite low sequence similarity between prokaryotic and eukaryotic IPPases, their
three dimensional folding is highly conserved as shown in the superimposition of above three
IPPases.
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A

D

B

C

E

Figure 1.2. Comparison of structures of E. coli and S. cerevisiae IPPases. Quaternary structures
of E. coli (PDB ID: 2au6) and S. cerevisiae IPPases (PDB ID: 2ihp) are homohexamer – dimer of
trimers (A) and homodimer (B), respectively. S. cerevisiae IPPase is about 110 amino acids longer
than E. coli IPPase but their core fold is highly conserved. Superimposition (C) of E. coli IPPase
(cyan colored) and S. cerevisiae IPPase (combination of yellow, green, blue and green colored)
show the additional residues of the latter, besides the homologous common core (yellow), present
in N-terminal (blue), C-terminal (green) and insertions in the interior (red). The two-dimensional
secondary structure topology for E. coli (D) and S. cerevisiae (E) IPPases are shown. Cartoon
diagram was rendered using Pymol and topology was obtained using PDBsum [27, 28].
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A

B

Figure 1.3. Structural conservation of active site in Family I IPPases. A) Monomer subunit of E.
coli IPPase (PDB ID: 2au9) with active site residues and substrate pyrophosphate shown as sticks.
B) Active site of Family I IPPases in all domains of life – E. coli, S. cerevisiae (PDB ID: 1e6a) and
T. thioreducens (PDB ID: 3q9m) – are highly conserved in their three dimensional structure.
Orientation of active site residues in B is same as that in A. Substrate pyrophosphate, labelled POP,
is shown in the center. Metal ions bound at active site are shown as spheres.

The active site of Family I IPPases is comprised of 13 active site residues, and is
highly conserved (Figure 1.4). Though quaternary structure differs for E. coli and
S. cerevisiae IPPases, their active site residues, bound metal ions, substrate and product
share significant structural similarity (Figure 1.3). Many of the conserved active site
residues are polar and are involved in the binding of 3-4 metal ions as well as their
substrate, pyrophosphate or their product, phosphate during catalysis [23, 25].
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Figure 1.4. Conservation of active site residues in Family I IPPases. Sequences of Family I IPPases
from archaea, bacteria and eukaryotes were aligned using ClustalW. Conserved residues are
highlighted based on their polarity (blue – basic, red – acidic, green – polar, yellow – non-polar).
Active site (arrow-marked) is conserved in all sequences, despite low sequence similarity between
animal and prokaryotic IPPases. At the right of second sequence block, %identity of sequences to
Human IPPase is shown.

Animal and yeast cells have a cytosolic IPPase and a mitochondrial IPPase, both
of which are Family I IPPases and are of eukaryotic origin (i.e., similar to S. cerevisiae
IPPase). In contrast to this, in Chlamydomonas reinhardtii, a microalga species,
mitochondrial IPPase is of prokaryotic origin and chloroplastic IPPase is of eukaryotic
origin [29]. Arabidopsis thaliana, a higher plant species, contains six Family I IPPases
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(PPA1-6). While one of them is localized in chloroplast and is of eukaryotic origin, the
remaining are localized to cytosol and are of prokaryotic origin [30, 31]. Despite having
several cytosolic IPPases and high concentration of pyrophosphate (0.2–0.3 mM) in the
cytosol of higher plant cells, pyrophosphatase activity was found predominantly only in
chloroplast and not in cytosol, thereby suggesting that cytosolic IPPases are highly
regulated [31, 32]. Interestingly, both chloroplastic and mitochondrial IPPases of
C. reinhardtii and cytosolic IPPases PPa2 and PPa4 of A. thaliana are monomers
[33, 34], unlike their E. coli and S. cerevisiae counterparts that are hexamers and dimers
respectively.
1.2.2 Family II IPPases
Family II IPPases are manganese-dependent two-domain proteins with active site
in their domain interface (Figure 1.5). They have been reported to be present only in
prokaryotes, many of which are pathogenic [18, 20, 21, 35, 36]. They are homodimeric
in quaternary structure and belong to DHH phosphoesterase superfamily (where DHH
refers to conserved Asp-His-His motif) with two domains linked by a flexible linker
[18, 20]. Family II IPPases require three metal ions for their activity [17, 18]. They
prefer Mn2+ ions, in contrast to Mg2+ ions for Family I IPPases, and this preference has
been attributed to the presence of histidine residues, at the active site, that coordinate two
metal ions (Figure 1.5) [18]. In addition to two domains, a quarter of Family II IPPases
also have regulatory CBS (cystathionine β-synthase) and DRTGG (named after most
conserved amino acids) domains [20].
Family I and II IPPases do not share sequence or structural homology [16-18].
Though catalytic mechanism of pyrophosphate hydrolysis by both Family I and II
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IPPases was initially believed to be similar, recent studies suggest that they may not be
related [18, 20]. A prokaryotic species contains either Family I or Family II IPPases.
However, four Vibrionales species, including Vibrio cholera, a Human pathogen, are
known to have both in their genome [37].

A

B

Figure 1.5. Structure of Family II IPPase and its active site. Bacillus subtilis IPPase (PDB ID:
2haw) is a two-domain protein with active site at its domain interface (A). Active site residues at
the domain interface are highlighted in red. Active site is shown (B) with substrate analog PNP.
Only side chains of active site residues are shown.

1.2.3 Membrane IPPases
Membrane IPPases are single-polypeptide, integral membrane bound IPPases that
catalyze transfer of protons or sodium ions through active transport across the membrane,
by coupling hydrolysis of inorganic pyrophosphate to two orthophosphate molecules
(Figure 1.6) [38-40]. They are Mg2+ ion dependent but the requirement of K+ ions for
activity varies depending on the species [40].
Membrane IPPases are present in the cytoplasmic membrane of bacterial and
archaeal species, and in the membrane of vacuoles and acidocalcisomes in plants [38-43].
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They are found to be significant when organisms undergo stress due to unfavorable
environmental conditions such as drought, cold, etc. [44]. They are conserved in all
domains of life but are absent in mammals [44]. They do not have significant homology
with Family I IPPases, though at least 4 – 6 of active site residues appear to be conserved
[45].

A

B

Figure 1.6. Membrane IPPases. A) Schematic diagram of catalysis by membrane IPPase.
B) Crystal structure of Thermatoga maritima membrane IPPase (PDB ID: 4av3) in dimeric state,
with its upper side facing the cytosol.

1.3

IPPases as potential drug target
Antibiotic and antimicrobial resistant bacteria are on the rise in last decade and

pose a major threat to Human health. At least two million people get infected with
antibiotic resistant bacteria every year in the United States. About 23,000 and 25,000
people die each year in the United States and Europe, respectively, due to such infections
[46]. These statistics are expected to increase in the near future, if new classes of drugs
to treat such infections could not be found.
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In recent years, IPPases have been tested for their ability to be drug target with
promising outcomes [47-50]. Though their quaternary structures vary between
prokaryotic and eukaryotic domains, their highly conserved active site poses challenge
for drug-designing. Instead, differences in the oligomeric interfaces of bacterial IPPases
(hexameric – dimer of trimers) and Human IPPases (dimeric) could be exploited, if drugs
can be found or designed to bind exclusively at the oligomeric interface of bacterial
IPPases and thereby inhibiting its function. Oligomerization plays a major role in their
function, as it was shown in hexameric E. coli IPPase that trimeric and dimeric IPPase
lose activity by 60 % and 40 %, respectively. Thus cooperativity between subunits in
hexameric IPPase is required to hold complete activity [51, 52] and targeting their
interface to inhibit activity is a viable option. Recently, a compound called
3-[3-(3-Chlorophenyl)pyrrolidin-1-yl]-5-(5-methylfuran-2-yl)-1,2,4-triazine was found to
weakly inhibit M. tuberculosis IPPase (Mt-IPPase). On further elaborate study using this
weak inhibitor as a lead compound, a derivative called 4-(3-(3-(3Chlorophenyl)pyrrolidin-1-yl)-1,2,4-triazin-5-yl)aniline was synthesized. It showed
significant antibacterial activity against M. tuberculosis¸ Bacillus anthracis and ten
different antibiotic-resistant Staphylococcus aureus strains while not being toxic to
mammalian cells [48].

1.4

Human IPPase
Humans have cytoplasmic as well as mitochondrial Family I IPPases.

Mitochondrial IPPase is nuclear-genome encoded, with mitochondrial localization signal
sequence in its N-terminal, and is 60 % identical to the cytosolic IPPase [53]. In contrast
to cytosolic IPPase, which do not have isoforms, mitochondrial IPPase has at least four
10

isoforms produced by alternative splicing [54]. Most, if not all, isoforms have residues
missing around the signature sequence and hence are missing few active site residues.
From here on, the term ‘Human IPPase’ refers to cytoplasmic Human IPPase.
In 1966, Pynes et al. purified IPPase from Human red blood cells, and it had
optimal activity at pH 7.7. It was specific for hydrolysis of pyrophosphate and was
inhibited by ATP, ADP, inosine triphosphate and inorganic tripolyphosphate [55].
Rumsfield et al., in 2000, purified recombinant Human IPPase (35-37 kDa) and found it
to be homodimer in solution. It had optimal pyrophosphate hydrolysis activity at pH
7.25 – 7.5 in presence of magnesium ions [56].
Human IPPase ppa1 is a housekeeping gene [57], and its role in health and
diseases is coming to light only since the last decade. It has been identified as the
potential biomarker – of metastasis in laryngeal squamous cell carcinoma [58] and of
poor prognosis in gastric cancer [59]. Gene knockdown of Human IPPase in breast
cancer cells reduced their colony forming ability and survival [60]. Increased expression
of IPPase has also been implicated in other cancers such as primary colorectal cancer
[61], lung adenocarcinoma [62] and prostate cancer [63]. IPPase might be overexpressed in tumor cells because of their increased requirement of energy as well as
protein synthesis and degradation pathways [62]. Since IPPase is a housekeeping gene
[57], it is likely that this enzyme is over-expressed in other cancers. In addition, Human
IPPase was found to be associated with Human immunodeficiency virus type -1 (HIV-1)
particles, for which low pyrophosphate concentration is believed to provide advantage to
virus [64].
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1.5

St-IPPase
Salmonella typhi, a serovar of Salmonella enterica, is a Human pathogen that

causes typhoid fever, a life-threatening systemic disease [65]. Its devastating effect is
primarily seen in developing countries where it causes 200,000 fatalities annually, mostly
children. Salmonella typhi has a Family I IPPase (herein referred to as St-IPPase), which
remains to be studied. It shares 94 % sequence identity to E. coli IPPase and just 27 %
identity to Human IPPase.

1.6

Tt-IPPase
Tt-IPPase is a soluble Family I IPPase obtained from Thermococcus thioreducens,

a hyper-thermophilic, sulfur-reducing archaeon isolated from Rainbow hydrothermal vent
site on the Mid-Atlantic Ridge [66]. Its shares 88 % sequence identity to IPPase of
Pyrococcus horikoshii, a hyper-thermophilic archaeon and just 41 % to that of E. coli, a
bacterium. The Ng lab has previously studied the crystal structures of Tt-IPPase (Figure
1.1), by both X-ray and neutron crystallography, at various stages of its substrate
hydrolysis and proposed a catalytic mechanism for pyrophosphate hydrolysis [67, 68].
The three-dimensional structure of protein deciphered by X-ray or neutron
crystallography offers a single snapshot view, at high atomic resolution, of average
molecular configurations. However, to truly understand a protein’s action and the
molecule’s complete description, one must also consider the dynamic contribution
affected by the protein’s different conformational states and the energy barriers between
them.
Quasielastic neutron scattering (QENS) has been a prevailing spectroscopic
method to measure the biophysical properties from which protein dynamics can be
12

inferred [69, 70]. Hydration layer of protein is a layer of water molecules around protein
that plays a major role in protein dynamics and hence in its activity. QENS resolves the
change in kinetic energy derived from limiting inelastic collisions between neutrons and
the nuclei in the sample providing results expressed as the dynamic structure factor
S(Q,E), predominantly of the hydrogen atoms in the protein or the water molecules in the
protein hydration layer [71, 72]. Since protein structures are exceptionally sensitive to
the interactions of their hydrogen bonds with water, the diffusive dynamics of hydration
water in proteins measured by QENS reveals important information on the protein’s
global and local conformational flexibility; and in turn, its functionality [73].

1.7

Crystallization by protein engineering
X-ray crystallography is the most commonly used techniques to determine three

dimensional structure of proteins at atomic resolution, and it requires protein sample to be
crystallized before exposing them to X-ray for diffraction data collection [74]. Protein
crystallization, in most cases, requires protein samples to have high purity, stability,
solubility and homogeneity in order to form high quality crystals. In difficult cases of
protein crystallization, crystal formation or improvement in crystal quality can be
achieved by rationally engineering amino acid residues on the surface of protein
molecules. Four different rationales of protein engineering to enhance success
probability of improving crystal quality of Human IPPase are discussed here - (1) crystal
contact engineering (to improve crystal packing), (2) surface entropy reduction (to reduce
disorder by long amino acids), (3) truncation of flexible regions (to reduce disorder by
long flexible regions) and (4) fusion-protein assisted crystallization (to improve lattice
contact points).
13

1.7.1 Crystal contact engineering
During crystallization, certain amino acids on the surface of protein molecules
bind with residues of other protein molecules by means of salt bridges or/and, in some
cases, through ligand-bridge, forming the crystal contact points [75]. These contact
points are essential for stabilization of protein molecules during ordered crystal packing
and thus also for crystal quality. In cases where structural information of protein is
available and improvement in crystal quality is desired, such crystal contacts on surface
of protein can be introduced or modified rationally. One classic example is the
facilitation of crystallization of Human protein called ferritin, which in its native form led
to unusable, poor diffracting crystals [75]. Human ferritin was successfully crystallized
from its variant Lys86Glu, and this mutation was led by the observation that Glu86 in the
crystal structures of its homologous proteins – rat and horse ferritin – was involved in
cadmium-bridge interconnecting ferritin molecules in the crystal structure.
Systematic studies on the effects of such crystal contact engineering on protein
crystallization were later carried out using bacterial and archaeal proteins, whose crystal
structures were already available, by promoting, disrupting or adding crystal contacts by
mutation. This led to the conclusion that crystal packing quality and diffraction quality
are affected accordingly, as expected [76, 77]. Incidentally, several protein were
crystallized by mutation of surface exposed residues, although such mutations were
intended to increase protein solubility, to avoid protein aggregation, to replace
hydrophobic residues with hydrophilic residues, etc. but not originally designed to
promote crystal contacts [78-80]. This demonstrates the importance of crystal contacts
for protein crystallization.
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1.7.2 Surface-entropy reduction
Disorder in the conformation of amino acids with long side chains on the surface
of protein, which is otherwise intrinsically well-structured, lead to increase in entropy or
disorder in and around that region. Such high entropy on protein surface hinders
crystallization process [81]. Surface-entropy reduction (SER) is a relatively recent
method in which long side-chain residues such as lysine, glutamate and glutamine, when
present in cluster on the surface of protein, are mutated into small side-chain residues
such as alanine in order to reduce disorder in that region, and therefore promoting
crystallization. This method has been successful in recent years in crystallizing several
proteins, including Human, whose wild type variants were otherwise resistant to
crystallization. Interestingly, in several SER mutants, mutated residues were observed to
be involved in formation of crystal contacts and thereby, directly assisting in stabilization
of crystals [81, 82].
1.7.3 Truncation of flexible regions
Presence of disordered or flexible segments in protein very often hinders ordered
packing of protein molecules due to increased entropy around that region, and therefore
impedes crystallization. These flexible regions could be present in C- or N-terminals or
in the interior of protein. Removal of such regions, especially in C- and N-terminals, has
been an efficient method to enhance the success rate of protein crystallization. Such
truncated constructs may still hold their wild type variant’s biological activity in cases
where truncated disordered regions are not part of active site and are not necessary for
their proper folding. Prediction programs, for example, DISOPRED2 can be used to
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determine potential flexible regions in the protein and mutant constructs can be designed
by truncating these regions [81, 83, 84].

1.8

Analysis of conservation of residues
Conservation of residues in protein, DNA or RNA plays a significant role in

conservation of their function, in their folding and quaternary structure and in interactions
between the macromolecules. Multiple sequence alignment (MSA) can be used to
determine the extent of such conservation of residues of homologous sequences.
ScoreCons and AL2CO webservers can analyze conservation of all amino acid residues
with respect to reference sequence in MSA by calculating residue frequency and on basis
of entropy, variance and matrix score at each residue position [85, 86]. Webserver
ConSurf calculates evolutionary rate of residues in protein and nucleotide sequences and
structures using homologous sequences through empirical Bayesian and maximum
likelihood methods [87]. These webservers are greatly helpful when overall conservation
of sequences and motifs in them need to be determined. However, in cases where
conservation of only a particular set of residues in protein or nucleotide sequences, for
example in analysis of conservation of defined active site residues, known motifs, etc.
need to be analyzed, the process is not straightforward. This difficulty is especially true
where sequences data contain multiple types of protein or gene families, but one
particular family of homologous sequences needs to be separated in order to analyze
conservation of residues in them. Furthermore, directly associating taxonomy lineage
information with such analysis is rather cumbersome. To address these difficulties,
ResCon, a cross-OS platform software suite, was developed in-house using Python.
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1.8.1 FASTA format:
FASTA format is a commonly used text-based sequence format to represent
protein and DNA/RNA sequences using one-letter amino acid and nucleotide codes,
respectively. ResCon utilizes FASTA format for input sequences, and knowledge of
FASTA format is required to properly use ResCon. A FASTA sequence has two
sections: a header line and one or multiple lines of sequence data, preferably 60 or 80
characters per line (Figure 1.7) [88]. A FASTA file may have one or more sequences.
First line of a FASTA sequence is the header line and it has three parts (Figure 1.7):

Identifier (ID)
Description
>NP_313231.1r|Escherichia|coli| inorganic pyrophosphatase [E.
coli]
MSLLNVPAGKDLPEDIYVVIEIPANADPIKYEIDKESGALFVDRFMSTAMFYPCNYGYIN
HTLSLDGDPVDVLVPTPYPLQPGSVIRCRPVGVLKMTDEAGEDAKLVAVPHSKLSKEYDH
IKDVNDLPELLKAQIAHFFEHYKDLEKGKWVKVEGWENAEAAKAEIVASFERAKNK
Figure 1.7. Elements of FASTA sequence format. FASTA header line contains > symbol
followed by identifier (red colored) and then description. Header line is followed by sequence.

a. First character in header line is always ‘>’ (greater than symbol). This
signifies the beginning of a new sequence record, and it should always be
present for each sequence record for a valid fasta format.
b. The section that follows ‘>’ until the first empty space character is called as
identifier (ID). IDs are optional in FASTA format, and space character is not
allowed to be part of them.
c. The part of header line after a space character to ID is called description. This
part is optional in FASTA format, and space characters are allowed to be
present.
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Though IDs are optional, they are always required in circumstances where
sequences need to be identified by their ID. For example, ResCon utilizes them to
identify sequences, and hence is always required where FASTA sequences are provided
as input to them. Furthermore, certain programs may limit the length of identifier to
certain preset number of characters. For example, PHYLIP, a MSA format, allows
sequence names of only 10 characters [89].
1.8.2 Residue Conservation Scoring
Residues in certain positions of a sequence are well conserved than others among
homologous sequences during molecular evolution. The extent of such conservation
depends on the role of residues at those positions towards structure and function of
protein or nucleic acids. Knowledge of such conservation of residues is essential for
predicting functionally and structurally significant residues, and several scoring methods
have been proposed to determine conservation of residues from MSA [90].
ResCon utilizes residue conservation scoring methodology proposed by Liu et al.
in 2008, which considers both frequency and physio-chemistry of residues in MSA [91].
This method, which we call Liu08 scoring, measures physio-chemistries of residues by
using Similarity matrix S (Table A.1). This matrix S was obtained by normalizing
BLOSUM62 matrix such that 2 ≤ S(a,b) ≥ 9 if a and b are two different residues and
S(a,b) = 10 if a and b are identical residues. That is, if residues a and b match, then
S(a,b) = 10, or else they range from 2 to 9 depending on BLOSUM62 matrix score for
(a,b). The formula used to measure residue conservation scoring by Liu08 methodology
is described here.
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At column k in MSA, for standard amino acids i = 1, 2…20, if
 ܽܽ is the ith amino acid type and ݂൫ܽܽ ൯ is its frequency at this column k

 ܽܽ is the amino acid with highest frequency at column k such that
݂൫ܽܽ ൯ = max (݂(ܽܽ ሻሻ
ୀଵ..ଶ

 ܵ൫ܽܽ , ܽܽ ൯ is the similarity score from Liu08 Similarity matrix S

then, Liu08 non-sequence-weighted conservation score (ݑ݅ܮ08_ܹܰܵ  ) at this column is
calculated as [91, 92]
ݑ݅ܮ08_ܹܰܵ  = 

ଶ

ୀଵ

݂൫ܽܽ ൯ . ܵ൫ܽܽ , ܽܽ ൯

(1.1)

Position based sequence weighting [93] is then incorporated in to this method in
order to consider evolutionary correlations between sequences considered. For a
sequence s in a MSA with alignment length L, if
 x is the residue position in that sequence s
 ݇௫ is number of unique residues at column x

 ݊௫ೞ is number of times particular residue appears in that column x

then, position based sequence weight (Ws) for that sequence is calculated as

ܹ௦ =

ଵ






ଵ

(1.2)

௫ୀଵ ೣ . ೣೞ

This position based sequence weight (Ws) is then applied to equation (1.1) to
obtain Liu08 sequence-weighted conservation score. At column k in MSA and for amino
acids i = 1, 2…20, if
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 ܽܽ is the ith amino acid type

 ܽܽ is the amino acid with highest frequency at column k such that
݂൫ܽܽ ൯ = max (݂(ܽܽ ሻሻ
ୀଵ..ଶ

 ܵ൫ܽܽ , ܽܽ ൯ is the similarity score from Liu08 Similarity matrix S
 



ୀଵ

ܹ is the sequence weight of ݊ number of sequences with ith

amino acid at column k
then, Liu08 sequence-weighted conservation score (ݑ݅ܮ08_ܹܵ  ) at this column is
calculated as

ݑ݅ܮ08_ܹܵ = 


ଶ
ୀଵ

ቆ



ୀଵ

ܹ ቇ . ܵ൫ܽܽ , ܽܽ ൯

(1.3)

This score ranges from 0 to 10 with 10 representing complete conservation of
residues at the column of interest.
1.8.3 Regular Expressions
Regular expressions are used in ResCon for pattern-matching the contents of
sequences’ header. They are syntaxes made of certain notations to match, or not, to
sequence of characters in text if they are in a particular pattern [94]. In simpler terms,
they are similar to ‘search and replace’ feature commonly used in text editors and word
processors except that regular expressions are way more powerful as they could match
not just the typed characters/words but also patterns in text. For example, if 10 of 100
students have John as first name, regular expression can be used to find and extract all
full names in that list with John as first name. This is typically achieved using wildcards.
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Wildcards are special characters or symbols that could match single or multiple
characters or symbols unlike simple ‘search and replace’ feature where characters are
matched character for character. Most commonly used wildcards are listed in Table 1.1
[95]. Use of these wildcards are readily expanded by using plus (+) symbol immediately
after a wild card where it will then search for the matching term one or more times in
succession until they don’t match anymore. For example, in the text ‘James Bond 007
Spectre’, regular expression ‘\d+’ (without quotes) matches only to ‘007’.

Table 1.1. Common wildcards used in regular expressions.
Wildcard

Matches to

\w

Letters, numbers and underscore symbol

\d

Digits (0 to 9)

\t

Tabs

\s

Spaces, tabs and end-of-line characters

\r, \n
.

End-of-line characters
Any letter, number or symbol except end-of-line characters

Furthermore, any part of regular expression that are enclosed inside parenthesis
can be used to capture parts of the original text and save or use for replacement. For
example, regular expression ‘(\w+ \w+ \d+) \w+’ matches to text ‘James Bond 007
Spectre’ and use of \1 to create replacement text will result in extracting just ‘James Bond
007’ as this part was captured using parenthesis.
Regular expressions are known to be intimidating to the untrained eyes or
beginners, but they can be easily learnt with small amount of practice, and put to great
use for powerful purposes where matching or extraction of pattern of text from original
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text is required. Many text editors – for example, Notepad++, TextWrangler, etc. – have
regular expressions feature as part of their inbuilt search feature and can be used for
testing or practicing regular expressions.

1.9

Objectives
As IPPases are essential for life in both prokaryotes and eukaryotes, they can be

potential drug targets. Family I IPPases are present in both prokaryotes and eukaryotes
including Humans, whereas Family II IPPases are present only in prokaryotes, many of
which are pathogenic. Potentially, Family II IPPases could be safely targeted for drugs as
they are absent in Humans. In case of Family I IPPases, though their quaternary structure
vary between prokaryotes and eukaryotes, highly conserved active site presents challenge
to design of drugs targeting the active site for function inhibition. However, differences
in the oligomeric interfaces of bacterial IPPases (hexameric – dimer of trimers) and
Human IPPases (dimeric) could be exploited, if drugs can be found or designed to bind
exclusively at the oligomeric interface of bacterial IPPases to inhibit their activity.
Moreover, obtaining structural information for the Human IPPase would be beneficial for
searching effective inhibitors against pathogenic IPPases by knowing what may
deactivate the enzyme belonging to the pathogen and not to that of Human.
The objective of this study is to provide platform for future drug-design studies
that targets IPPases. This would be achieved in a combination of bioinformatics,
biochemistry and crystal structure analysis of IPPases as follows: 1. Bioinformatic
analysis of evolutionary conservation of amino acids in Family I and Family II IPPases;
2. Study of Family I IPPases from Human and Salmonella typhi, representing a bacterium
pathogenic to Humans.
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In order to study residue conservation in Family I and II IPPases, ResCon, an
open source, cross-OS platform software suite with graphical user interface, will be
developed in Python. Protein sequences will be retrieved from NCBI RefSeq Protein
database, and Family I and II IPPase sequences will be identified and separated. The
extent of conservation of active site residues in them will be analyzed in relation to their
taxonomy, and sequences with mismatches at active site will be studied to determine
susceptibility of those residues for mutation. Species with more than one family of
IPPases will be identified, and their nature will be probed. Furthermore, evolutionary
conservation of all residues will be analyzed in context of their three dimensional
structure and function.
The crystal structure of Salmonella typhi IPPase (St-IPPase) will be determined
using X-ray crystallography, and evolutionary residue conservation data will be utilized
to locate potential drug binding sites on St-IPPase. Human IPPase will be cloned,
heterologously expressed in E. coli, purified and characterized. Protein crystallization
screening will be carried out using vapor diffusion and capillary counter-diffusion
methods. Thermal shift assay will be utilized to measure the stability of protein, and to
identify important structural elements for protein engineering. Subsequently, Human
IPPase crystallization can be achieved by means of building lattice contacts, surfaceentropy reduction, terminal truncation and fusion protein engineering.
Furthermore, in a related study in collaboration with Biophysicists at Oak Ridge
National Laboratory (ORNL), a large quantity (about one gram) of Thermococcus
thioreducens IPPase (Tt-IPPase) will be purified and characterized for Quasielastic

23

neutron scattering to study the similarities and differences of protein dynamics between
large oligomeric and small monomeric proteins.
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Chapter 2

MATERIALS AND METHODS

2.1

Software development of ResCon
ResCon is a standalone software suite written in Python 2.7.10. It was developed

using Notepad++ text editor and PyCharm IDE in Windows OS 8.1 and 10, and
TextWrangler text editor and PyCharm IDE in OS X 10.9. ResCon employs Tkinter, the
Python binding to Tk graphic user interface (GUI) toolkit, for its GUI. The Tk widgets
utilized are: button, checkbutton, entry, frame, label, menu, radiobutton and text [96].
Third-party Python modules, which are not natively distributed with Python
installers but needs to be installed separately, utilized here are Biopython (ver 1.63),
natsort (ver 3.5.6) and matplotlib (ver 1.3.1). Module Biopython (v1.63) is heavily
utilized in ResCon to read and write sequence data in various formats [97, 98]. Module
natsort is utilized to enable ‘natural sorting’. This module allows to sort strings properly
- for example, to sort a list of strings ['9', '10', '1'] as ['1', '9', '10'] instead of Python’s
native sorting to ['1', '10', '9']. Usage of this module is not required but is recommended.
Module matplotlib was initially utilized to create bar graph as part of HTML5 output
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from ResCon’s tool ‘Mismatch Analyzer’. But use of this module now is disabled by
default in the script as it results in executable package of size >100 MB. Instead,
JavaScript, using open source charts tool ChartNew.js, is now utilized to create this
graph.
ResCon allows to perform Clustal Omega MSA through webserver offered by
EMBL-EBI web services [99, 100]. EMBL-EBI provides REST architecture based web
API (Application Program Interface) for this webserver. But, this web API was available
only in Python 3.4 and could not directly be used with ResCon’s Python 2.7 code.
Hence, Python tool called 3to2 (ver 1.1.1) was utilized for initial backporting of this code
from Python 3.4 to Python 2.7. Then, Python module urllib2 was used instead of urllib3
used in the API. This backported web API compatible with Python 2.7, with few usage
improvements over original Python 3.4 version was submitted to EMBL-EBI and is now
available freely at http://www.ebi.ac.uk/Tools/webservices/services/msa/clustalo_rest.
In order to make 32-bit executable from the Python script for Windows and
Ubuntu OSs, cx_Freeze was utilized in respective OSs. In OS X, py2app was used to
make a standalone application bundle for OS X version. Furthermore, for Windows, Inno
Setup 5.5 was utilized to create standalone 32-bit installer.
Version control software Git was utilized in later part of software development.
Repository called ‘ResCon’ was created in GitHub, a web based Git repository, to
distribute source code, standalone executables and installer files. It can be accessed from
https://github.com/ManavalanG/ResCon.
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2.2

Analysis of conservation of active site residues of Family I and II IPPases

2.2.1 Retrieving RefSeq data
The term ‘inorganic pyrophosphatase’ was used as search keyword in NCBI
Protein database with RefSeq chosen as the source database, and the hits were retrieved
in GenPept format (as it includes taxonomy information) on February 22, 2016 [101].
ResCon’s GenPept to FASTA Converter tool was used to convert them in to FASTA
format while retrieving fields of accession ID with version number, first three ranks of
taxonomy lineage, genus and species into ID of sequences’ header with pipe symbol as
the delimiter. Symbols – round braces, square braces, comma, single quote, colon and
semicolon were defined as sensitive symbols, and underscore symbol was used to replace
them in sequence ID. Maximum length allowed for sequence ID was 127. Sequences
annotated as either incomplete or partial were ignored during this format conversion.
2.2.2 Removing redundant sequences
Python 2.7 scripts ‘RefSeq_IDs_Ranked_by_Status.py’ and
‘iterate_find_duplicates.py’ were utilized to eliminate redundant sequences from the data
using BLAST+ (ver 2.2.31) local sequence alignment [102]. These scripts are available
for download at https://github.com/ManavalanG/Scripts_IPPase_Analysis. Sequences
were considered to be redundant if they were from same species, sub-species or strain,
≥98 % identical and their sequence lengths vary only by ±2/100 residues. Among those
redundant sequences, one sequence was retained as representative sequence on the basis
of their RefSeq status ranks (Table 2.1) retrieved from COMMENT section of GenPept
format of the sequence records, with rank 1 being the highest. If more than one sequence
had the same highest rank, the longest one was chosen if their lengths differed, or else a
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sequence was randomly chosen if they were of same lengths. Furthermore, sequences
whose organism’s genus rank was defined but species rank was undefined were
eliminated if another species from that genus had a sequence satisfying criteria for
redundant sequences.

Table 2.1. RefSeq status ranks used to identify best candidate among redundant sequences
RefSeq Status

Rank

REVIEWED

1

VALIDATED

2

PROVISIONAL

3

PREDICTED

4

MODEL

4

INFERRED

4

REFSEQ

5

2.2.3 Isolating Families I-P, I-E and II IPPases
NCBI’s Protein BLAST was utilized to perform local sequence alignment for
dataset with reference sequences (Table 2.2) as queries, and results were retrieved in
XML format [103]. ResCon’s Filter BLAST by Bit or E-value tool was used to extract
respective family of homologous sequences with bit score >50 as threshold [104].
Python script ‘find_unique_seqs_in_two_files.py’ (available from
https://github.com/ManavalanG/Scripts_IPPase_Analysis) was then used to extract
unique sequences from Family I homologous sequences when Escherichia coli and
Saccharomyces cerevisiae were used as reference sequences. Sequences whose
taxonomy domain rank was listed as ‘UNCLASSIFIED’ were eliminated from dataset, if
they satisfied criteria for redundancy when compared to sequences for which domain
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rank was known. For Family I IPPases, sequences corresponding to Family I-P and
Family I-E were separated by constructing a neighbor joining phylogenetic tree using
Clustal omega with iterations set to 5 [105]. Clades of sequences corresponding to
Family I-P (branch length: 0. 569368) and Family I-E (branch length: 0. 920752) were
extracted using ResCon’s Subtree Sequences’ Extractor.

Table 2.2. Reference sequence of Family I and II IPPases and their active site residues.
Protein
Accession ID

Organism

IPPase Active site residues
Family

Source

NP_313231.1*

Escherichia coli

I-P

20E, 29K, 31E, 43R, 55Y, 65D, 67D, 70D,
97D, 102D, 104K, 141Y, 142K

[106]

NP_009565.1*

Saccharomyces
cerevisiae

I-E

48E, 56K, 58E, 78R, 93Y, 115D, 117D,
120D, 147D, 152D, 154K, 192Y, 193K

[106]

NP_391935.1

Bacillus subtilis

II

9H, 13D, 15D, 75D, 97H, 98H, 149D, 203D, [17, 18,
205K, 294S, 295R, 296K
107]

*

Edited sequence, with first Met residue removed, was used as reference.

2.2.4 Active site conservation analysis
ResCon’s Mismatch analyzer was used to construct MSA by Clustal omega
locally [105], with number of iterations set to three, and then analyzed for conservation of
active site residues in corresponding family of IPPases using respective reference
sequence (Table 2.2). ResCon’s Filter FASTA by Sequences’ ID was used as needed to
extract matching and mismatching sequences using their accession ID with version
numbers. Protein isoforms among mismatching sequences were identified using IsoSVM
[108]. However, automated isoform prediction by IsoSVM was not used, as the
limitations reported by its author led to misleading predictions. Instead, alignment
produced by IsoSVM were visually checked for isoforms after instructing them to make
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alignments for all sequences within corresponding species or genus of a mismatching
sequence.
2.2.5 Identifying species with more than one family of IPPases
In order to determine species that contain both Family I and II IPPases and those
that contain both Family I-P and I-E IPPases, only sequences of those families that do not
have any mismatches at their active site were analyzed. Sequences for which species
rank was unavailable were ignored. A python script was used to identify such species.
2.2.6 UniProtKB/Swiss-Prot – Data analysis
The term ‘inorganic pyrophosphatase’ was used as search term in NCBI Protein
database with UniProtKB/Swiss-Prot chosen as the source database, and the resulted hits
were retrieved in GenPept format on April 15, 2016 [54, 101]. ResCon’s GenPept to
FASTA Converter tool was used to convert them into FASTA format with same
parameters used in RefSeq data analysis earlier. Neighbor joining phylogenetic tree was
constructed for the dataset using Clustal omega [105] locally with 4 iterations. Clades
containing Family I-P, Family I-E and II IPPases were identified and corresponding
sequences were extracted using ResCon’s Subtree Sequences’ Extractor. ResCon’s
Mismatch analyzer was used to construct MSA using Clustal omega, with three
iterations, and then analyzed for conservation of active site residues for the extracted
clades of sequences using respective reference sequences (Table 2.2).

2.3

Conservation of all residues of Family I and Family II IPPases
Sequences in Family I-P, I-E and II IPPases, with completely conserved active

site, were clustered using CD-HIT with 90 % sequence identity as a threshold [109].
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MSA was performed with Clustal omega, using ResCon’s Mismatch analyzer, with
number of iterations set to three [105]. Residue conservation analysis was performed
with ConSurf server by Bayesian method – using MSA, appropriate reference sequence
and protein structure PDB ID – 2au6 (Family I-P), 2ihp (I-E) or 2haw (II) [87, 110].

2.4

Crystallization, data collection and structure determination of St-IPPase
St-IPPase (UniProtKB ID: P65749), with hexa-histidine tag in its N-terminal

(Appendix A), was cloned, expressed and purified with the final buffer as 50 mM HEPES
at pH 7.5 and 50 mM NaCl. The major steps involved in crystallization and
crystallographic structure determination are demonstrated in Figure 2.1. St-IPPase was
trace fluorescent labeled with carboxyrhodamine-succinimidyl ester for initial
crystallization screening [111]. Crystal hits were identified, using CrystalX2 plate reader
(iXpressGenes, USA), in presence of precipitant 0.1 M Tris HCl at pH 8.5, 1 M
ammonium dihydrogen phosphate and 10% glycerol, and crystals were optimized using
unlabeled St-IPPase.
Crystals were mounted on nylon loop (Hampton Research), cryo-conditioned by
soaking in 10 % glycerol, and then flash-cooled in liquid nitrogen. X-ray diffraction data
was collected from a single crystal at SBC-CAT 19BM beam line (Argonne National
Lab, USA) using a ADSC Quantum 210r CCD detector. Diffraction data was indexed,
integrated and scaled using HKL3000 software suite [112]. Resolution was limited to
Bragg reflections with I/σ above 3, during scaling. The crystal belonged to space group
I213 with unit-cell parameters a=b=c=142.076 Å with all angles to be 90o.
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Figure 2.1. Major steps in crystallographic structure determination. Crystals were screened using
trace fluorescent labeled protein, and then were optimized. Crystals were then mounted on loop,
and X-ray diffraction data was obtained at the synchrotron. Crystal structures were then phased
and modeled to fit the electron density map, obtained from diffraction data.

Molecular replacement was performed using Phaser-MR of PHENIX suite [113]
with E. coli IPPase crystal structure (PDB: 2AU6) as the initial search model and number
of search copies as two. Space group I23 was used, instead of I213, with same unit-cell
parameters. Model obtained was rebuilt using AutoBuild and then cleaned using
Sculptor within the PHENIX suite [113]. This model was then refined using
phenix.refine and manually modeled iteratively using COOT [113, 114]. During
refinement, TLS refinement was included with automated selection of TLS groups. Due
to poor electron density, residues 98-102 were not modelled in chain B. In the end of
refinement, the crystallographic Rwork and Rfree factors converged to 18.26 % and
20.89 %, respectively. MolProbity, part of PHENIX suite, was used for structural
validation [115].
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2.5

Human IPPase

2.5.1 Design of oligonucleotides for gene synthesis
Hexa-histidine tag with thrombin cleavage sequence was designed at the
N-terminal of coding DNA sequence of cytosolic Human IPPase PPA1 (NCBI RefSeq
Accession ID: NM_021129.3). This sequence, along with 5’ and 3’ overlapping
sequences from linearized pET3a vector (linearized using restriction enzymes BamHI and
NdeI), was codon optimized for expression in E. coli using DNAWorks webserver
(Appendix A) [116]. In DNAWorks, TBIO mode was chosen with following parameters:
annealing temperature as 60 °C, oligonucleotide length as 60, oligo concentration as
1E-7 M, Na concentration as 50 mM, Mg2+ concentration as 2 mM and codon frequency
threshold as 10 %. 24 Oligonucleotides, with annealing temperatures 59-60 °C, were
synthesized by Operon (USA) on a 10nmol scale (Table 2.3). 100 μM stock solutions
and 2 μM working solutions were made using 10 mM Tris HCl pH 7.5 and stored at
-20 °C. Similarly, oligonucleotides for gene assembly were obtained for C-terminal Histagged Human IPPase (Table 2.4, Appendix A).
2.5.2 Gene assembly
SeqTBIO, a PCR-based gene synthesis method [117], was used for gene assembly
of N-terminal (Table 2.3) and C-terminal (Table 2.4) His-tagged Human IPPase . Gene
was assembled inside out in a series of 12 PCR (Polymerase Chain Reaction) reactions
using GeneAmp PCR system. The first reaction assembles oligonucleotides f1 and r1
(Table 2.3, Table 2.4), second reaction assembles this construct further using f2-r2, and
so on till the final 12th reaction. Volume of first 11 reactions was 12 μl, but was 24 μl for
the 12th reaction. PCR reaction mix included PfuUltra II Fusion HS DNA polymerase
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(Agilent Technologies, USA), its corresponding buffer obtained from manufacturer,
0.2 mM dNTP, 0.4 μM each of corresponding oligonucleotides and varying volume of
previous PCR product (1.2 μl for reactions 2 to 5, 3.0 μl for the final reaction and 1.2 μl
of double distilled water instead for the 1st reaction). Each PCR was subjected to 5 cycles
of 95 °C denaturation for 30 s, 56 °C annealing for 20 s and 72 °C extension for 15 s.
Extension time was 15 s only for first three reactions and 20 s for remaining nine
reactions. Also, the 12th reaction was carried out using 12 cycles instead of five. In the
end of each PCR, final extension was carried out at 72 °C for 60 s. Gene assembly was
verified using 1 % agarose gel electrophoresis.
2.5.3 Transformation and plasmid purification
Competent E. coli DH5α cells were prepared using rubidium chloride method
[118]. For transformation, 125 μl of E. coli DH5α competent cells were gently mixed
with 125 μl solution containing 10 μl of final PCR solution, 5 μl of linearized pET3a
plasmid and KCM buffer. This mix was incubated on ice for 20 min and then at room
temperature for 10 min. Luria-Bertani (LB) medium (500 μl) was added to this mix,
incubated at 37 °C for 1 h, plated on LB agar plates containing 100 μg/ml carbenicillin
and incubated at 37 °C for 16 h. E. coli colonies obtained were propagated in LB broth
with 100 μg/ml carbenicillin at 37 °C/225 rpm for 16 h. Plasmids were purified using
EZNA plasmid miniprep II kit (Omega Biotek) and had concentrations 80-97 ng/μl with
Abs260/Abs280 ratio ranging from 1.87-2.02. Gene insertion in these plasmids was
verified with PCR using corresponding plasmid (80-97 ng), dNTP (0.2 mM), T7
promoter and terminator primers (1 μM each), PfuUltra II Fusion HS DNA polymerase
and its buffer (Agilent Technologies, USA). PCR was performed using 25 cycles of
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95 °C denaturation for 30 s, 55 °C annealing for 20 s and 72 °C extension for 30 s. Final
extension was carried out at 72 °C for 60 s. PCR products were visualized using 1 %
agarose gel electrophoresis.

Table 2.3. Oliogonucleotides for gene synthesis of recombinant N-terminal His-tagged
Human IPPase.
No.
Oligonucleotide sequence (5’  3’)
f12 TGTTTAACTTTAAGAAGGAGATATACATATGGGCTCCTCTCACCACCACCATCACC

Length
56

f11 TCACCACCACCATCACCATTCTTCTGGTCTGGTGCCGCGTGGTTCTATGTCTGGTTTCTC

60

f10 TGGTTCTATGTCTGGTTTCTCTACCGAAGAACGTGCAGCGCCGTTCTCTCTGGAATATCG

60

f9 CCGTTCTCTCTGGAATATCGTGTTTTCCTGAAAAACGAAAAGGGTCAGTACATCTCTCCA

60

f8 GGGTCAGTACATCTCTCCATTCCACGACATCCCGATCTACGCGGACAAAGATGTCTTTCA

60

f7 GCGGACAAAGATGTCTTTCACATGGTTGTTGAAGTTCCTCGTTGGTCTAATGCGAAAATG

60

f6 CGTTGGTCTAATGCGAAAATGGAAATCGCGACCAAGGACCCGCTGAACCCGATCAAACAA

60

f5 GCTGAACCCGATCAAACAAGACGTTAAGAAAGGTAAACTGCGTTACGTTGCGAACCTGTT

60

f4 GTTACGTTGCGAACCTGTTCCCGTACAAAGGTTATATCTGGAACTACGGCGCGATCCCAC

60

f3 CGGCGCGATCCCACAAACGTGGGAAGACCCAGGTCATAATGATAAACACACCGGTTGCTG

60

f2 ATAAACACACCGGTTGCTGCGGTGACAATGACCCGATTGATGTTTGCGAGATTGGCTCTA

60

f1 GTTTGCGAGATTGGCTCTAAGGTTTGCGCGCGTGGCGAAATCATCGGTGTTAAAGTACTC

60

r1 AATCCGTCTCACCTTCGTCGATCATCGCCAGGATACCGAGTACTTTAACACCGATGATTT

60

r2 GGCCGCGTCAGGGTCGTCCACGTTGATTGCGATAACTTTCCAATCCGTCTCACCTTCGTC

60

r3 GATAGCCCGGCTTCAGGCGTTTAACATCGTTAATGTCGTTGTAGTTGGCCGCGTCAGGGT

60

r4 TCCGGAACCTTGTAGCGACGGAACCAGTCAACGGTCGCTTCGAGATAGCCCGGCTTCAGG

60

r5 CTTGAATTCCGCGTTGAACGCGAACTCGTTCTCCGGCTTGCCGTCCGGAACCTTGTAGCG

60

r6 TCGTGGGTAGATTTAATGATGTCGATGGCGAAGTCTTTATCCTTGAATTCCGCGTTGAAC

60

r7 TGCCGTTGGTTTTCTTGGTAACCAGCGCTTTCCAGTGGTCGTGGGTAGATTTAATGATGT

60

r8 ACGGGGATTCAGACAGCGTCGTGTTCATACAAGAGATACCTTTGCCGTTGGTTTTCTTGG

60

r9 AGCGCGTCAACGATCGCACGAGCCGCATCCGGGTCGCATTTGAACGGGGATTCAGACAGC

60

r10 CAACGTCCGTCGGTACAGTGCACGCAGATTCGCACGGCGGTGGCAGCGCGTCAACGATCG

60

r11 TTAGCAGCCGGATCTTAGTTTTTCTGATGATGGAACCATTTGTCAACGTCCGTCGGTACA

60

r12 CTTTCGGGCTTTGTTAGCAGCCGGATCTTAGT
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Table 2.4. Oliogonucleotides for gene synthesis of recombinant C-terminal His-tagged
Human IPPase.
No.
f12
f11
f10
f9
f8
f7
f6
f5
f4
f3
f2
f1
r1
r2
r3
r4
r5
r6
r7
r8
r9
r10
r11
r12

TGTTTAACTTTAAGAAGGAGATATACATATGAGCGGCTTCTCTACCGAAGAACGTGCG
CTCTACCGAAGAACGTGCGGCTCCGTTCTCTCTGGAATACCGTGTTTTCCTGAAAAACGA
CCGTGTTTTCCTGAAAAACGAAAAAGGCCAGTACATTTCTCCTTTCCACGACATCCCGAT
CTTTCCACGACATCCCGATCTACGCGGATAAAGACGTTTTCCACATGGTTGTTGAGGTCC
CCACATGGTTGTTGAGGTCCCGCGTTGGTCTAACGCGAAAATGGAGATCGCGACCAAGGA
GGAGATCGCGACCAAGGACCCGCTGAACCCGATCAAACAGGATGTTAAAAAGGGTAAACT
AACAGGATGTTAAAAAGGGTAAACTGCGTTACGTTGCGAACCTGTTCCCGTACAAAGGTT
CCTGTTCCCGTACAAAGGTTACATCTGGAACTACGGTGCGATCCCGCAGACCTGGGAAGA
CCGCAGACCTGGGAAGACCCTGGTCACAACGACAAGCACACCGGTTGCTGCGGTGATAAT
CGGTTGCTGCGGTGATAATGATCCAATCGACGTTTGCGAAATCGGTTCTAAAGTTTGCGC
AATCGGTTCTAAAGTTTGCGCGCGTGGTGAAATCATCGGTGTTAAGGTTCTGGGTATCCT
GTGTTAAGGTTCTGGGTATCCTGGCGATGATCGACGAAGGTGAAACGGACTGGAAAGTGA
TGTAGTTGGCCGCGTCAGGATCGTCCACGTTAATCGCAATCACTTTCCAGTCCGTTTCAC
TCCAGGTAGCCCGGTTTCAGGCGCTTAACGTCGTTAATATCGTTGTAGTTGGCCGCGTCA
CCATCAGGAACTTTATAACGGCGGAACCAGTCAACGGTCGCTTCCAGGTAGCCCGGTTTC
TAAATTCGGCGTTAAAGGCGAACTCGTTCTCCGGTTTGCCATCAGGAACTTTATAACGGC
TGGGTAGATTTAATGATGTCAATCGCGAAGTCTTTGTCCTTAAATTCGGCGTTAAAGGCG
TGGTTTTCTTCGTGACGAGCGCTTTCCAATGATCGTGGGTAGATTTAATGATGTCAATCG
TCAGACAGGGTGGTGTTCATGCAAGAGATACCTTTACCGTTGGTTTTCTTCGTGACGAGC
CGATAGCACGCGCAGCGTCCGGGTCGCATTTGAACGGGGATTCAGACAGGGTGGTGTTCA
CGGCACGGTGCAAGCAGATTCGCAAGGAGGCGGCAGCGCGTCTACGATAGCACGCGCAGC
CGGCACCAGGTTTTTTTGGTGATGGAACCACTTGTCAACGTCCGTCGGCACGGTGCAAGC
GCAGCCGGATCTTAGTGGTGATGATGGTGGTGGCTGCCACGCGGCACCAGGTTTTTTTGG
CTTTCGGGCTTTGTTAGCAGCCGGATCTTAGTGG

Length
58
60
60
60
60
60
60
60
60
60
60
60
60
60
60
60
60
60
60
60
60
60
60
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2.5.4 Small scale protein expression and gene sequencing
Purified plasmids were transformed in to competent E. coli Rosetta cells using
KCM protocol as described earlier (with 50 μl as final volume). Control reactions were
performed using native pET3a plasmid without gene insertion and another without any
plasmid added. Cells were plated on LB agar, containing 100 μg/ml carbenicillin and
35 μg/ml chloramphenicol, and incubated at 37 °C for 16 h. Colonies were obtained for
all plasmid transformation experiments.
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For each plasmid, three colonies were chosen and were tested for expression of
recombinant Human IPPase in small scale. Colonies were grown in 2 ml LB broth
containing 100 μg/ml carbenicillin and 35 μg/ml chloramphenicol in 15 ml Falcon
conical tubes (Corning) and were incubated overnight at 30 °C/230 rpm. Cells were
pelleted by spinning at 1,500 x g for 10 min (Ependorf 5810R), resupended in above
described LB medium with antibiotics and incubated at 30 °C/230 rpm. Cells were
induced at 0.6-0.8 optical density (OD600) using 1 mM isopropyl β-D-thiogalactoside
(IPTG) and incubated at same conditions for 3½ hours. Cells were then pelleted and
resuspended with lysis buffer (50 mM Tris HCl pH 7.5, 50 mM NaCl, 1 mM EDTA,
100 μg/ml lysozyme) after discarding supernatant. This mixture was incubated at 37 °C
for 10-15 min, spun at 13,000 rpm for 10-15 min (Ependorf 5417R) and supernatant was
tested for recombinant protein expression using 12 % SDS-PAGE. Competent E. coli
Rosetta transformed with native pET3a plasmid was used as control. Two samples with
recombinant plasmid or native pET3a plasmid were left uninduced with IPTG for control.
Stocks of 15 % glycerol were made for cells that showed successful expression of
recombinant Human IPPase and stored at -80 °C. Recombinant gene in plasmids were
sequenced using T7 forward and reverse primers (Operon, USA), and results were
analyzed using DNA Baser Sequence Assembler (Heracle BioSoft SRL). In order to
rectify sequence error in C-terminal his-tagged Human IPPase, oligonucleotide f12
(Table 2.4) was used as primer using QuikChange site directed mutagenesis (SDM).
Protocol for SDM is as described in ‘mutagenesis’ section.
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2.5.5 Protein expression and purification
Binding of recombinant Human IPPase (His-tagged) to nickel beads (Ni-NTA
His-bind resin, Novagen) was tested using recombinant E. coli Rosetta cells, transformed
with P2 plasmid or native pET3a plasmid without gene insert, using manufacturer‘s
instructions under native conditions.
The recombinant E. coli Rosetta cells (with plasmid P2) were cultivated in LuriaBertani (LB) broth in the presence of carbenicillin (100 µg/ml) and chloramphenicol
(35 µg/ml). Two liter culture preparations were propagated in 4 l Erlenmeyer flask
shaken at 225 rpm in a 30 ºC incubator. When the cell growth density reached an O.D.600
of 0.4-0.8, the shaker flasks were transferred to an 20 ºC shaking incubator and induced
with 0.5 mM or 1.0 mM IPTG for 16 hours. Cells were collected by centrifugation at
9,000 rpm in a JA-14 rotor in Beckman J2-21 centrifuge. The pellets were then stored in
-80 ºC until further processing.
The following steps were performed on ice or at 4 ºC. Cell pellets were
resuspended in chilled Buffer A (50 mM Tris pH 8.0, 500 mM NaCl, 5 mM imidazole) in
ratio of 10 ml per one gram wet weight of cells, and cells were disrupted by 5 cycles of
1 min sonication using Branson sonifier 250 cell disruptor (VWR Scientific). The
resulting lysate was centrifuged for 25 min at 15,000 rpm in a in a JA-20 rotor in
Beckman J2-21 centrifuge and the resulting supernatant was loaded onto a 5 ml profinity
IMAC nickel column (Bio-Rad) that had been pre-equilibrated with Buffer A. After
washing with five column volumes of Buffer A, the protein was eluted using a 0.13 –
0.38 M imidazole linear gradient in Buffer A using BioLogic LP (Bio-Rad) over five
column volumes (50 ml).
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Eluted fractions were analyzed using SDS-PAGE after heating the sample for
5 min in boiling water. Fractions that contain strong protein expression corresponding to
about 34 kDa, as revealed by SDS-PAGE, were pooled and concentrated using a 50K
Spin-X UF concentrator (Corning, USA) by spinning at 6,000 x g to reduce the volume to
1.5 ml using an Eppendorf 5810R centrifuge. The concentrated sample was then loaded
onto a 120 ml Sephacryl 200 (GE Healthcare) size exclusion column pre-equilibrated
with a Buffer C (50 mM Tris at pH 8.0, 50 mM NaCl and 1 mM EDTA). Fractions
corresponding to the major elution peak were analyzed by SDS-PAGE revealing an
abundance of protein expressed near 34 kDa molecular weight. Consequently, the
fractions were collected and concentrated using a 50K Spin-X UF concentrator (Corning,
USA).
Protein concentration was measured by Bradford assay with BSA as standard for
enzyme assay experiments, and for other experiments, it was determined using O.D.280
with a NanoDrop (Thermo Scientific) spectrophotometer, using recombinant Human
IPPase’s predicted extinction coefficient 1.540 (Abs 0.1%) [119, 120].
2.5.6 Molecular weight determination
Molecular weight of Human IPPase was determined using molecular weight
calibrated XK26/100 Superdex 75 column (GE Healthcare), at room temperature, preequilibrated with 50 mM Tris at pH 8.0, 50 mM NaCl and 1 mM EDTA.
2.5.7 Thermal shift assay
A master solution mix was made with 100 μg/ml protein, 5x sypro orange dye
(Thermo Fisher) in the presence of double distilled water or buffer (working
concentration -10 mM HEPES pH 8.0, 25 mM NaCl). 15 μl Of this mix was dispensed in
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to a 96 well PCR microplate (Axygen) at room temperature and then 5 μl of additives
(listed below) from 96 well blocks to PCR plate using a 8 or 12 multichannel pipette.
When pH was the variable under analysis, additives were 25 mM and 50 mM buffer
components in the presence of 25 mM NaCl. When salt was the variable, 50, 100 or
200 mM additives were tested in presence of 50 mM sodium acetate pH 5.0. When
divalent metal ions were the variable, 5, 10 or 50 mM metal solutions were the additives
in presence of 50 mM sodium acetate pH 5.0 and 50 mM NaCl.
The plates were sealed with sealing film (Platemax), and thermal shift assay was
conducted using Mastercycler ep gradient PCR thermal cycler (Eppendorf, Germany).
Each plate was heated from 25 °C to 95 °C in increments of 1 °C/min, and fluorescence
was measured at each step with Ex/Em: 470/580 nm. Melting temperatures were
obtained using DSF analysis, a MS Excel based scripting tool [121] and Graphpad Prism
(Graphpad).
2.5.8 Mutagenesis
Primers for site directed mutagenesis were designed, except for Trun1 and Trun2,
using QuikChange Primer Design tool (Table 2.5) [122] and synthesized by Operon
(USA). 100 μM stock solutions and 5 μM working solutions were made using 50 mM
Tris HCl pH 7.5 and stored at -20 °C.
Mutants that required mutation at only one site were obtained using Quikchange
II SDM-based protocol [123]. PCR reaction mix (50 μl volume) contained PfuUltra II
Fusion HS DNA polymerase (Agilent Technologies, USA), its corresponding buffer
obtained from manufacturer, 40 ng template pET3a plasmid containing recombinant wild
type Human IPPase gene (except for mutants ccVar1 and ccVar3 for which plasmid of
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mutant ccVar2 was used as template), 125 ng each of forward and reverse primers and
0.2 mM dNTP. PCR was carried out using initial denaturation at 95 °C for 1 min,
followed by 18 cycles of 95 °C denaturation for 30 s, 55 °C annealing for 1 min and
68 °C extension for 6 min. In the end of PCR, final extension was carried out at 68 °C
for 6 min. At the end of PCR, 20 U DpnI (New England Biolabs) was added to the mix
and incubated at 37 °C for 1 h to digest methylated and hemi-methylated DNA.
Mutated plasmids were then transformed in to competent E. coli DH5α using
KCM transformation protocol (50 μl volume with 1 μl of DpnI treated PCR mix) as
described earlier, except SOC medium was used here for recuperation instead of LB
medium. They were plated on LB agar plates containing 100 μg/ml carbenicillin and
incubated at 37 °C for 16 h. For mutagenesis control, pWhitescript control plasmid
(Agilent Technologies) with manufacturer provided primers were used and, after DpnI
treatment and transformation, they were plated on LB agar plates containing 100 μg/ml
carbenicillin, 0.1 mM IPTG and 40 μg/ml X-gal (5-bromo-4-chloro-3-indolyl-β-Dgalactopyranoside) before incubation. For negative control, distilled water was used
instead of DpnI-treated PCR mix during KCM transformation in to competent E. coli
DH5α cells.
Truncation mutants –Trun1 and Trun2 – were obtained using modified
Quikchange mutagenesis protocol described by Makarova et al. [124]. Primers were
designed using Geneious 7.1.9 (Table 2.6). PCR reaction mix (25 μl) included 97 ng
template pET3a plasmid containing recombinant Human IPPase gene and 200 nM of
appropriate primer, 0.2 mM dNTP, PfuUltra II Fusion HS DNA polymerase (Agilent
Technologies, USA) and its reaction buffer obtained from manufacturer. Two slightly

41

differing PCR protocols were followed. In the first protocol, PCR was carried out using
initial denaturation at 95 °C for 2 min, followed by 18 cycles of 95 °C denaturation for
30 s, 68 °C annealing for 1 min and 68 °C extension for 10 min. In the end of PCR, final
extension was carried out at 68 °C for 10 min. Second PCR protocol involved following
changes from the first protocol: 66 °C for annealing instead of 68 °C, 21 PCR cycles and
elimination of final extension step. This was followed by DpnI (6 U) digestion at 37 °C
for 2 h, transformation in to competent E. coli DH5α, as described earlier, plating of cells
on LB agar with 100 μg/ml carbenicillin and incubation at 37 °C for 16 h.
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Table 2.5. Primer sequences used for site-directed mutagenesis of Human IPPase.

Primer sequence (5’  3’)

Duplex energy Energy cost of
at 68°C
mismatches
(kcal/mole)
(%)

Type

K195E

f

AACTACAACGACATTAACGATGTTGAACGCCTGAAGCC

38

78.37

-46.29

0.16

r

GGCTTCAGGCGTTCAACATCGTTAATGTCGTTGTAGTT

38

78.37

-42.87

0.53

f

GACGTTGACAAATGGTTCCATCATTCTAAAAACTAAGATCCGGCTGCTAAC

51

78.46

-56.66

8.49

r

GTTAGCAGCCGGATCTTAGTTTTTAGAATGATGGAACCATTTGTCAACGTC

51

78.46

-52.79

9.68

f

ATAAAGACTTCGCCATCGACATCATTAAAGAAACCCACGACCACTGG

47

78.20

-59.21

2.33

r

CCAGTGGTCGTGGGTTTCTTTAATGATGTCGATGGCGAAGTCTTTAT

47

78.20

-55.24

2.67

f

GACCCTGACGCGGCCAAATACAACGACATTAACG

34

80.41

-50.31

4.14

r

CGTTAATGTCGTTGTATTTGGCCGCGTCAGGGTC

34

80.41

-46.92

2.99

f

CCAGGTCATAATGATAAACACCCGGAAACCGGTTGCTGCGGT

42

80.47

-44.24

29.41

r

ACCGCAGCAACCGGTTTCCGGGTGTTTATCATTATGACCTGG

42

80.47

-42.45

29.84

1f

GCTGAACCCGATCAAACAAGACACCAAGAAAGGTAAACTGCGTTACG

47

78.20

-60.16

6.72

2f

CGTTCAACGCGGAATTCAAGGATAAAAAATTCGCCATCGACAT

43

78.31

-57.76

7.94

1f

CCCGATCTACGCGGACAAAGATAACAACGTCTTTCACATGG

41

80.44

-46.69

23.39

2f

GGTTACCAAGAAAACCAACGACAAAGGTATCTCTTGTATGA

41

78.60

-49.72

8.90

f

GGACCCGCTGAACCCGATCAAACAAGACGTTGCGGCAGGTGCGCTGCGTTACGTTGCGAAC

61

79.12

-78.75

4.46

r

GTTCGCAACGTAACGCAGCGCACCTGCCGCAACGTCTTGTTTGATCGGGTTCAGCGGGTCC

61

79.12

-81.80

2.26

Q306S

S241E

Length

Tm
(°C)

Mutant

43
N187K

Mut5

Mut6

Mut7

Ser1

Mutant
Ser2

Ser3

Ser4

ccVar1

Primer sequence (5’  3’)

Type

Length

Tm
(°C)

Duplex energy Energy cost of
at 68°C
mismatches
(kcal/mole)
(%)

ATATCGTGTTTTCCTGAAAAACGCAGCGGGTCAGTACATCTCTCCATTCC

50

78.40

-53.74

3.07

r

GGAATGGAGAGATGTACTGACCCGCTGCGTTTTTCAGGAAAACACGATAT

50

78.40

-58.92

5.51

f

CACTGGAAAGCGCTGGTTACCGCGGCAACCAACGGCAAAGGTATCTC

47

78.69

-61.72

1.30

r

GAGATACCTTTGCCGTTGGTTGCCGCGGTAACCAGCGCTTTCCAGTG

47

78.69

-59.16

4.78

f

CTGGTTTCTCTACCGCAGCACGTGCAGCGCCGTT

34

78.68

-49.40

2.72

r

AACGGCGCTGCACGTGCTGCGGTAGAGAAACCAG

34

78.68

-55.33

4.97

f

GACGTGGACAAATGGTTCCACCACTCTAAAAACTAAGATCCGGCTGCTAAC

51

80.47

-40.33

40.40

r

GTTAGCAGCCGGATCTTAGTTTTTAGAGTGGTGGAACCATTTGTCCACGTC

51

80.47

-39.25

37.85

f

GACGTGGACAAATGGTTCGCTTCTGACGCGGAATCTGATGCTAGCTAAGATCCGGCTGCTAAC

63

80.47

-39.67

55.90

r

GTTAGCAGCCGGATCTTAGCTAGCATCAGATTCCGCGTCAGAAGCGAACCATTTGTCCACGTC

63

80.47

-38.59

56.85
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f

ccVar3

Table 2.6. Primer sequences for mutants Trun1 and Trun2
Mutant
Trun1

Trun2

No.

Oligonucleotide sequence (5’  3’)

Total
Length

GC
%

Primer head
Length Tm (°C)

a

GCGACCCGGATGCGGCTCGTtaagatccggctgctaacaaagc

43

60.4

20

70.7

b

GACCCGGATGCGGCTCGTtaagatccggctgctaac

36

61.1

18

66.7

a

CTACCCACGACCACTGGAAAGCGtaagatccggctgctaac

41

56.0

23

68.1

b

CCACGACCACTGGAAAGCGtaagatccggctgctaacaaagc

42

54.7

19

64.5

Mutants Mut6 and Mut7 were obtained using Quikchange lightning multi-SDM
kit (Agilent Technologies, USA) [125]. PCR reaction mix (25 μl) included 50 ng
template pET3a plasmid containing recombinant WT-Human IPPase gene and
appropriate primers (Table 2.5) in addition to kit components as per manufacturer
recommendations. PCR was carried out using initial denaturation at 95 °C for 2 min,
followed by 30 cycles of 95 °C denaturation for 20 s, 55 °C annealing for 30 s and 65 °C
extension for 3 min. In the end of PCR, final extension was carried out at 65 °C for
5 min. After DpnI digestion for 15 mins at 37 °C, they were then transformed in to
XL10-Gold ultracompetent cells using manufacturer’s recommendations, except SOC
medium was used here for recuperation instead of NZY+ medium. They were then plated
on LB agar plates containing 100 μg/ml carbenicillin and incubated at 37 °C for 16 h.
Control template plasmid and multi primer mix, provided by the manufacturer, were used
during PCR for the mutagenesis control reaction. The control reaction was transformed
in to XL10-Gold ultracompetent cells and subsequently plated on LB agar containing
100 μg/ml carbenicillin, 20 mM IPTG and 80 μg/ml X-gal.
Mutant ccVar2 was obtained using PCR-based SeqTBIO gene assembly method
[117], similar to synthesis of WT-Human IPPase gene as described earlier.
Oligonucleotide sequences used are listed in Table 2.7.
For mutant LysIns (Appendix A), oligonucleotides listed in Table 2.8 were
assembled in to a sequence using PCR-based SeqTBIO gene assembly method [117].
Then, using the assembled sequence as primer and pET3a plasmid with WT-Human
IPPase gene as template plasmid, modified QuikChange SDM described by Geiser et al.
was performed to obtain LysIns mutant [126].
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Table 2.7. Oliogonucleotides for gene synthesis of Human IPPase mutant ccVar2.
No.
f12
f11
f10
f9
f8
f7
f6
f5
f4
f3
f2
f1
r1
r2
r3
r4
r5
r6
r7
r8
r9
r10
r11
r12

Oligonucleotide sequence (5’  3’)
Length
TGTTTAACTTTAAGAAGGAGATATACATATGGGTTCTTCTCACCATCATCACCACCA
57
TCTCACCATCATCACCACCACTCTTCTGGTCTGGTACCTCGTGGCTCTATGTCTGGCTTC 60
GTGGCTCTATGTCTGGCTTCTCTACCGAAGAACGTGCAGCGCCTTTCTCTCTGGAATACC 60
CGCCTTTCTCTCTGGAATACCGTGTTTTCCTGAAAAACGAAAAAGGCCAGTACATCTCCC 60
AAAAAGGCCAGTACATCTCCCCGTTTCACGACATCCCGATCTACGCGGACAAAGATAACA 60
TCTACGCGGACAAAGATAACAACGTTTTCCACATGGTTGTTGAAGTTCCTCGTTGGTCTA 60
GTTGAAGTTCCTCGTTGGTCTAACGCAAAAATGGAAATTGCGACTAAGGACCCTCTCAAC 60
CGACTAAGGACCCTCTCAACCCGATCAAACAGGACACCAAGAAAGGTAAACTGCGTTACG 60
AAGAAAGGTAAACTGCGTTACGTTGCGAACCTGTTCCCGTACAAGGGCTACATTTGGAAC 60
GTACAAGGGCTACATTTGGAACTATGGTGCGATTCCGCAGACTTGGGAGGACCCAGGTCA 60
TGGGAGGACCCAGGTCATAATGACAAGCACCCAGAGACCGGTTGCTGCGGTGACAACGAC 60
GCTGCGGTGACAACGACCCGATTGACGTTTGCGAAATCGGTAGCAAAGTTTGTGCTCGCG 60
TCATCGCCAGGATACCCAGAACCTTAACACCGATGATTTCACCGCGAGCACAAACTTTGC 60
GTTGATCGCAATGACCTTCCAGTCGGTTTCACCTTCGTCGATCATCGCCAGGATACCCAG 60
CGTTAATATCGTTGTATTTCGCCGCGTCAGGGTCGTCTACGTTGATCGCAATGACCTTCC 60
GTCGCTTCCAGGTAACCTGGTTTCAGACGTTCAACATCGTTAATATCGTTGTATTTCGCC 60
GTTTACCGTCCGGAACTTTGTAACGACGGAACCAGTCAACGGTCGCTTCCAGGTAACCTG 60
TTGTCTTTGAATTCGGCATTGAACGCGAACTCATTTTCCGGTTTACCGTCCGGAACTTTG 60
GGTCGTGGGTCTCCTTAATGATGTCAATAGCAAACTTCTTGTCTTTGAATTCGGCATTGA 60
CCTTTATCGTTCGTCTTTTTGGTGACGAGTGCTTTCCAATGGTCGTGGGTCTCCTTAATG 60
CGGAGATTCAGACAGGGTGGTGTTCATGCAAGAGATGCCTTTATCGTTCGTCTTTTTGGT 60
GCATCCACGATGGCGCGTGCGGCGTCCGGGTCGCATTTGAACGGAGATTCAGACAGGGTG 60
CGTCGGTCGGAACGGTGCACGCAGATTCGCACGGTGGCGGCAGCGCATCCACGATGGCGC 60
CTTTCGGGCTTTGTTAGCAGCCGGATCTTAGAACCATTTGTCCACGTCGGTCGGAACGGT 60

Table 2.8. Oliogonucleotides for gene synthesis (partial) of Human IPPase mutant LysIns.
No.
f7
f6
f5
f4
f3
f2
f1
r1
r2
r3
r4
r5
r6
r7

Length
Oligonucleotide sequence (5’  3’)
CTGGTCTGGTGCCGCGTGG
19
TCTGGTGCCGCGTGGTTCTAACATCTTCGAAATGCTGCGTATCGACGAAGGTCTGCGTCT
60
CGACGAAGGTCTGCGTCTGAAAATCTACAAAGACACCGAAGGTTACTACACCATCGGTAT
60
GAAGGTTACTACACCATCGGTATCGGTCACCTGCTGACCAAATCTCCGTCTCTGAACGCG
60
TCTCCGTCTCTGAACGCGGCGAAGTCTGAACTGGACAAAGCGATCGGTCGTAACACCAAT
60
CGATCGGTCGTAACACCAATGGTGTCATCACCAAAGACGAAGCGGAAAAACTGTTCAACC
60
AAGCGGAAAAACTGTTCAACCAGGACGTTGACGCAGCCGTTCGTGGTATCCTGCGTAACG
60
ACGAACCGCGTCCAGAGAGTCGTAGACCGGTTTCAGTTTGGCGTTACGCAGGATACCACG
60
CGGTCTCACCCATCTGGAAAACCATGTTGATCAGGGCCGCACGACGAACCGCGTCCAGAG
60
TCTGTTGCAGCATACGGAGGGAGTTGGTGAAACCCGCAACGCCGGTCTCACCCATCTGGA
60
ACGAGATTTCGCCAGGTTAACGGCAGCCTCGTCCCAACGTTTCTGTTGCAGCATACGGAG
60
TGATAACACGTTTTGCACGGTTCGGGGTTTGGTTGTACCAACGAGATTTCGCCAGGTTAA
60
CCAGACATATACGCGTCCCAGGTGCCGGTACGGAAGGTGGTGATAACACGTTTTGCACGG
60
TCTTCGGTAGAGAAACCAGACATATACGCGTCCC
34
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2.5.9 Plasmid purification, sequencing and transformation for mutants
Mutant plasmids (except Trun1 and Trun2) were transformed into competent
E. coli DH5α cells. Plasmid purification was carried out from 3-7 colonies of
transformed E. coli using the EZNA plasmid miniprep II kit (Omega Biotek). These
plasmids had concentration typically around 100 ng/μl with Abs260/Abs280 ratio typically
around 1.95.
Colony PCR was performed on selected Trun1 and Trun2 transformed colonies
using PfuUltra II Fusion HS DNA polymerase (Agilent Technologies, USA) and then
evaluated using 0.8 % agarose gel electrophoresis. For colonies that yielded appropriate
band (Trun1 – 1 for primer a and 2 for primer b; Trun2 – 1 for primer a and 3 for primer
b), plasmids were purified as described earlier.
Sequencing was performed (Operon, USA) with primers Pr-a (5’CATCGGTGATGTCGGCGATA-3’), Pr-b (5’-AGTTCCTCCTTTCAGCAAAA-3’), Prc (5’-TGATAAACACACCGGTTG-3’) and Pr-d (5’-TCAGGGTCGTCCACGTTGAT 3’), except for Trun1 and Trun2 for which T7 promoter and terminator primers were
used. Primers Pr-a-d were designed using Geneious 7.1.9 [127] in order to obtain better
sequencing coverage than that accomplished with T7 primers. Primers Pr-a and Pr-c
correspond to the forward strand of plasmid and Pr-b and Pr-d correspond to the reverse
strand. Sequencing results were analyzed using DNA Baser Sequence Assembler
(Heracle BioSoft SRL).
2.5.10

Small scale expression and purification of mutants

For each mutant, 2-3 plasmids containing appropriate mutation were transformed
in to competent E. coli Rosetta cells, and their small-scale protein expression was
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analyzed, as described previously for wild type Human IPPase. Human IPPase mutants
were purified using the same protocol as WT-Human IPPase.
2.5.11

Crystallization screening

Commercial sparse matrix screens such as Crystal Screen HT and Index HT
(Hampton Research) were used for crystallization screening. Protein solutions were
usually freshly prepared or from storage at 4 °C, at concentrations ranging from 8 mg/ml
to 18 mg/ml. Purified protein were substantially pure from nucleic acids, as
demonstrated by Abs280/Abs260 routinely determined in the range of 1.75-1.88. Screening
was carried out with unlabeled as well as trace fluorescent labeled (with
carboxyrhodamine-succinimidyl ester. excitation: 528 nm and emission: 551 nm) [111].
Additives 3-10 mM sodium pyrophosphate or sodium phosphate may or may not be
added. Similarly, other additives, if any, were added to protein solution before setting up
the plates.
CrystalEX second generation 96-well plates with 3 protein wells were used for
screening by sitting drop vapor diffusion. A volume of 40 μl precipitant was added to
each reservoir. A range of 0.6 μl-1.6 μl of protein solution was mixed with the reservoir
solution in ratios of 1:1, 2:1 and 4:1. The plates were setup using Nanodrop II
(Innovadyne) or manually using multichannel pipette at room temperature or at 4 °C cold
room. These plates were incubated primarily at 10 °C and also routinely at 18 °C, 14 °C
and room temperature. For random microseed matrix screening, microseed stock was
prepared using seed bead (Hampton Research) as described by Stewart et al. [128].
Optimization were carried out for potential hits using both sitting drop vapor diffusion
method and capillary counter-diffusion method [129]. For the latter, 0.1-0.2 mm ID
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capillaries were setup with 8-30 mg/ml protein, and open end of those capillaries were
introduced to 1.5 ml microcentrifuge tube containing precipitant. This capillary setup
was incubated at temperatures mentioned earlier. Drops were imaged using CrystalX2
plate reader (iXpressGenes, USA) or viewed using a standard microscope.
Furthermore, 1,536 microbatch-under-oil crystallization screening experiments
were performed at high-throughput crystallization screening lab (Hauptman-Woodward)
using fluorescent labeled as well as unlabeled protein sample at concentration of 10
mg/ml. The Silver Bullets screen (Hampton Research) was also used for further
crystallization screening.

2.6

Tt-IPPase

2.6.1

Protein expression and purification
Plasmid pET3a containing the Tt-IPPase gene [67] was transformed in to E. coli

Rosetta2 (EMD Biosciences, USA). The recombinant E. coli cells were cultivated in
Luria-Bertani (LB) broth in the presence of carbenicillin (100 µg/ml) and
chloramphenicol (35 µg/ml). One liter culture preparations were propagated in 2.8 l
Fernbach flasks shaken at 250 rpm in a 37 ºC incubator. When the cell growth density
reached an O.D.600 of approximately 0.6, the shaker flasks were transferred to an 18 ºC
shaking incubator and induced with 1 mM isopropyl thio-β-D-galactoside (IPTG) for
16 hours. Thereafter, the cells were collected by centrifugation at 6000 rpm for 20 min
using a FiberLite F9S-4x1000y rotor in a Sorvall RC-6 Plus centrifuge (Thermo
Scientific, USA). The pellets were then stored in -80 ºC until further processing.
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The following steps were performed on ice or at 4 ºC. Cell pellets (~10 grams
wet weight) were resuspended in 100 ml of chilled Buffer A (50 mM Tris pH 7.8, 50 mM
NaCl, 0.5 mM EDTA) and sheared with an EmulsiFlex-C3 homogenizer at 15,000 psi
(Avestin, Canada). The resulting lysate was centrifuged for 20 min at 17,000 rpm in a
FiberLite F21S-8x50y rotor and the supernatant was heated for 30 min in an Erlenmeyer
flask submersed in a 75 ºC water bath. Denatured protein was removed via centrifugation
at 17,000 rpm for 20 min in a FiberLite F21S-8x50y rotor and the resulting supernatant
was loaded onto a 60 ml Q Sepharose HP anion exchange column (GE Healthcare, USA)
that had been pre-equilibrated with Buffer A at room temperature. After washing with
two column volumes of Buffer A, the protein was eluted using a 0.05 – 1.0 M NaCl linear
gradient in Buffer A using an ÄKTApurifier UPC 100 (GE Healthcare, USA) over ten
column volumes (600 ml).
Eluted fractions from the anion chromatographic separation were analyzed by
SDS-PAGE. Fractions that contain strong protein expression corresponding to about
20 kDa as revealed by SDS-PAGE were pooled and concentrated using a 50K Spin-X UF
concentrator (Corning, USA) and centrifuged at 4,000g to reduce the volume to 1.5 ml.
Consequently, the partially purified sample was loaded onto a HiLoad 16/60 Superdex
200 size exclusion column (GE Healthcare) pre-equilibrated with Buffer C (50 mM Tris
at pH 7.8 and 50 mM NaCl) at room temperature. Fractions corresponding to the major
elution peak were analyzed by SDS-PAGE revealing an abundance of protein expressed
near 20 kDa molecular weight. Consequently, the fractions were collected and
concentrated using a 50K Spin-X UF concentrator (Corning, USA) to 30 mg/ml as
determined by Bradford analysis [130].
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2.6.2 Molecular weight determination
Molecular weight of Tt-IPPase was determined using gel filtration markers kit –
12 to 200 kDa (Sigma-Aldrich) as per manufacturer’s instructions. Molecular weight
marker proteins and Tt-IPPase, with Buffer C as the solvent, were loaded separately onto
a HiLoad 16/60 Superdex 200 size exclusion column (GE Healthcare), pre-equilibrated
with Buffer C at room temperature. Void volume was calculated using blue dextran.
2.6.3 pH measurement of Tris as a function of temperature
A 100 ml PYREX glass round bottle (Corning, USA) containing 100 ml of
50 mM Tris at pH 9.0 (pH measured at 21 ºC) was loosely closed with screw-cap
containing 12 mm pH probe insertion fitting (Corning, USA), and pH electrode (VWR,
USA) was inserted. Another bottle with similar setup was used where temperature probe
(VWR, USA) was used instead of pH probe. Both bottles were incubated in a water bath,
and after equilibrating to the intended temperature for at least 5 min, pH was noted.
Experiment was repeated with fresh buffer solution for measurement at each desired
temperature. Loss of solution through evaporation was found to be negligible.
2.6.4 Enzyme activity assay
Tt-IPPase catalytic activity was measured for its ability to hydrolyze inorganic
pyrophosphate (PPi) to orthophosphate (Pi) at temperatures 25 °C to 95 °C and pH 8.0.
The pH of Tris buffers used were chosen based on in-house experiments, as described
earlier, to maintain a pH 8.0 at intended temperatures. The enzyme reaction mixture
(1 ml) comprised of 34.3 mM Tris HCl pH 8.0, 1.5 mM MgCl, 1.5 mM sodium
pyrophosphate and 9.75 ng of purified Tt-IPPase (quantified using Bradford assay with
BSA as standard [119]). Prior to addition of enzyme, this reaction mixture was preheated
51

at the intended temperature in a 1.5 ml microcentrifuge tube for two min in a water bath.
Each reaction was initiated by adding the enzyme and then incubated at the specified
temperature for 10 min. The reaction was then arrested by adding 125 µl of this reaction
mixture in to 625 µL of Tausky-Shorr reagent (1 % ammonium heptamolybdate (w/v),
2.7 % sulfuric acid (v/v), 5 % iron (II) sulfate (w/v)) and 500 µL of distilled water at
room temperature. After 5 min, the absorbance of the phosphomolybdate complex was
measured at 660 nm. The amount of phosphate liberated by the enzyme was determined
using potassium dihydrogen phosphate as standard [131]. The specific activity was
defined as the micromoles of phosphate produced per milligram of IPPase per minute.
For Tt-IPPase assay against a wide range of pH (5 to 9) at 85 °C in presence of
MgCl, the buffer’s pH was adjusted for pH drift due to change in temperature using
temperature coefficient as follows: ΔpKa/°C = -0.017 for Bis-Tris, -0.015 for AMPSO
and -0.032 for CAPS [132]. In case of Tris, the pH drift was measured directly and the
pH for assay was selected accordingly. Tt-IPPase was also assayed to determine optimal
divalent metal cations in the presence of Tris pH 7.5 (pH 8.75 at 21 °C) at 85 °C.
2.6.5 Dynamic light scattering (DLS)
Dynamic light scattering (DLS) was performed at 25 °C using DynaPro NanoStar
instrument (Wyatt) with disposable cuvettes. The protein concentration used for each
measurement was 1 mg/ml.
2.6.6 Hydrogen exchange
Labile hydrogen atoms were exchanged for deuterium by taking the concentrated
purified protein (~30mg/ml) and mixing with 9 volumes of pure D2O (99.8% D,
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Cambridge Isotope Laboratories, USA) in the presence of 10 mM NaCl. The resulting
resuspension was concentrated as previously described using a 50K cut-off Spin-X UF
concentrator (Corning, USA) until the original protein concentration was achieved. After
repeating this process twice, protein was lyophilized using Labconco FreeZone
lyophilizer and then stored at -80 ºC. Prior to neutron scattering analysis, this was
lyophilized, again, overnight and dried Tt-IPPase powder was hydrated isopiestically at
25 ºC by exposing it to D2O vapor in a closed chamber while monitoring the hydration
level by thermogravimetric analysis and confirmed by weight measurement of absorbed
D2O using an analytical scale. The final hydration level was determined to be 0.37 g of
D2O per gram of protein (h = 0.37) corresponding to almost an approximate monolayer of
heavy water covering the protein surface[133].
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Chapter 3

RESULTS AND DISCUSSION

3.1

ResCon – Software Development of ResCon and its Features
ResCon is an open source, user-friendly, cross-OS platform GUI software suite

developed in Python. It enables extraction of intended family of homologous sequences
from a large dataset containing multiple families of proteins or genes, and then analyzes
conservation of residues only at positions of interest in those sequences based on their
multiple sequence alignment (MSA). In addition, if such a dataset has been retrieved
from NCBI database, taxonomy information can be directly associated with the above
analysis.
3.1.1

Source Code and Software Availability
ResCon is freely available as open source software under GNU Lesser General

Public License (LGPL). ResCon’s repository is hosted on GitHub at
https://github.com/ManavalanG/ResCon. Source code and installer or executable are
available for all OS platforms – Windows, OS X and Ubuntu (Linux). Directions to use
them for each OS platform are described below.
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3.1.1.1 Running ResCon from Python script
To use ResCon from its Python script through a terminal in any operating system,
the following needs to be installed properly: Python 2.7.x where x≥6, BioPython library
(≥ v1.63) and optionally module natsort (≥ v4.0.4). ResCon’s Python script and folder
‘Rescon_Files’, which has dependent files of ResCon including its settings file, must be
stored in the same directory. Then ResCon can be initiated by simple command:
python ResCon.py
As appearance of Tcl/Tk widgets vary in different OSs, ResCon’s GUI appears
differently in each OS (Figure 3.1).
3.1.1.2 Installation instructions
Standalone, easy to use executables or installers for ResCon are made available
for use in all operating systems – Windows, OS X and Linux (Ubuntu). These files are
available at
www.github.com/ManavalanG/ResCon/tree/master/Executables_and_Previous_versions.
Installation procedures vary by OS used and are described below.
Windows OS
Installer file is available for Windows OS (tested with versions XP, Vista, 7, 8
and 10). It is recommended install these files in to default location of ‘C:/Program Files’
but it can be installed at any location of user’s choice. Administrator privileges may be
required for this installation. In rare cases, following issues may arise:
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A.

B.

C.

D.

Figure 3.1. GUI appearance of ResCon in different OSs. ResCon’s Mismatch Analyzer tool is
visualized in operating systems - OS X (A), Windows 10 (B) and Ubuntu 14 (C). ResCon’s logo
(D) was designed under the principle of mismatches present in left arm and only matches in the
right arm.
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Microsoft Visual C++ 2008 redistributable package is required to install
and use ResCon. Most Windows OS computers would have this package
already installed but if it is not, it could be obtained from
http://www.microsoft.com/en-us/download/details.aspx?id=29.



Tcl/Tk is required to use ResCon, and most Windows OS computers
would have it already installed. If not, it could be obtained from
http://www.activestate.com/activetcl/downloads.

OS X (Mac)
Packaged application for ResCon is available for OS X in zipped format (tested in
versions 10.9 – 10.11). It is recommended to unzip this file and then move ‘ResCon.app’
file in to Applications folder but it can be moved to any location of user’s choice. One
may get error ‘ResCon can’t be opened because it is from an unidentified developer’
when opening this application, and this could be resolved by right clicking the application
and choosing “Open” from the menu.
Troubleshooting


ResCon may start minimized in certain versions of OS X. In such case, it could
be opened simply by double-clicking ResCon’s icon at the dock.



If ResCon raises error ‘Clustal omega is not installed on your Mac’ even when
Clustal Omega is properly installed, then ResCon needs to be opened from
terminal to enable proper communication between Clustal Omega and ResCon.
Open a terminal window, type open and after a space character, insert the
complete file path of ResCon application (or drag and drop ResCon application
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into terminal after typing ‘open ’). For example, if application is located inside
Applications folder, then the command is
open ~/Applications/ResCon.app
Ubuntu (Linux) OS:
User friendly executable application is available for ResCon to use in Ubuntu OS
(tested in version 14.04) but an installer is not available at the moment. This executable
application is provided as a zipped file from which contents can be extracted to location
of user’s choice. Double clicking file called ‘ResCon’ in the extracted folder would open
the application.
3.1.1.3 Demo files
Sample files are provided with ResCon in a folder called ‘Demo files’ to practice
its tools. Along with sample files for input to each tool of ResCon, sample output files
are also provided in a folder called ‘Sample_Output’. Input parameters used to obtain
these output files are stored in a file called ‘INPUT_PARAMETERS.txt’ in above folder.
3.1.2

Logging
When running any application, logging is useful to keep track of input - including

files and parameters used- provided to that application, progress during its execution and
errors that may arise when requirements for proper input are not met or other unexpected
issues. ResCon utilizes Python’s logging module to write a log file for each session.
Here, a ‘session’ refers to the tasks executed between initiation of ResCon and its
termination, and a ‘job’ refers to a task executed once using one of ResCon’s seven tools.
When ResCon initiates, it writes an empty master log file called ‘Logs_ResCon.txt’. This
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master log file would save logs for each job executed during the session, and logs of each
job are separated by two empty lines (Figure 3.2). In the end of each job, a copy of this
master log file is written in to output folder selected for the job. This means that the
output folder selected for a job would always have a log file called ‘log.txt’ along with
output files from that job. So, logs for a particular job correspond to the last block of logs
in this log file.

Figure 3.2. An example log file. Blocks A, B and C refer to separate jobs executed by ResCon in
a session with block C as the most recent job. Two empty lines separate logs for each job.

59

ResCon logs time, date and name of the tool executed, in addition to execution
progress, warning or any error that may arise. Each log in log file is associated with tag
INFO, WARNING or ERROR, and thereby informing its status (Figure 3.2). These log
files can also be used to quickly figure out the input files and parameters provided to a
tool for a particular job.
In cases where ResCon terminates the job due to unexpected errors, a log file may
not get written in to output folder selected for the job. However, the master log file stores
logs and errors in such circumstances. This master log file can be easily accessed
through File menu from ResCon’s main GUI window. The location where this master
log file is saved varies depending on the operating system. In Windows, it is saved at
‘C:\Temp’ but if the computer does not have C:, it will be saved in folder ‘Temp’ in one
of the other drives. In OS X and Linux OS, it gets saved where ResCon’s Python source
file is located. If run using executable in OS X, it can be accessed by right clicking on
the ResCon app, choosing ‘show package contents and navigating to
‘Contents\Resources\’. In Ubuntu or other Linux OS, it will be found in the same
directory where ResCon’s source script or executable file is located.
3.1.3

User Editable Parameters
In addition to parameters that are allowed be chosen or modified in a GUI

window of each tool, ResCon allows several parameters for certain tools to be modified
either only for the session in progress or permanently for use with all future sessions.
Parameters that can be modified by either of the above methods are listed in later part of
this chapter under description of each ResCon tool. A ‘session’ refers to the tasks
executed between initiation of ResCon and its termination. When changes need to be
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made only for the session in progress, they can be modified easily through ‘Edit settings’
GUI window (Figure 3.3) available from ResCon’s File menu.
In cases where modifications are required to be made permanently for all future
sessions, ResCon allows making changes in default parameter values by editing a source
settings file called ‘Settings_ResCon.txt’. This is a structured text file where user could
easily modify the default parameters using any text editor. Each modifiable parameter in
this file is associated with corresponding variable used in ResCon’s source script, its
description, default values and available options, if any.

Figure 3.3. Windows to edit default preferences in ResCon. Changes made here are applicable
only for the session in progress. Blue text at bottom of the window provides direct access to
ResCon’s source settings file to which any changes made are permanent for all future sessions.
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This file can be opened easily from the bottom of ‘Edit settings’ GUI window
(Figure 3.3). This settings file is located in a folder called ‘Rescon_Files’. Location of
this folder varies by OS used and is described below:
1. In any OS, if ResCon is run from its Python script, this folder would be at the
same location as ResCon’s source Python Script.
2. If ResCon was installed in Windows OS, this folder can be located at the
installation location. For example, if installed in typical destination, it can be
found at ‘C:\Program Files (x86)\ResCon’.
3. If executable ResCon application is used in OS X (Mac), this folder can be
accessed by right clicking the ResCon app (stored typically in Applications
folder), choosing ‘show package contents’ and then navigating to
‘Contents\Resources\’.
4. If executable ResCon application is used in Linux OS (Ubuntu), this folder is
located at the same folder where ResCon’s executable file is stored.
3.1.4

ResCon’s tools and features
ResCon contains seven independent tools:
1. Mismatch Analyzer
2. Subtree Sequences Extractor
3. GenPept/GenBank to FASTA Converter
4. Filter BLAST by Bit or E-value
5. Filter FASTA by Sequence’s ID
6. Filter FASTA by Sequences’ Description
7. FASTA Description / ID Extractor
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These tools can be used independently or in tandem as needed. Here, uses and
features of these tools are discussed, and then a pipeline is presented to study large
dataset of sequences for residue conservation using ResCon’s tools.
3.1.4.1 Mismatch Analyzer
This tool analyzes conservation of residues only at query sites corresponding to a
reference sequence in MSA (Figure 3.4). Input for this tool can be either a preconstructed MSA or sequences in fasta format, which will then be used to construct
MSA. In the latter case, ResCon uses Clustal Omega to construct MSA either locally in
the computer if installed or through Internet using EMBL-EBI’s web server [97, 99, 100,
105]. A reference sequence in fasta format and residue positions under testing should
also be provided as input. Three scoring methodologies with two of them based on Liu08
scoring are offered to analyze conservation of residues at the query sites.
Input Parameters
Mode:
Two modes are available: Protein mode and DNA/RNA mode. The difference
between the two modes is that in protein mode, similar residues are identified using
reduced amino acid alphabet grouping set (described in Conservation scoring section
below) and highlighted in color differently in output HTML (and used for conservation
score analysis if ‘amino acid grouping’ method is used). Such similarity analysis is
ignored, and conservation scores are not calculated in DNA/RNA mode.

63

Figure 3.4. ResCon’s Mismatch Analyzer tool. Visualized in OS X 10.11 (El Capitan).

Sequences file:
This must be a FASTA file with sequences that need to be analyzed for residue
conservation. All sequences must have ID but description is optional. Sequences file
may or may not have the reference sequence included in it. If the reference sequence is
included in it, its sequence and ID must be identical to the sequence provided in
‘Reference file’. If IDs match but not the sequence, then ResCon will throw a warning in
pop-up window. Number of sequences allowed is not restricted when Clustal Omega
MSA is performed locally, but it is restricted to 2000 sequences including the reference
sequence when EMBL web-server is used to compute Clustal Omega MSA.
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Reference file:
This file requires reference sequence in FASTA format. Only one sequence is
allowed in this file. It must have an ID but description is optional.
Output folder:
This shows where output files will be saved. By default, ResCon will select to
save output files in to a folder called ‘Output’ where ‘Sequences file’ is located.
However it can be changed to any folder where user has privileges to write files.
Residue positions:
This field will have query residue positions, based on the reference sequence, of
user’s interest for which residue conservation analysis will be performed among the
sequences using MSA. They must be integers, and multiple integers should be separated
by comma or tab character. Space character is allowed but not as delimiter. Allowed
integer numbers ranges from 1 to the length of reference sequence. Checkbox ‘All’ can
be used to analyze all residues of the reference sequence.
Clustal Alignment required? – Checkbox:
Status of this checkbox determines whether a MSA needs to be constructed using
Clustal Omega, or a pre-constructed MSA needs to be provided as input for mismatch
analysis by this tool.
a. If checkbox is not selected:
In this case, ‘Sequences file’ field gets disabled and field called ‘Alignment File’
gets activated. In the latter field, a pre-constructed MSA must be provided as input in
any of the following formats: fasta, aln (clu or clustal), nexus, phylip4, ig and stockholm.
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Reference sequence must be a part of this MSA, and its ID and sequence must match to
that of corresponding sequence in MSA. If they do not match or if reference sequence is
not part of MSA, ResCon will raise a pop-up error message.
b. If checkbox is selected:
In this case, test sequences and reference sequence must be provided as input in
FASTA format and ResCon will utilize Clustal Omega to construct MSA before
performing mismatch analysis. ResCon allows utilizing Clustal Omega either locally in
user’s computer or through a webserver via Internet. In the former case, Clustal Omega
needs to be installed in user’s computer and its environmental variables properly set up
[105]. In the latter case, Internet access is required as ResCon interacts with EMBLEBI's Clustal Omega webserver to obtain MSA [99, 100]. While number of sequences is
not restricted to utilize Clustal Omega in local mode, 2,000 is the maximum number of
sequences allowed in webserver mode due to EMBL-EBI’s restrictions. In either mode,
parameters for Clustal Omega can be modified to fit user needs but their method of entry
varies as is described below.
Local Clustal Omega mode:
Clustal Omega installed locally is a command line program to which
parameters can be passed as required for data analysis. By default, ResCon uses
following command:
{'outfmt': 'fasta', 'iterations': 3, 'force': True, 'guidetree_out': 'default.newick'}
This default command can be modified as needed but such modifications
must meet the following rules as it should be in Python’s dictionary format:
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1. Command must open and close with curly braces.
2. Parameter and its value must be separated by a colon.
3. Each set of parameter and value must be separated by a comma.
4. Each parameter and its value, separately, must be quoted with single or
double quotation unless the value is an integer, or is a Boolean (i.e. True or
False). For example, in the default command above, all parameters and
values are, separately, in single quotes except the values 3 and True.
All parameters available for Clustal Omega through terminal, their corresponding
parameters for ResCon, their function and allowed values are listed in Table B.1
of Appendix B. However, parameters infile and outfile are not allowed in
ResCon because these parameters are defined by ResCon itself depending on the
input file and output folder provided.
Webserver mode:
EMBL-EBI’s Clustal Omega webserver is utilized in this mode to obtain
MSA for input sequences. The default command used here is:
--email your_email@here.com --iterations 3
The ‘--email’ parameter is always required as EMBL-EBI requires them to
use their web services. Value for the email parameter in the default command, i.e.
‘your_email@here.com’, must be replaced by user’s valid email id. This
command can be modified as needed. Table B.2 in Appendix B lists all the
parameters, along with their example usage, that could be used to execute Clustal
Omega in webserver mode. For proper usage, parameters must have two hyphens
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in their front, and parameter and its value must have a space between them. Use
of single or double quotes for parameters or value is not required unless they have
space character.
Conservation scoring methods
ResCon offers three scoring methodologies to calculate conservation of residues
at the query sites. The first method involves simple amino acid grouping by their
properties, and both second and third methods are based on Liu08 conservation scoring
methodology [91]. In all three methods, conservation score is presented as percentage
score (ranging from 0 % to 100 %).
a. Amino Acid Grouping
Twenty amino acids can be grouped into few sets or groups depending on their
traits such as their chemical properties or their properties within proteins such as contact
potential, etc. Several such grouped sets are reported in literature [134]. ResCon by
default uses amino acid sets - AVFPMILW, DE, RK, STYHCNGQ – that are grouped on
the basis of physiochemical properties of amino acids [99]. In this method, if amino
acids are in same set, they are considered similar or else they are considered dissimilar.
For example, amino acids Leu and Ile are similar whereas Leu and Tyr are dissimilar. If
similar, conservation score is calculated as if they are identical. For instance, if A is the
residue in reference sequence at query site, score for residues ‘AFPIW’ at that column is
100% whereas for ‘AFPDR’, it is 60%.
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b. Liu08 Non-Sequence-Weighted
Liu08 scoring methodology utilizes Similarity substitution matrix S to account for
physiochemistries of amino acids, and gaps are given similarity score of zero [91].
ResCon instead utilizes modified form of Liu08 Similarity matrix S called ‘Similarity
matrix SM’ (Figure A.1). In addition to similarity scores used for standard amino acids in
matrix S, ResCon’s modified matrix SM also contains non-standard amino acids
(B,J,O,U,X,Z) and gap, and they are given similarity score of zero.
ResCon calculates Liu08 non-sequence-weighted conservation score
(ݑ݅ܮ08_ܹܰܵ  ) using equation (1.1) but utilizes matrix SM instead of Similarity matrix S.
That is,
ݑ݅ܮ08_ܹܰܵ



=

ଶ

ୀଵ

݂൫ܽܽ ൯ . ܵܯ൫ܽܽ , ܽܽ ൯

(1.4)

Equation (1.1) is used to calculate Liu08 non-sequence-weighted conservation
score (ݑ݅ܮ08_ܹܰܵ  ). In this case, frequency of amino acids and similarity score from
modified Liu08 Similarity matrix SM are considered but sequence weighting is not
factored. This method is recommended when Liu08 scoring is desired but sequences in
MSA have significantly different sequence lengths as these differences result in
artifactual lower scores.
c. Liu08 sequence-weighted
This method is recommended when Liu08 scoring is desired and sequences in
MSA do not differ significantly in their sequence lengths. Equation (1.3), which is used
to calculate Liu08 sequence-weighted conservation score (ݑ݅ܮ08_ܹܵ  ), is implemented
in ResCon as in equation (1.4) as it simplifies the calculation process:
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ݑ݅ܮ08_ܹܵ  = 



ܹ௦ . ܵܯ൫ܽܽ , ܽܽ௦ ൯

௦ୀଵ

(1.5)

where
 ݈ is the length of column ݇ or number of sequences in the MSA

 ܹ௦ is sequence weight of sequence ݏ

 ܽܽ௦ is the amino acid type at column ݇ in sequence ݏ

 ܽܽ is the amino acid with highest frequency at column k such that ݂൫ܽܽ ൯ =
max (݂(ܽܽ ሻሻ

ୀଵ..ଶ

 ܵܯ൫ܽܽ , ܽܽ௦ ൯ is the similarity score from modified Liu08 Similarity matrix SM
Include reference sequence:
This provides an option to include or exclude a reference sequence for calculation
of % Identity and % conservation scores. If chosen not to, it is important to understand
this caveat – in cases where residues at a query position are identical in all sequences
except in the reference sequence, ResCon will report it as completely conserved as
reference sequence is not included in such calculation.
Output
In addition to a log file, a HTML5 file and a CSV file are written as output. If
Clustal Omega alignment was requested, a MSA file and a phylogenetic tree file in
Newick format are also written.
1. HTML5 file
This file can be read using any HTML5 compatible web browser - for example,
Firefox, Chrome, etc. - on all OS platforms including mobile (smartphone) platforms.
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Mismatch analyses results are visualized in this output. Besides brief summary of results
at the top and information on parameters used at bottom of this page, it has three major
sections as shown in Figure 3.5.
First section has a bar chart and a table showing % Identity and % Conservation
scores belonging to only the query sites. In DNA/RNA mode, conservation scores are
not calculated. Second section color-codes the reference sequence at query sites with
colors representing conservation scores in 10 % increments. Third section has MSA with
residues at query sites and IDs color-coded. Amino acid grouping set is used to identify
whether residues in test sequences are matching or mismatching in comparison to residue
of reference sequence. By default, ResCon uses the set [AVFPMILW, DE, RK,
STYHCNGQ]. For example, if reference sequence’s residue is D at a column x in MSA,
presence of residue D in test sequence at this column is considered as a matching residue
(highlighted in green), residue E is a mismatch but similar residue (yellow) and residue K
is a mismatch and dissimilar residue (pink). If DNA/RNA mode was used, residues are
identified only as either matching or mismatching residues, and are highlighted in green
and pink respectively.
In addition to highlighting residues at query sites, sequence IDs are also
highlighted. Reference sequence’s ID gets highlighted in cyan and for test sequences,
first two letters of their IDs are highlighted in green, yellow or pink. Green represents
that the test sequence has matching residues at all of the query sites. Yellow represents
that test sequence has mismatching residues present in at least one of the query sites but
they are only similar and not dissimilar. Pink represents a test sequence has at least one
residue at the query sites that is mismatching and dissimilar.
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Figure 3.5. HTML output of Mismatch analyzer. Sequence ‘Ex4|Bacteria|Escherichia’ is the
reference sequence and conservation of residues 3, 10, 41 and 55 of reference sequence were
investigated. Conservation scoring method used and the status of inclusion of reference sequence
in the calculation are shown at the bottom of the figure. Data in blocks 1–3 are described in text.
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Figure 3.6. CSV output of Mismatch analyzer. Sequence records with (1) and without (3)
mismatches at the sites under investigation are separated and sequence IDs are divided into multiple
fields with pipe symbol delimiter. Residues and their fraction along with identity and conservation
score at each site of analysis are presented (2). Conservation score is calculated using Liu08 nonsequence weighted method, and reference sequence is included for calculations.

2. CSV Output
This file can be conveniently viewed using any spreadsheet software - for
example, Microsoft Excel. It contains detailed descriptions on conservation of residues at
every query site (Figure 3.6). Sequence records are divided on the basis of the presence
or absence of mismatches on at least one of the query residue positions. This includes a
section that shows each unique residue present at the query sites along with % identity
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and % conservation score at those sites. If sequence identifiers (ID) contain multiple
fields connected by a delimiter, which is a pipe symbol ‘|’ by default, those fields are
disjoined when written in to the CSV file. This enables later sorting of those fields as
needed in the spreadsheet software. This sorting feature is used to a great extent in the
research reported in this dissertation as part of data analysis where sequence IDs contain
multiple taxonomic ranks in them and hence if there is a trend in the results, it can be
easily observed.
Editable parameters
Besides the parameters that could be modified as described in section 3.1.3,
ResCon allows parameters below to be modified either for a session (marked with *) or
permanently. See section 3.1.3 for instructions.


Colors used for highlighting matching and mismatching IDs or residues in html
output file.*



Delimiter used in FASTA IDs to separate fields in CSV output file.*



Amino acid similarity set to identify matching and mismatching residues, also for
‘Amino acid grouping’ conservation scoring method.*



Color codes to rank conservation of residues in reference sequence in HTML
output file.



Default option to include or exclude reference sequence in %Identity and
%residue conservation analysis.



Default method to calculate conservation score.



Default Clustal Omega command (local or via web-server) used.



Default method to draw bar chart in HTML output file
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3.1.4.2 Subtree Sequences Extractor
Phylogenetic tree analysis is widely used to determine evolutionary relationship
among a group of sequences. When large number of sequences (several thousands, for
example) are used to construct a phylogenetic tree, it may be useful at times to extract
and analyze sequences that are part of a particular clade (subtree) in that tree. This is
particularly necessary when multiple families of proteins are part of data used in
phylogenetic tree, and each family must be separated for any useful further analysis.
ResCon’s ‘Subtree Sequences Extractor’ tool (Figure 3.7) does just this by extracting
only the sequences corresponding to a particular clade (subtree), which is identified by its
branch length (Figure 3.8), by comparing sequence IDs in that clade to those in pool of
fasta sequences provided as input.
Input parameters
Tree file:
This field requires a phylogenetic tree and the following formats are accepted:
newick, nexus, nexml and phyloxml.
FASTA file:
This field requires sequences that were originally used to construct a phylogenetic
tree in FASTA format. Sequences must have IDs but its description is optional.
Output folder:
This field shows where output files will be saved. By default, ResCon will select
to save output files in to a folder called ‘Output’ where ‘Tree file’ is located. However, it
can be changed to any folder where user has privileges to write files.
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Figure 3.7. ResCon’s Subtree Sequences Extractor tool. Visualized in OS X 10.11 (El Capitan).

Figure 3.8. A sample phylogenetic tree. Branch lengths of clades are marked with arrow marks.
Clade with branch length 0.001938 has three sequences in it.
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Clade’s branch length:
This field requires one or more branch length values separated by commas. If the
branch length is 0.123456, it may be entered in one of the following formats:
1) 0.123456

2) 123456E-6

3) 123456e-6

Obtaining correct branch length is not trivial as it needs to be complete with all
decimal digits but not all phylogenetic tree viewers are capable of showing complete
branch length values. Most popular tree viewers allow modifying number of decimal
digits to be shown but our experience suggests they may sometimes tend to round off to
certain digits even with such setting modification. For example, branch length 0.0323797
may appear as 0.03238 or 0.0324 depending on the tree viewer and setting used. In order
to alleviate difficulty in instances where entered branch length does not match to any in
the input tree file, ResCon suggests five branch length values of the phylogenetic tree
nearest to the requested branch length. Intended branch length value can easily be
identified among these options by looking for the closest match. In most cases, the third
number among these five options would be the intended branch length. If a phylogenetic
tree has more than one clade with the same branch length, one of them needs to be
manually edited to a different number in order to extract sequences from their clade.
Output
A FASTA file with sequences extracted from the clade of requested branch length
is stored in the output folder selected. Filename of this FASTA file would have
corresponding branch length as part of it - ‘Clade_0.001938_Specific_sequences.fasta’,
for example. A log file is also written as output.
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3.1.4.3 GenPept/GenBank to FASTA converter
In several file formats that handle FASTA sequences, multiple sequence
alignments and phylogenetic trees for example, sequence identifiers are required in order
to identify sequences whereas inclusion of sequence descriptions may or may not be
supported. Protein or gene sequences retrieved from NCBI databases in fasta format
include only identification numbers in their sequence identifier part, for example
accession and locus numbers in case of gene sequences from GenBank [135].
This result makes it difficult to interpret sequence’s name directly as in most
cases it does not provide easily recognizable name including name of the organism. This
is particularly disadvantageous in file formats such as Clustal MSA where such sequence
identifiers are the only link to their corresponding sequences and they do not provide any
information which can be instantly recognized by us. The webserver tool
‘Genbank/EMBL to FASTA Conversion Tool’ allows extracting certain qualifiers of
GenBank in to FASTA sequence ID, but they cannot use GenPept format or include
taxonomy information in sequence ID [136]. Hence, tool ‘GenPept/GenBank to fasta
Converter’ was developed as part of ResCon to address this difficulty (Figure 3.9).
Input Parameters
GenPept/GenBank file:
This requires a sequences file in GenPept/GenBank format. Number of sequence records
present in them is not restricted.
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Figure 3.9. ResCon’s GenPept/GenBank to FASTA Converter tool. Visualized in OS X 10.11
(El Capitan).

Output folder:
This field shows where output files will be saved. By default, ResCon will select
to save output files in to a folder called ‘Output’ where ‘GenPept/GenBank file’ is
located. However, it can be changed to any folder where user has privileges to write
files.
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Figure 3.10. GenBank file format. Fields that can be extracted for ‘Header options’ from
GenBank/GenPept data format are labelled as follows: 1) Locus ID, 2) Sequence name – only the
part inside braces, 3) Version, 4) GI number, 5) Genus, 6) Species, 7) Taxon-1, 8) Taxon-2, 9)
Taxon-3 and 10) Taxon ID. COMPLETENESS tag (A) is used determine if sequences are
annotated as complete or not.

FASTA ID length:
This indicates the maximum length of identifier in FASTA sequence headers in
output file. Certain applications may restrict the length of FASTA identifier to certain
number of characters and this feature is helpful in such cases. Default value is 127 as
Clustal omega can handle up to 127 characters in fasta header, though this does not
appear to be documented elsewhere and is found from our experience.
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Header options:
This shows eleven different fields that can be extracted from GenPept/GenBank
format and then included in to FASTA sequence ID in output file. Figure 3.10 shows a
sample GenPept data with labels representing those nine available fields. It is
recommended to choose at least one field that will be unique for a sequence (Locus ID,
Version or GI, for example). The chosen fields will be extracted, separated by a delimiter
(pipe symbol ‘|’, by default) and written into sequence ID in output FASTA in the order
of left to right and then top to bottom for the chosen fields. If any of requested fields are
missing in GenBank records, they will be recorded as NA. Number of header options
chosen here is not restricted. However, if length of ID exceeds the defined ‘FASTA ID
length’ threshold, it will get truncated. For sequence description, text from
‘DEFINITION’ field (Figure 3.10) is extracted and written in to output FASTA
sequences.
Extent of taxonomy information available varies among GenBank/GenPept
records. Taxonomic ranks of options taxon-1, taxon-2 and taxon-3 vary depending on the
organisms. For prokaryotic organisms, these three fields typically represent domain,
phylum and class respectively. However, for eukaryotic organisms, these fields do not
always represent a particular taxonomic rank as the hierarchy of ranks for eukaryotic vary
when compared to that of prokaryotic organisms.
Retrieval options:
a. Replace sensitive symbols in header id with underscore symbol:
Choosing this option instructs ResCon to replace certain pre-defined/customchosen symbols with underscore symbol in sequence IDs. Certain applications/softwares
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restrict use of certain symbols when they are part of sequence IDs. For example, Newick
phylogenetic tree format will result in error if sequence ID contains symbols such as
colon, semicolon, parenthesis and square brackets as part of sequence’s ID[137].
Furthermore, it is recommended not to use symbols comma and double quote in FASTA
IDs [88]. In our experience, in addition to above symbols, presence of single quote in
sequence IDs resulted in error when reading Newick formatted tree. ResCon, by default,
allows replacing all above-mentioned symbols, (i.e. : ; ( ) [ ] , ' ") with underscore, but the
user can customize the symbols that need to be avoided and also the symbol to use for
replacement from File -> Edit settings.
b. Ignore incomplete/partial sequence records:
This option allows to exclude the sequence records that are recorded as
incomplete in COMMENT field or partial in DEFINITION field of GenBank/GenPept
sequence records (Figure 3.10). It should be noted that not all incomplete or partial
sequences are well annotated as such in GenBank/GenPept records.
Output
A FASTA file is written as output along with a log file in the output folder
chosen. If GenPept record in Figure 3.10 was the input to this tool, and parameters
shown in Figure 3.9 were used (except checkbox ‘Ignore incomplete/partial sequence
records’ was left unchecked), then the output FASTA sequence would have the following
header:
>WP_052913983|Bacteria|Proteobacteria|Gammaproteobacteria|Escherichia|coli| inorganic
pyrophosphatase, partial [Escherichia coli].
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Editable Parameters
Besides the parameters that could be modified as described in section 3.1.3,
ResCon allows parameters listed below to be modified either only for a session (*marked)
or permanently. See section 3.1.3 for instructions.


Delimiter symbol connecting chosen header options in FASTA IDs in output file.*



Sensitive symbols that are to be replaced if present in sequence IDs.*



Symbol to replace above defined sensitive symbols.*



Maximum number of characters allowed in Fasta IDs.

3.1.4.4 Filter BLAST by Bit or E-value
BLAST (Basic Local Alignment Search Tool) is commonly used algorithm to
search for optimal local sequence alignment by comparing database of sequences to a
query sequence, and confidence of such alignment are represented by Expect (E) value
and bit score. High confidence BLAST alignment will have low E-value and high bit
score [138]. In order to separate a particular family of sequences from a pool that contain
multiple families, apart from constructing a phylogenetic tree, BLAST can be used to
separate that family of sequences by comparing them to a known sequence of that family.
ResCon’s Filter BLAST by Bit or E-value tool (Figure 3.11) reads a BLAST output file
in XML format and sequences in FASTA format and then extracts only the sequences
that satisfy the criteria of Expect (E) value or bit score threshold by matching the
sequence IDs in them.
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Figure 3.11. ResCon’s Filter BLAST by Bit or E-value tool. Visualized in OS X 10.11 (El Capitan)

Input Parameters
XML BLAST file:
This field requires BLAST file obtained from other sources in XML format.
FASTA file:
This field requires sequences in FASTA format – preferably the same set of
sequences used to obtain BLAST file provided as input. Sequences must have ID but
description is optional.
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Output folder:
This field shows where output files will be saved. By default, ResCon will select
to save output files in to a folder called ‘Output’ where ‘BLAST XML file’ is located.
However, it can be changed to any folder where user has privileges to write files.
Filter method:
Here options are provided to choose between filtering by E-value and bit score
filtering, and also if sequences that need to be extracted should have score higher or
lower than the threshold chosen. High confidence BLAST alignment would have low
E-value and high bit score. The threshold provided may be an integer or a decimal
number. If it is a decimal number, for example 0.0023, it could be entered in one of the
following formats:
a) 0.0023

b) 2.3E-3

c) 2.3e-3

Output
A FASTA file of extracted sequences would be saved in to the output folder
chosen. Filename of this FASTA file would reflect the filtering parameters used for the
job, for example – ‘Filtered_Seqs_E-value_Lower than_1e-32.fasta’. Also, a log file is
written.
Tips / Troubleshooting:
Number of sequences are not same as expected:
Many programs that perform BLAST, including NCBI BLAST tool, displays bit
score as integer values and E-value as decimal numbers. However, in reality, bit scores
are indeed decimal numbers. Therefore BLAST XML output files would have them
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stored as decimal numbers, and ResCon uses them as such. These hidden decimal digits
may lead a user to assume ResCon is not extracting correct number of sequences.
Consider this example - a BLAST hit has a bit score of 500.433 and a program that
performs BLAST displays it instead as 500. If 500.2 is used as bit score threshold and
ResCon is set to extract sequences with bit score lower than this threshold, sequence
corresponding to above hit with bit score 500.433 will not be extracted as it does not
satisfy the instructed criteria.
Similarly, NCBI BLAST tool may display E-value as rounded number to few
digits. For example, it may display E-values 2.3, 2.30116 or 2.2844 simply as 2.3, and
this may result in similar circumstances as described above. Hence, such possibilities
must be considered when number of sequences extracted are not same as the expected.
3.1.4.5 Filter FASTA by Sequence’s ID
This tool reads sequences in FASTA format and extracts only those sequences
whose sequence ID match, or not, with IDs of interest provided in a text file
(Figure 3.12). Such extraction can be achieved either by using complete or partial
sequence IDs. We heavily use this tool to extract certain sequences, for example
sequences that does or does not fulfill certain criteria during analysis, primarily by using
partial IDs that are absolutely unique to only one sequence in a large pool of sequences.
A command line utility ‘faSomeRecords’ (UCSC Genome Bioinformatics,
http://genome.ucsc.edu/) has the same functionality but, unlike ResCon, is available only
for Linux OS.
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Figure 3.12.
(El Capitan)

ResCon’s Filter FASTA by Sequence’s ID tool.

Visualized in OS X 10.11

Input parameters
FASTA file:
This field requires a sequences file in FASTA format. Sequences must have ID
but description is optional.
File with IDs:
This field requires a text file that has only one sequence ID per line. Number of
sequence IDs in this file is not restricted. If ‘IDs are partial’ checkbox is checked, IDs in
this file can be partial which means they do not have to completely match to sequence
IDs in input FASTA file.
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Output folder:
This field shows where output files will be saved. By default, ResCon will select
to save output files in to a folder called ‘Output’ where ‘FASTA file’ is located.
However, it can be changed to any folder where user has privileges to write files.
Include/Exclude IDs in list:
This option determines if sequences in input FASTA file need to be included or
excluded, based on IDs present in ‘File with IDs’, when written in to output file.
IDs are partial:
This option allows usage of partial IDs instead of complete IDs in ‘File with IDs’
text file. If partial IDs are to be used, it is highly recommended to choose partial IDs that
are unique to only one sequence. This is to ensure that unintended sequence IDs are not
mistakenly matched and therefore corresponding sequence being unintentionally included
in or excluded from output.
Output
A FASTA file of extracted sequences would be saved in to the output folder
chosen. Also, a log file is written.
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3.1.4.6 Filter FASTA by Sequences’ Description
This tool is similar to “Filter FASTA by Sequences’ ID” except that here it filters
by sequence descriptions in FASTA headers (Figure 3.13). Such extraction can be
achieved either by using complete or partial sequence descriptions. When partial
sequence descriptions are used for filtering, unlike tool “Filter fasta by Sequences’ ID”,
regular expression is used to match them to a particular defined portion of the
description.

Figure 3.13. ResCon’s Filter FASTA by Sequences’ Description tool. Visualized in OS X 10.11
(El Capitan)
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Input Parameters
FASTA file:
This field requires a sequences file in FASTA format. Sequences must have ID
and description.
Output folder:
This field shows where output files will be saved. By default, ResCon will select
to save output files in to a folder called ‘Output’ where ‘FASTA file’ is located.
However, it can be changed to any folder where user has privileges to write files.
List of descriptions:
Descriptions that will be used for filtering sequences in FASTA file needs to be
provided here. If more than one description is used, they need to be separated by double
commas without any extra space characters. Double commas are used instead of single
comma as the latter may sometimes be an inherent part of the description itself. Care
must be taken to avoid any additional characters, including extra space character, to this
field as this results in failure to extract intended sequences.
Include/Exclude descriptions in list:
This option determines if sequences in input FASTA file need to be included or
excluded, based on descriptions provided as input, when written in to output file.
Get descriptions from text file
If this option is selected, input descriptions must be provided in a text file with
one description per line.
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Filter using partial descriptions:
This option allows usage of partial descriptions instead of complete descriptions
as input. This requires certain regularity in the structure of descriptions of all input
sequences, as regular expression is utilized here to match input partial description to a
defined portion of the sequences’ description. By default, ResCon uses regular
expression (.+) \[.+ but this can be customized to fit user’s needs. For example, if
sequence description is ‘inorganic pyrophosphatase [Escherichia coli]’, then the use of
above regular expression will result in ‘inorganic pyrophosphatase’ as the partial
description that will be used to match to sequences in FASTA file.
Output
In addition to a log file, A FASTA file of sequences extracted on the basis of
descriptions would be saved in to the output folder chosen.
Editable parameters
ResCon allows to modify the default regular expression used in this tool. See
section 3.1.3 for instructions.
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3.1.4.7 FASTA Description / ID Extractor
This tool allows extraction of descriptions or IDs, complete or partial, from
FASTA sequence headers (Figure 3.14).

Figure 3.14. ResCon’s FASTA Description / ID Extractor tool. Visualized in OS X 10.11
(El Capitan)

Input Parameters
FASTA file:
This field requires sequences in FASTA format. IDs are required. Descriptions
are required if Description Extractor tool is used.
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Output folder:
This field shows where output files will be saved. By default, ResCon will select
to save output files in to a folder called ‘Output’ where ‘FASTA file’ is located.
However, it can be changed to any folder where user has privileges to write files.
Extract partial description:
In Description Extractor tool, this option allows extraction of partial descriptions
using regular expression, instead of complete descriptions, from input FASTA sequences.
Certain regularity in the structure of descriptions of all input sequences is required as
regular expression is utilized. By default, ResCon uses regular expression (.+) \[.+ but
this can be customized to fit user’s needs. For example, if a sequence description is
‘inorganic pyrophosphatase [Escherichia coli]’, then use of above regular expression will
result in extraction of ‘inorganic pyrophosphatase’.
Extract partial identifier:
In Identifier Extractor tool, this option allows extraction of partial IDs using
regular expression, instead of complete IDs, from input FASTA sequences. The default
regular expression used here is (\w+)\|.+ but this can be modified. If a sequence’s ID is
‘WP_123890|Bacteria|Escherichia|coli’, above regular expression would result in
extraction of ‘WP_123890’.
Output
A CSV file and a log text file are written as output. In CSV file, along with the
summary of results, extracted IDs or descriptions and their total count are written one per
line.
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Editable parameters
ResCon allows to permanently modify default regular expressions used in both
Description Extractor and ID Extractor. See section 3.1.3 for instructions.
3.1.5

Pipeline for residue conservation analysis:
The study of conservation of certain residues among a type of protein sequences

from a database requires that all relevant sequences be retrieved properly. Such retrieval
depends on the annotation available in that database and their accuracy. For a rather well
studied protein, it is likely that such curation is dependable to certain extent. However
this is not always the case for all the protein sequences available, and in such cases, they
pose difficulty in separating only the intended sequences in a simple straightforward
manner.
For example, inorganic pyrophosphatase (IPPase) is a family of enzymes that
include three major subfamilies namely Family I, Family II and membrane IPPases and
further involves other proteins that can hydrolyze pyrophosphate. Though Family I
IPPases have been studied for decades, it is not completely possible to retrieve all
available Family I IPPases from RefSeq database as a large fraction of them are
generically annotated as ‘inorganic pyrophosphatase’ and they do not have their subfamily kind included. Hence, to retrieve all available Family I IPPases, term ‘inorganic
pyrophosphatase’ need to be used as the search term but this will result in all other
IPPases. While it is possible to use bitwise operations to remove well annotated Family
II and membrane IPPases to avoid retrieving such enzymes, it will inadvertently result in
retrieval of poorly annotated sequences from those families, albeit possibly in greatly
reduced quantity.
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Scheme A

Scheme B

Search and retrieve data from
NCBI in GenPept format

Convert to FASTA format
(use GenPept/GenBank to
fasta Converter)
Build Phylogenetic Tree
(Optional – use Clustal Omega
through Mismatch analyzer)

Run BLAST against protein
sequences of interest and
save in XML format

Identify subtree that contains
protein family of interest

Extract sequences
corresponding to that subtree
(use Subtree Sequences' Extractor)

Filter sequences based on
E-value threshold
(use Filter fasta by BLAST‘s
E-value/Bit-score)

Build MSA* and analyze for
residue conservation
(use Mismatch Analyzer)

Optional: Extract matching or
mismatching sequences
(use Filter fasta by Sequences’ ID)

Figure 3.15. Process pipeline on residue conservation analysis using ResCon’s tools. Flowchart
demonstrates filtering sequences of an intended protein family from a large dataset containing
multiple protein families and then analyzing conservation of residues at the sites of interest.
Scheme A employs phylogenetic tree whereas Scheme B employs BLAST to separate protein
sequences of interest. Italicized text refers to ResCon’s tools to achieve the job. *MSA may be
inherently constructed through Clustal Omega using ResCon’s Mismatch analyzer or externally
built MSA can be utilized for Mismatch analysis.

Here, the tools from ResCon suite are utilized in a pipeline under two different
schemes, to filter only the sequences of interest from a large dataset of sequences
containing multiple families of protein (Figure 3.15). Scheme A involves constructing
phylogenetic tree for the large dataset to separate protein families and then identifying the
clades containing intended sub-family of sequences and extracting them. Scheme B
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involves using BLAST to compare known sequence with the retrieved dataset and then
extracting only intended sub-family of sequences using an E-value threshold. Then, in
both schemes, conservation analysis of residues of interest is carried out using ResCon’s
Mismatch analyzer.

3.2

Conservation of active site in Family I and Family II IPPases
ResCon tools are used to analyze conservation of active site residues in both

Family I and II IPPases using large dataset of IPPase sequences retrieved from NCBI
RefSeq Protein database [101]. Because the use of search terms ‘soluble inorganic
pyrophosphatase’, ‘Family I inorganic pyrophosphatase’ or ‘Family II inorganic
pyrophosphatase’ resulted in severely reduced number of respective protein sequences
from NCBI Protein database, generic term ‘inorganic pyrophosphatase’ was used.
However, this dataset presents several challenges as the resulting data also includes other
proteins with function of pyrophosphate hydrolysis, in addition to intended sequences of
Family I and II IPPases. Various tools of ResCon were used as shown in Scheme B
(Figure 3.15) in order to separate Family I and II IPPases from such a large dataset and
then to analyze conservation of active site residues in them.
Conventionally, in literature, Family I IPPases present in bacteria and archaea are
referred to as prokaryotic IPPases and those in eukaryotes as eukaryotic IPPases. Family
I IPPases from E. coli and S. cerevisiae are typically used as representative for
prokaryotic and eukaryotic IPPases respectively, and these enzymes have been well
studied, biochemically and structurally. Such simplistic reference was sufficient in the
earlier period, but it was later established that plant cells have more than one IPPase and
one of them is closely related to prokaryotic IPPases and the other to eukaryotic IPPases.
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Such reference is still under practice today but this could lead to confusion when they are
called upon frequently as done in this study. Hence, in this study, to avoid confusion,
prokaryotic IPPases are referred to as Family I-P IPPases and eukaryotic IPPases as
Family I-E IPPases. Lahti research group has shown that their active site is well
conserved across three domains of life using 8 and 37 sequences that were available in
1992 and 1999 respectively [25, 106].
Crystal structures of Family II IPPases from Streptococcus mutans, Streptococcus
gordonii and Streptococcus agalactiae have been determined and active site residues
were proposed [17, 107]. While 10 residues that were proposed to be part of active site
from above crystal structures are same, an additional residue that has been proposed for
Family II IPPases from S. gordonii (296S) and S. mutans (203D which corresponds to
205D of S. gordonii) do not (Table 1). In this study, conservation of all twelve proposed
active site residues for Family II IPPases and 13 active site residues for Family I IPPases
were analyzed.
Among 22,173 sequences retrieved from RefSeq Protein database in GenPept
format using keyword ‘inorganic pyrophosphatase’, 418 had annotations as either
incomplete or partial sequences and hence were not considered for further analysis.
Remaining 21,755 sequences were converted to FASTA format using ResCon with
following fields in the sequence ID: accession ID with version number, first three ranks
of taxonomy lineage, genus and species. None of the sequence IDs were truncated by
ResCon as they all were below threshold ≤127 characters.
If a species has more than one sequence in the data, they were considered
redundant if their sequence lengths were within range of ±2/100 residues and ≥98%
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identical. For example, if sequences A and B from species X were of length 250 aa and
255 aa respectively and were 99 % identical, then B is redundant for A. One among them
was then selected as a representative sequence of this group on the basis of their RefSeq
status ranks (Table 2.1). If more than one sequence had the same highest rank, largest
sequence was chosen, and if they were of same size, one among them was randomly
chosen. In addition, if only genus rank but not species rank was known for an organism
in this dataset, they were eliminated if another sequence from that genus was present in
the dataset and they were redundant. This criteria was executed using a Python script that
utilizes BLAST+ to identify redundant sequences among all sequences in a genera, select
unique sequence among them and iterate the process until no further duplicate sequences
were identified. 4,423 Sequences were identified as redundant sequences and were
eliminated from the dataset for further analysis (Figure 3.16).
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Figure 3.16. Identification and elimination of redundant sequences by iterations of local sequence
alignment by BLAST. Of 21,755 sequences, 4,423 were identified as redundant sequences and
removed.
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The next step was to separate Family I and Family II sequences in the remaining
17,326 sequences, and this was accomplished using BLAST bit score filtering. Sequence
similarity determined using BLAST is commonly used to identify homologous protein
sequences. Expect (E) value and bit scores provide better measure of homology when
compared to the measure using just certain level of sequence identity (typically 30 %)
between them. Bit score >50 is considered to be almost always significant for protein
sequences and therefore homologous [103, 104]. NCBI Protein BLAST was utilized to
obtain bit scores for sequences in the dataset with IPPase sequences from Escherichia
coli (Family I-P), Saccharomyces cerevisiae (Family I-E) and Bacillus subtilis (Family
II) as query sequences (Table 2.2). ResCon was then utilized to extract corresponding
homologous sequences with bit score >50. The number of homologous sequences
obtained was 5,381 sequences using E. coli IPPase as the query sequence, 3,347 to
S. cerevisiae IPPase and 2,487 for B. subtilis IPPase.
Among these homologous sequences, six sequences had taxonomy domain rank
listed as ‘Unclassified’, and they were found to satisfy criteria for redundant sequences
when compared to sequences for which domain rank was known. Hence, these six
sequences were removed from further analysis.
Homologous sequences obtained using E. coli IPPase and S. cerevisiae IPPase as
queries had 2,343 common sequences. This is due to both IPPases being homologous
sequences, and hence BLAST bit score cannot be utilized to completely separate Family
I-P from Family I-E sequences. To circumvent this problem, phylogenetic tree was used
to isolate one subfamily from another. Sequences obtained from bit-score filtering with
E. coli IPPase and S. cerevisiae IPPase as queries were pooled together (6,383 sequences)
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after removing duplicate sequences. A neighbor-joining phylogenetic tree was
constructed using Clustal omega [105], and clades corresponding to Family I-P (branch
length: 0. 569368) and Family I-E (branch length: 0. 920752) were identified and then
extracted using ResCon.
In the end of cleaning up data to classify IPPase sequences as families of IPPases,
5,383 sequences were categorized as Family I-P IPPases, 996 sequences as Family I-E
IPPases and 2,485 sequences as Family II IPPases.
3.2.1

Taxonomy
Taxonomy of sequences plays a major role in our data analysis as we analyze the

nature of protein sequences and categorize them on basis of similarity, or lack of it, in
their taxonomy lineage. Hence, it is necessary to be aware of certain difficulties involved
in usage of taxonomy information obtained alongside protein sequences from NCBI
RefSeq database. The hierarchy of taxonomy ranks available for sequences may vary
depending on their domain rank. For most sequences from prokaryotic domains
(Bacteria and Archaea), the first three hierarchy in their taxonomy lineage would be
domain, phylum and class, whereas for domain Eukaryota, hierarchy is not the same
across the board as eukaryotic taxonomy classification is rather complicated. Hence, in
our analysis, the second rank of taxonomy lineage would primarily be phylum for
prokaryotes, but for eukaryotes, it may vary between ranks kingdom, class, order and
unranked (Table 3.1).
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Table 3.1. Summary of sequences by taxonomy ranks for Family I-P, I-E and II IPPases.
Family I-P
Domain

Phylum/Kingdom/Group

Bacteria
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Proteobacteria
Firmicutes
Actinobacteria
Bacteroidetes
Cyanobacteria
Tenericutes
Deinococcus-Thermus
Spirochaetes
Fusobacteria
Acidobacteria
Chlamydiae
Verrucomicrobia
Planctomycetes
Thermotogae
Chloroflexi
Aquificae
NA*
Chlorobi
Thermodesulfobacteria
Nitrospirae
Deferribacteres
Armatimonadetes
Candidatus Saccharibacteria
Synergistetes

Family I-E

Without
With
mismatches mismatches

Without
With
mismatches mismatches

Family II
Without
With
mismatches mismatches

Total
number of
sequences

Total no. of
sequences
with
mismatches

4581

225

1

2385

21

7213

246

2476
108
1092
413
177
128
26
23

85
1
38
26
59

1

691
1486
61
9

10
3
1

95
4
39
26
60

24
20
5
14
5
16
18
11
10

8

3263
1598
1192
448
237
128
52
41
33
33
22
22
20
18
18
18
15
13
7
7
6
3
3
3

1

25
17
32
1

1
1
2

1

1

16
6
13
1
4

3

4
1
3

1

1

7
3
6
1
3

1
1
1
8
2
1

1

3

1

Family I-E

Family I-P
Domain

Phylum/Kingdom/Group

Without
With
mismatches mismatches

Fibrobacteres
Gemmatimonadetes
Chrysiogenetes
Nitrospinae

Family II

Without
With
mismatches mismatches

2
2

Without
With
mismatches mismatches
1
2

5

Candidate division SR1
Ignavibacteriae
Candidatus_Berkelbacteria
Eukaryota
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Metazoa1
1

Viridiplantae

1
344

29

859

136

15

3

461

89

314

23

94

15

197

19

22

9

35

1

21

1

1

Fungi

5

7

2

5

Stramenopiles
Euglenozoa

5

Amoebozoa

1

5

Ichthyosporea

Parabasalia
Apusozoa

12
3

1

1
1

1

1
1
1

10

1
1390

175

1

569

93

1

450

39

4

220

23

40

11

39

3

23

1

2

12
4

2

5

4

2

5

3
1

Choanoflagellida3
Diplomonadida

1

Nucleariidae and Fonticula group

1
1
2

1

4
3

1

3

1
1

1

5

5
5

7
6

5

5

1

12

2

Haptophyceae
Rhodophyta

1

1

Caldithrix

Alveolata

1
1

4

Total no. of
sequences
with
mismatches

3
2
2
1

1

Thermobaculum4

Total
number of
sequences

1

1

1
1

2

1

2

1

Family I-E

Family I-P
Domain

Phylum/Kingdom/Group

Without
With
mismatches mismatches

Cryptophyta2
Heterolobosea
Rhizaria

1
2

1
202

Euryarchaeota
Crenarchaeota
Thaumarchaeota
NA*
Total
1

104

Kingdom, 2Class, 3Order, 4Genus, 5Unranked.
Phylum/Kingdom/Group entry was not provided.

165
28
8
1
5127

Without
With
mismatches mismatches
1

1

5

Archaea

*

Without
With
mismatches mismatches

Family II

2

2

57

2

57

860

Total no. of
sequences
with
mismatches

2

1

256

Total
number of
sequences

136

2454

1
261

31

224
28
8
1
8864

2
2
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While most of the sequences have their taxonomy lineage well defined, certain
sequences may have their taxonomy information partly or completely missing. For
example, information about domain or other taxonomy rank of the species may be
unavailable. However, genus rank would always be defined unlike species rank, which
may not always be included. In our analysis, if a taxonomy rank was intended to be
extracted but was not present, then such rank was marked as ‘NA’. For sequences in the
data that were classified under Family I or II IPPases, effect of such missing information
in domain and phylum/kingdom ranks was minimal (Table 3.1). However, a significant
number of sequences (7.18 %) retrieved from RefSeq database had species rank
undefined (Table 3.2). Hence, during the process of removal of redundant sequences,
attempt was made to reduce their impact with inclusion of the criteria that such sequences
would be removed if they were redundant to sequence with known species rank in that
genera. This criteria helped significantly as number of sequences with unknown species
rank were brought down by about 250 %.

Table 3.2. Summary of sequences with species rank unavailable.
Stage

Sequences
Total

Species rank as ‘NA’
No. of sequences

Retrieved RefSeq sequences
21,755
1,562
Only non-redundant sequences
17,332
636
*
Only Family I and II IPPase sequences
8,864
434
*
After removal of redundant sequences with domain rank ‘Unclassified’.

Distinct genera
319
251
221

Furthermore, species, strains and subspecies have not been differentiated for two
reasons – to identify strains of species that may have a particular gene and for the sake of
making it simple for analysis. For example, species Escherichia coli and strain
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Escherichia coli IAI39 are not differentiated here. Hence, in the analysis, usage of term
‘species’ may refer not just to species but also to strains and subspecies. Also, certain
species (or strain or subspecies) in our data may have more than one IPPase sequence.
This could be due to that species having more than one IPPase gene present in its genome
(paralogs), they are isoforms or they are indeed redundant sequences in the data.
3.2.2

Extent of active site conservation
ResCon was utilized to study conservation of 13 active site residues in Family I-E

and I-P IPPases and 12 active site residues in Family II IPPases. IPPase sequences from
Escherichia coli, Saccharomyces cerevisiae and Bacillus subtilis were used as reference
sequences for Families I-P, I-E and II, respectively (Table 2.2). For each family, multiple
sequence alignment was constructed using Clustal Omega through ResCon, and then
conservation of active site residues in reference to reference sequences were analyzed.
Among Family I and Family II IPPases, the latter demonstrates remarkably high
conservation of active site with just 31 of 2454 sequences (1.25 %) containing at least
one mismatch at the active site (Table 3.3, Figure 3.17, Table 3.1). Among Family I
IPPases, significant number of Family I-E sequences (13.65 %) contain mismatches at the
active site than those of Family I-P (4.77 %). When sequences in subfamilies of Family I
were analyzed, sequences from prokaryotic domains Archaea and Bacteria belonged to
Family I-P as expected. However, one IPPase sequence from bacterial species delta
proteobacterium NaphS2 surprisingly corresponded instead to Family I-E (Table 3.1).
This sequence (Accession ID: WP_040873136.1) is closely related to S. cerevisiae
Family I-E IPPase (39 % identity, 60 % coverage) than to E. coli Family I-P IPPase (27
% identity, 30 % coverage).
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Table 3.3. Summary of families of IPPases by taxonomy domain and mismatches present in them.
Family I-P
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*

Family I-E

Family II
Total
Number
of
Sequences

Total
%
Sequences
with
mismatches

Domain

Number
of
Sequences

%
Sequences
with
mismatches

Number
of
Sequences

%
Sequences
with
mismatches

Number
of
Sequences

%
Sequences
with
mismatches

Archaea

204

0.98

0

-*

57

0

261

0.77

Bacteria

4806

4.68

1

0

2406

0.87

7213

3.41

Eukaryota

373

8.04

995

13.67

22

45.45

1390

12.70

Total

5383

4.77

996

13.65

2485

1.25

8864

4.77

Not applicable.

a. Family I-P IPPases (Total – 5382 sequences)

b. Family I-E IPPases (Total – 997 sequences)

c. Family II IPPases (Total – 2485 sequences)

Figure 3.17. Conservation of active site residues among all sequences categorized as
Family I-P (a), I-E (b) and II (c) IPPases. Purple bars represent % identity in reference to active
site residue of reference sequence and orange bars represent % Liu08 conservation score. Total
number of sequences for each family of IPPases are shown.
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Among sequences from eukaryotes in Family I, about 72.7 % of sequences were
Family I-E and the remaining were Family I-P (Table 3.1). The latter is primarily due to
Viridiplantae species as they have both Family I-P and I-E IPPases. Among sequences
from bacterial species, 66.6 % are Family I IPPases with all except one as Family I-P
IPPase and the remaining belong to Family II IPPases. So far, only bacterial and archaeal
species were found to contain Family II IPPases [20]. Hence it is an interesting finding
that 22 sequences from eukaryotes were found to belong to Family II IPPases. About
78.2 % of sequences from archaea domain are Family I-P IPPase while the rest are
Family II IPPases.
Five bacterial phyla (Proteobacteria, Firmicutes, Actinobacteria, Bacteroidetes,
Cyanobacteria), three eukaryotic kingdoms (Metazoa, Viridiplantae, Fungi) and one
archaeal phyla (Euryarchaeota) have >200 sequences in the data examined, and together,
they contribute ~92.5 % of Family I and II IPPase sequences in our data (Table 3.1).
While bacterial phylum Proteobacteria and eukaryotic kingdom Metazoa have the most
number of mismatching sequences (95 and 93, respectively), phylum Cyanobacteria with
just 237 sequences has highest fraction (25.3 %) of mismatching sequences.
Only few phyla, kingdoms or unranked groups of domains Archaea, Bacteria and
Eukaryota exclusively have only one kind among Families I-P, I-E and II IPPases, but
several others have more than one kind represented in them (Table 3.1). To further
understand this distribution of IPPases, phyla/kingdoms that have at least 25 distinct
species and have IPPase sequences with completely conserved active site were analyzed
(Figure 3.18). Except Viridiplantae, eukaryotes primarily have Family I-E IPPases, and
bacterial and archaeal phyla predominantly have Family I-E and/or Family II IPPases. In
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Archaea, phylum Crenarchaeota only has Family I-P IPPases unlike phylum
Euryarchaeota. Among bacterial phyla, Cyanobacteria and Tenericutes have just Family
I-P IPPases whereas Fusobacteria contains only Family II IPPase; Actinobacteria and
Bacteroidetes primarily have Family I-P IPPases, whereas Firmicutes predominantly
contains Family II IPPases.
Six phyla/kingdoms (Proteobacteria, Firmicutes, Actinobacteria, Euryarchaeota,
Metazoa and Viridiplantae) contain species that have more than one family of IPPases in
them (Figure 3.18). Proteobacteria has most such species (116 species). Majority of
species in kingdom Viridiplantae contain both Family I-P and I-E IPPases, which is
expected as Viridiplantae species are known to have both of these IPPases in cytoplasm,
chloroplast and/or mitochondria [31, 33].

Figure 3.18. Type of IPPases present in major phyla/kingdoms with conserved active site. Only
the phyla/kingdoms that have ≥25 distinct species are shown. Numbers above bars represent the
number of distinct species for the corresponding phylum/kingdom.
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3.2.3

Sequences with active site mutation
While a predominant number of Family I and Family II IPPases have their active

site completely conserved as expected, those sequences with mismatches are equally
important findings here. As soluble IPPases are essential for life in both prokaryotes and
eukaryotes [1-3], and mismatches at active site are likely to cripple their enzymatic
activity [139], it is of significance to learn if such mutant IPPases are the only IPPases in
the species. Furthermore, it is not known if such active site mutations occur in multiple
phyla, genera or species, and if they occur among closely related species. Here,
sequences with similar mismatches were grouped together and taxonomical similarity, or
lack of it, among them were analyzed.
3.2.3.1 Family I-P IPPases
Out of 5,383 Family I-P IPPase sequences, 256 have mismatches at at-least one of
13 active site residue positions (Table 3.4). Residue numberings used in this section
correspond to that of E. coli IPPase (Table C.1 in Appendix C).
Group A
This group has 55 similar sequences from 40 distinct bacterial species that belong
to phylum Cyanobacteria. Among these 40 species, 33 of them also have another Family
I-P IPPase with completely conserved active site. 19 Strains are in genus
Prochlorococcus, 20 in genus Synechococcus and 1 in genus Cyanobium. Sequences in
this group share high similarity to each other as they have 62 % - 96 % identity with
query cover >87 % when a sequence from this group (Accession ID: WP_011294476.1)
was used to compare with other sequences in this group by BLAST.
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Table 3.4. Summary of sequences present in Family I-P IPPases by their taxonomy distribution.
No. of sequences
(Includes redundant species)
Domain

Phylum/Kingdom/Group

Bacteria

112

Proteobacteria
Actinobacteria
Bacteroidetes
Cyanobacteria
Tenericutes
Firmicutes
Acidobacteria
Deinococcus-Thermus
Spirochaetes
Chlamydiae
Aquificae
Chloroflexi
Planctomycetes
Chlorobi
NA*
Verrucomicrobia
Thermotogae
Nitrospirae
Candidatus
Saccharibacteria
Armatimonadetes
Gemmatimonadetes
Fibrobacteres
Nitrospinae

Without
mismatches

With
mismatches

4581
2476
1092
413
177
128
108
24
26
23
20
18
16
14
10
11
5
5
4

225
85
38
26
59
1
8
1

1
3
1

3
1
2
2
1

1

No. of distinct species#

Total

Without
mismatches

With
mismatches

4806
2561
1130
439
236
128
109
32
27
23
20
18
17
14
13
11
6
5
4

3993
2083
956
397
160
125
96
21
25
22
19
18
15
14
9
8
5
5
4

191
73
35
24
43

3

3

2
2
2
1

1
2
2
1

1
7
1

1
3
1

Total
4042
2100
969
400
170
125
97
21
26
22
19
18
15
14
11
8
6
5
4
3

1

1
2
2
1

No. of sequences
(Includes redundant species)
Domain

Phylum/Kingdom/Group

Without
mismatches

Ignavibacteriae

With
mismatches

1
1

4

Caldithrix

Without
mismatches

1
1

1
1

343
314

1
372
337

Metazoa1

15

3

Alveolata5

7

Parabasalia5

3

Cryptophyta2
Apusozoa

Viridiplantae

1
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Rhizaria5
Heterolobosea2
Archaea
Euryarchaeota
Crenarchaeota
Thaumarchaeota
NA*
Total

With
mismatches

Total
1
1

74
58

1
20
16

1
75
58

18

7

1

7

2

9

4

2

5

1

4

1

1

1

1
1
1

1
1
1

1
1
1

1
1
1

1
202
165
28
8
1

1
204
167
28
8
1

1
191
155
28
7
1

1
191
155
28
7
1

5382

4258

5126

1

Kingdom, 2Class, 3Order, 4Genus, 5Unranked.

*

Phylum/Kingdom/Group entry was not provided.

#

Total

1
29
23

Candidate division SR15
Eukaryota

No. of distinct species#

Distinct species include distinct species, strains and subspecies.

2
2

256

1
1

212

4308

Sequences in this group have 1- 4 mismatching active site residues at Asp67,
Tyr141, Lys142 and Glu31. All 55 sequences have mutation at Asp67 with Ala or Ser as
mutated residue. In addition to this mutation, 27 sequences also have mutation Y141S
and 7 sequences have mutation at Lys142 with same charged residue arginine. Mutations
at these sites are known to significantly reduce activity of E. coli IPPase, and indeed this
was the case in Family I-P IPPase of Prochlorococcus marinus MED4, a cyanobacteria
species, that has active site mutations D67S and Y141S [29, 139]. This species has
another Family I-P IPPase with conserved active site that retained pyrophosphate
hydrolysis activity [29]. In addition to above-mentioned mutations, four sequences also
contain active site mutations E31R, D97E and/or Y141C/H.
Group B
This group has 29 sequences from 27 bacterial species and they all belong to
phylum Actinobacteria. Among these 27 species, 16 of them also have another Family IP IPPase with completely conserved active site. Class Streptomycetales is the major
contributor with 17 species of which 12 belong to genus Streptomyces. Genera
Streptacidiphilus and Mycobacterium each contribute 4 species. Sequences in this group
share moderately high similarity to each other as they have 48 % - 91 % identity with
query cover >83 % when a sequence from this group (Accession ID: WP_049714356.1)
was used to compare with other sequences in this group by BLAST.
Sequences in this group primarily have mutation at active site positions 67 and/or
at 31. Instead of Asp at position 67, they are likely to have same charged residue Glu and
few sequences have Gly or Thr instead. For sequences with mutation at Glu31, if they
have mutation D67E, they are likely to have mutation E31V or else they are likely to
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have mutation E31Q. Such mutation may severely affect their activity as E. coli IPPase
mutant variants D67E and E31D were shown to have severely reduced activity at 2 %
and 13 % respectively and such mutation in S. cerevisiae IPPase counterpart completely
kills their activity [139, 140]. In addition to above-mentioned mutations, two sequences
also contain active site mutations D97T and/or 102DT/E.
Group C
Just 58 species from eukaryotic Kingdom Viridiplantae contribute 337 sequences
to Family I-P IPPases, unlike phyla of Archaea and Bacteria where number of distinct
species does not vary drastically to number of sequences contributed by them (Table 3.4).
23 of those 337 sequences from 16 species have mismatches at active site. All of these
16 species belong to phylum Streptophyta and they have another Family I-P IPPase and
Family I-E IPPase with completely conserved active site. Plant species are known to
have alternative splicing isoforms of Family I-P IPPases, and mismatches seen here can
be attributed to that. Apart from a sequence from Elaeis guineensis that has mismatches
R43S and D67V, mismatches are due to isoforms or likely isoforms with residues
missing in C- or N-terminal, residues missing around 31E or 97D and insert in C-terminal
or around 142Y.
Group D
This group has 66 sequences from 55 bacterial species and they have higher
number mismatches (6 to 8) at the active site. Among 55 species, 48 speciesadditionally
have another Family I-P IPPase and 3 species (Deinococcus phoenicis, Maribius sp.
MOLA 401 and Pedosphaera parvula) have another Family II IPPase with completely
conserved active site. Phylum Proteobacteria (49 sequences from 39 species) is the major
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contributor to this group followed by Bacteroidetes (7 sequences from 7 species) and
Acidobacteria (7 sequences from 6 species). Sequences in this group are homologous
and they have varying homology from 31 % to 98% with query cover of >86 % when a
sequence from this group (Accession ID: WP_039146731.1, from Bradyrhizobium
japonicum) was used to compare with other sequences in this group by BLAST.
Active site residues Glu20, Lys29, Asp65, Asp67 and Asp70 are conserved in
sequences of this group but they are likely to have mutation at the remaining active site
residue positions. By comparison to sequences in UniProtKB database[54], IPPases were
confirmed the closest match by sequence similarity. However, as more than half of the
active site residues are not conserved, it appears that sequences in this group are unlikely
to have pyrophosphate hydrolysis activity.
Group E
This group has 36 sequences from 33 bacterial species with phyla Proteobacteria
and Bacteroidetes each contributing 17 sequences from 16 and 15 species, respectively,
besides 1 sequence each from phyla Chlorobi and Cyanobacteria. Among these 27
species, 14 species also have another Family I-P IPPase with completely conserved active
site, 3 species have active site conserved Family II IPPase and 6 species, surprisingly,
have both active site conserved Family I-P and Family II IPPases. All sequences in this
group have mutation at 43R and 11 sequences, in addition to mismatch at 43R, also have
mutation at 142K. 26 sequences have mutation R43E and the remaining have residues D
(5 sequences), S (3), A (1) and T (1). At 142K, mismatching residues seen are D
(7 sequences), E (3) and Q (1).
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Group F
This group has 14 sequences from 12 bacterial species and 1 eukaryotic species
with phylum Proteobacteria being the major contributor with 6 species. Among these 13
species, three species also have another Family I-P IPPase with completely conserved
active site, 1 species (Salmonella enterica) has both active site conserved Family I-P
IPPase and Family II IPPase, and eukaryotic species Pantholops hodgsonii (Tibetan
antelope) has both active site conserved Family I-P and Family I-E IPPases. Sequences
in this group have either truncated C- terminals (3 sequences) or N-terminals (11
sequences). However it is uncertain if these sequences are truly present in truncated
fashion or if these are incomplete or partial sequences.
Group G
Unlike the previous groups of sequences that were grouped together depending on
the type of mismatches in them, remaining 33 sequences could not be grouped as there is
not a definite trend among the mismatches in these sequences. These 33 sequences are
from 31 species (26 bacterial, 4 eukaryotic and 1 archaeal). 23 of these species have
another active site conserved IPPase in them (19 have Family I-P type, 2 have Families
I-P and II, 1 has Families I-P and I-E and 1 has Fam II). Of 33 sequences, 21 sequences
have one or two mismatches at any of 13 active site positions except at 55Y, and the
remaining 12 sequences have 3-9 mismatching residues. Two sequences have
mismatching residue as X and hence could be attributed to sequencing error.
3.2.3.2 Family I-E IPPases
Among 996 sequences of Family I-E IPPases, 136 have mismatch in at least one
of the 13 active site residue positions (Table 3.5). Residue numberings used in this
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section correspond to that of S. cerevisiae IPPase. These mismatching sequences are
divided into following groups (Table C.2 in Appendix C):
Group A
This group has 64 sequences from 37 eukaryotic species from kingdom Metazoa.
All except one species, which is from phylum Ecdysozoa, belong to phylum Chordata.
All of these species have another Family I-E IPPase with completely conserved active
site. By comparing sequences in this group to other IPPase sequences in same species or
genus, it is clear that 45 sequences are clearly alternate splicing isoforms whereas the rest
are likely to be alternate splicing isoforms as well. As isoforms of Human (a metazoan)
IPPases (Family I-P) are localized to mitochondria, it is likely that sequences in this
group are localized in mitochondria as well.
Metazoa, comprised of animals, is one of the major kingdoms of eukaryotes.
Humans (a metazoan) contain two forms of major soluble IPPases – cytosolic and
mitochondrial, both in Family I. Mitochondrial IPPases are nuclear genome encoded with
mitochondria localization signal sequence in N-terminal and are ~60% identical to
Human cytosolic IPPase [53]. In contrast to cytosolic IPPase to which do not have
isoforms, mitochondrial IPPase has at least four isoforms produced by alternative splicing
[54]. Most, if not all, isoforms have residues missing around the signature sequence and
hence are missing active site residues.
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Table 3.5. Summary of sequences present in Family I-E IPPases by their taxonomy distribution.
No. of sequences
(Includes redundant species)
Domain

Phylum/Kingdom/Group

No. of distinct species#

Without
mismatches

With
mismatches

Total

Without
mismatches

With
mismatches

Total

859
461

136
89

995
550

517
242

94
53

536
249

197

19

216

153

19

158

94

15

109

61

12

62

35

1

36

11

1

11

22

9

31

21

6

26

Euglenozoa5

21

1

22

10

1

10

Amoebozoa5

12

12

9

9

Rhodophyta5

5

5

3

3

Ichthyosporea2

4

4

2

2

Haptophyceae5

4

4

1

1

Choanoflagellida3
Nucleariidae and Fonticula
group5

2

2

2

2

2

1

1
1
1
1

1
1
1

996

518

Eukaryota
Metazoa

1

Fungi1
1

Viridiplantae

5

Stramenopiles
Alveolata

5

1

1

1

Heterolobosea2
Apusozoa

1
1
1

Bacteria
Proteobacteria
Total

860

136

1

Kingdom, 2Class, 3Order, 4Genus, 5Unranked.

#

Distinct species include distinct species, strains and subspecies.
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1
1

94

1
1
1
1
1
537

Group B
This group includes sequences that are isoforms or are likely to be isoforms but
are not from kingdom Metazoa. It has 11 sequences from 8 eukaryotic species with 7
from phylum Streptophyta of kingdom Viridiplantae and 1 species from Kingdom Fungi.
All Viridiplantae species have another Family I-E as well as Family I-P sequences with
conserved active site, which is not the case for fungal species. Mismatches in six
sequences from Viridiplantae can be attributed to alternate splicing, and the remaining
sequences are likely to be alternative spliced isoforms as well.
Group C
This group includes 6 sequences from 6 strains which belong to subkingdom
Dikarya of kingdom Fungi. 5 of these strains have another Family I-E IPPase with
conserved active site. These sequences have mismatch at position 193 where they have
Gly, Met or Arg instead of Lys.
Group D
Unlike the previous groups of sequences that were grouped together depending on
the type of mismatches in them, remaining 55 sequences could not be grouped as there is
not a definite trend among the mismatches in these sequences. These 55 sequences are
from 52 eukaryotic strains with kingdoms Metazoa (25 strains) and Fungi (12 strains) as
the major contributors. 32 Of these strains have another active site conserved Family I-E
IPPase, 3 strains have Family I-P, 2 have both Families I-P and I-E, and 1 has both
Families I-P and II. Of 55 sequences in this group, 35 sequences have 1-3 active site
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mismatches, and the remaining 20 have 4-11 mismatches. One sequence has
mismatching residue as X and hence could be attributed to sequencing error.
3.2.3.3 Family II IPPases:
In Family II IPPases type, 2454 sequences show great conservation of their active
site residues with only 31 sequences displaying mismatches at the active site (Table 3.6).
Residue numberings used in this section correspond to that of B. subtilis IPPase. These
sequences can be divided into following groups (Table C.3 in Appendix C):
Group A
This group has 14 sequences from 8 eukaryotic species and 6 bacterial species.
These sequences have mismatch at His9 where they instead have Asn. In addition, two
bacterial Neochlamydia species and a fungal species have mismatching residues Ala and
Thr, respectively, instead of Ser at position 294. All eukaryotic species have another
Family I-E IPPase with conserved active site. Bacterial strains except Neochlamydia
species have another active site conserved Family II IPPase whereas Neochlamydia
species have another active site conserved Family I-P IPPase.
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Table 3.6. Summary of sequences present in Family II IPPases by their taxonomy distribution.
No. of sequences
(Includes redundant species)
Domain

Phylum/Kingdom/Group

Bacteria
Firmicutes
Proteobacteria
Actinobacteria
Fusobacteria
Deinococcus-Thermus
Spirochaetes
Verrucomicrobia
Thermotogae
Bacteroidetes
Thermodesulfobacteria
Planctomycetes
Deferribacteres
NA*
Synergistetes
Nitrospirae
Chrysiogenetes
Chlamydiae
Armatimonadetes
Chloroflexi
Acidobacteria
Fibrobacteres
Thermobaculum4
Candidatus_Berkelbacteria
Cyanobacteria

Without
mismatches

With
mismatches

2385
1486
691
61
32
25
17
16
13
9
7
6
6
4
3
3
2

21
3
10
1
1
1

2
1
1
1
1
1
1
1

No. of distinct species#

Total
2406
1489
701
62
33
25
18
16
13
9
7
6
6
4
3
3
2
2
1
1
1
1
1
1
1
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Without
mismatches

With
mismatches

2069
1306
569
56
27
25
15
16
11
9
7
6
6
4
3
3
2

21
3
10
1
1
1

2
1
1
1
1
1
1
1

Total
2079
1306
572
57
28
25
15
16
11
9
7
6
6
4
3
3
2
2
1
1
1
1
1
1
1

No. of sequences
(Includes redundant species)
Domain

Phylum/Kingdom/Group

Without
mismatches

With
mismatches

57
57
12
3

Archaea
Euryarchaeota
Eukaryota
1

Viridiplantae
Fungi1

No. of distinct species#

Total

Without
mismatches

10
1

57
57
22
4

52
52
11
3

4

4

With
mismatches

Total

10
1

52
52
19
4

4

4

5

1

2

3

1

2

3

2

2

1

3

2

1

2

Diplomonadida5

1

1

2

1

1

1

Haptophyceae5

2

2

1

1

Choanoflagellida3

1

1

1

1

Cryptophyta2
Apusozoa

1
1

1
1
1
2485

1
1

1
1
1
2150

Stramenopiles
Ichthyosporea

Metazoa1
Total

2454

1
31

1

Kingdom, 2Class, 3Order, 4Genus, 5Unranked.

*

Phylum/Kingdom/Group entry was not provided.

#

Distinct species include distinct species, strains and subspecies.
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2132

1
31

Group B
This group has 7 sequences from 1 eukaryotic strain and 6 bacterial strains with
major phyla being Proteobacteria (4 strains). Six of these sequences have residues
missing in N-terminal whereas a bacterial sequence has residues missing in C-terminal,
which result in missing active site residues. The eukaryotic strain has another active site
conserved Family I-E IPPase and three bacterial strains have another active site
conserved Family I-P IPPase. 3 other strains do not have any other IPPase sequence in
our data.
Group C
This group has 10 sequences from 10 strains (9 bacterial, 1 eukaryotic) and these
sequences do not have any particular trend among mismatches in them. Five of these
strains have another active site conserved Family II IPPase, one has Family I-P IPPase
and one other strain has both Families I-P and II IPPase. Four sequences have only one
mismatch at positions 15, 149, 203 or 296, and the remaining six sequences have 3-10
mismatches at the active site.
3.2.3.4 Summary on mismatching sequences
Among the IPPases studied, Family I-E IPPases have the most number of
sequences with mismatches (13.65 %), and mismatches in about 55 % of those sequences
are due to protein isoforms (Table C.2 in Appendix C). Similarly, most of mismatching
Family I-P IPPase sequences in Kingdom Viridiplantae are due to isoforms as well. In
eukaryotes, especially among the kingdoms Viridiplantae and Metazoans, present of
active site mismatches are most likely due to protein isoforms. Mismatching IPPase
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sequences in other kingdoms or phyla of eukaryotes are not most likely not due to
presence of alternate splicing isoforms.
Mismatches in Family I-P IPPases are the most interesting as there are at least
three groups of mismatching sequences that are likely to be present only in closely related
species. Especially, groups A and B contain sequences from phyla Cyanobacteria and
Actinobacteria, respectively, and both these group were likely to have mutation
especially at Asp67 (E. coli IPPase numbering) albeit with different residues (Table C.1
in Appendix C). Furthermore, related sequences in group D have high number of
mutations (6-8) at active site but Family I-P IPPases are their closest matching protein
family. It remains to be seen if Group D is a new family of IPPases or protein of
different function.
Among all families, Family II IPPases shows great restraint against mutation with
just 1.25 % of sequences having any active site mutation. Group A had mismatch only at
their N-terminal active site residue His9 (Table C.3 in Appendix C) but unlike groups A
and B mismatching sequences of Family I-P sequences, these sequences are present not
just in the closely related species but across eukaryotes and prokaryotic species.
So far, importance of mismatching sequences are not known. It would be
interesting to study if such IPPases (both families) with active site mutations get
expressed in the cell and if they have any biological role, if any, in cells.
3.2.4

Mutation susceptible active site residues
With several Family I and II IPPase sequences found to have mismatches at active

site, it is of high significance to understand if such mismatches occur at all active site
positions in equal distribution, or certain positions get affected more than others. To
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answer this question, sequences that are, or are likely to be, alternate splicing isoforms,
missing residues in N- or C- terminals, have 4 or more mismatches and have unknown
residue X were ignored. Using these filters, the number of mismatching sequences used
in this analysis were 141 (of total 256) sequences in Family I-P IPPases, 40 (of 136)
sequences in Family I-E IPPases and 20 (0f 31) sequences in Family II IPPases. This
analysis shows that all active site residues are not affected equally, and this is true even
between Families I-P and I-E IPPases (Table 3.7) despite them being homologous
proteins.

Table 3.7. Number of mismatches at each active site residue position in Families I and II
IPPases.
Family I-P
No. of seqs. - 141

Family I-E
No. of seqs. - 40

Family II
No. of seqs. - 20

Active site

Total

Active site

Total

Active site

Total

20 E
29 K
31 E
43 R
55 Y
65 D
67 D
70 D
97 D
102 D
104 K
141 Y
142 K

2
2
17
43
0
1
84
1
6
3
1
32
22

48 E
56 K
58 E
78 R
93 Y
115 D
117 D
120 D
147 D
152 D
154 K
192 Y
193 K

10
8
4
11
1
1
1
0
4
4
2
9
15

9H
13 D
15 D
75 D
97 H
98 H
149 D
203 D
205 K
294 S
295 R
296 K

16
1
1
0
0
0
2
1
1
4
0
1
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Asp67 is highly susceptible to have mutation in Family I-P IPPases, though its
equivalent residue Asp117 of Family I-E IPPases is least likely to have mutation.
Interestingly, active site residues Asp65 and Asp70 that are nearby Asp67 are
predominantly unaffected in both Family I-P and I-E IPPases. In both subclasses of
Family I IPPases, residues Arg43 (E. coli numbering) and residues Tyr141 and Lys142,
which are near C-terminal, have higher number of mutations. However, for active site
residues near N-terminal, Glu20 and Lys29, unlike Glu31, are least likely to be affected
in Family I-P IPPases in contrast to their equivalent residues in Family I-E IPPases.
In summary, Asp67 (by E. coli residue numbering) is highly affected but only in
Family I-P IPPases, Arg43 and C-terminal residues Tyr141 and 142K are affected in both
Families I-P and I-E, and N-terminal residues Glu20 and Lys29 are affected only in
Family I-E IPPases. In contrast, residues Tyr55, Asp65, Asp70 and Lys104 are least
likely to be affected in both Families I-P and I-E IPPases. When active site was probed
in tertiary structure of Family I IPPases, most of these residues are spatially grouped in to
two opposite sides, mostly, depending on residues’ likeliness to have mutation
(Figure 3.19). This suggests that spatial arrangement of active site residues in tertiary
structure may potentially play a role in their natural selection towards mutation or
otherwise.
In Family II IPPases, active site residues that are likely to have mismatches are
His9 at N-terminal followed by Ser294 at C-terminal. In contrast, residues Asp75, His97,
His98 and Arg295 were not affected at all, while remaining active site residues have very
low number of mutations.
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Figure 3.19. Active site residues of E. coli IPPase colored by their likeliness to have mismatches
among both Family I-P and I-E IPPases. Residues that have low to moderate probability to have
mutation and those that are likely to have high probability for mutation in either Family I-P or I-E
IPPases are spatially arranged opposite to each other. However, Asp67 that has the highest
probability for mutation only in Family I-P IPPase is an exception. Color code: Red – Higher
number of mutations in both Families I-P and I-E; Blue: Lowest number of mutations in both
Families I-P and I-E; Cyan – Low to moderate number of mutations in both Families I-P and I-E;
Pink - Highest number of mutations in Families I-P only; Orange - Higher number of mutations in
Families I-E only; Green – Substrate pyrophosphate.

3.2.5

Species with more than one family of soluble IPPases
In order to identify species that contain more than one family of IPPases, only the

Family I and II IPPase sequences that have completely conserved active site were
considered. Among them, sequences with undefined species rank were ignored.
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3.2.5.1 Species with both Family I and II IPPases
Typically, an organism contains either Family I or Family II IPPase. However
four species, including pathogenic Vibrio cholera, were found to contain both families of
IPPases. Those four species belong to class Gammaproteobacteria and order Vibrionales.
Interestingly, genes of both IPPases were found to be transcriptionally active in species
V. cholerae, and their protein products were catalytically active when heterologously
expressed and purified from Escherichia coli. However, only Family I IPPase was found
to express at protein level in V. cholerae extracts [37]. Further in vivo expression
technology studies by infecting Humans and mice with V. cholerae showed that their
Family II IPPase gene is transcriptionally upregulated, but its deletion did not impact
their virulence. This suggests that presence of Family I IPPase in V. cholarae might be
sufficient for pyrophosphate hydrolysis in them [141], though experimental evidence is
yet to be obtained.
In this study, 149 species were identified to contain both Family I and Family II
IPPases (Table 3.8). 134 of these species are bacteria, 10 are eukaryotes and 5 are
archaea. Not surprisingly, all bacterial and archaeal species have Family I-P as their
Family I IPPase. However, while 8 of 10 eukaryotic species have Family I-E as their
Family I IPPase as expected, two eukaryotic species Guillardia theta CCMP2712 and
Thecamonas trahens ATCC 50062 instead have Family I-P IPPase.
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Table 3.8. Species that share active site conserved Family I (I-P and/or I-E) and Family II IPPases.
Domain

Phylum/Kingdom/
Genus
Group

Family
I-P

Species#

Family
I-E

Family
II

Bacteria

No. of Species#
134

Proteobacteria

110
Vibrio

alginolyticus
azureus
campbellii
cholerae
cholerae O1 biovar El Tor str. N16961
coralliilyticus
diazotrophicus
furnissii
genomosp. F10
harveyi
harveyi group
hepatarius
ichthyoenteri
litoralis
maritimus
mytili
nereis
nigripulchritudo
ordalii
owensii
parahaemolyticus
parahaemolyticus RIMD 2210633
proteolyticus
rumoiensis
sagamiensis
scophthalmi
sinaloensis
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x
x
x
x
x
x
x
x
x
x
x
x
x
x
x
x
x
x
x
x
x
x
x
x
x
x
x

x
x
x
x
x
x
x
x
x
x
x
x
x
x
x
x
x
x
x
x
x
x
x
x
x
x
x

Domain

Phylum/Kingdom/
Genus
Group

Photobacterium

Aeromonas

Citrobacter

Family
I-P

Species#
sp. 16
sp. AND4
sp. CAIM 1540
sp. N418
sp. ZOR0018
vulnificus
angustum
aphoticum
aquae
aquimaris
damselae
gaetbulicola
ganghwense
iliopiscarium
kishitanii
leiognathi
marinum
phosphoreum
profundum
sanctipauli
sp. JCM 19050
swingsii
allosaccharophila
bivalvium
enteropelogenes
hydrophila
hydrophila subsp. hydrophila ATCC 7966
molluscorum
rivuli
sobria
amalonaticus
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x
x
x
x
x
x
x
x
x
x
x
x
x
x
x
x
x
x
x
x
x
x
x
x
x
x
x
x
x
x
x

Family
I-E

Family
II
x
x
x
x
x
x
x
x
x
x
x
x
x
x
x
x
x
x
x
x
x
x
x
x
x
x
x
x
x
x
x

No. of Species#

Domain

Phylum/Kingdom/
Genus
Group

Klebsiella

Moraxella

Edwardsiella

Enterobacter

Colwellia
Pantoea
Marinomonas
Thalassomonas
Ferrimonas
Thioalkalivibrio

Family
I-P

Species#
freundii
koseri
pasteurii
sp. MGH 55
sp. MGH100
werkmanii
michiganensis
oxytoca
pneumoniae
variicola
boevrei
bovoculi
caprae
hoshinae
ictaluri
tarda
aerogenes
cloacae
cloacae subsp. cloacae ATCC 13047
psychrerythraea
sp. TT2012
ananatis
sp. At-9b
sp. MED121
sp. S3726
actiniarum
viridans
futtsuensis
kyonanensis
sp. AKL11
sulfidiphilus
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x
x
x
x
x
x
x
x
x
x
x
x
x
x
x
x
x
x
x
x
x
x
x
x
x
x
x
x
x
x
x

Family
I-E

Family
II
x
x
x
x
x
x
x
x
x
x
x
x
x
x
x
x
x
x
x
x
x
x
x
x
x
x
x
x
x
x
x

No. of Species#

Domain

Phylum/Kingdom/
Genus
Group

Family
I-P

Species#

Family
I-E

Family
II

Shewanella
Pluralibacter
Geoalkalibacter
Endozoicomonas
Salmonella
Budvicia
Sodalis
Enhydrobacter
Escherichia
marine
Pragia
Desulfuromonas
Serratia
Enterobacteriaceae
Shimwellia
Oleispira
Buttiauxella
Oxalobacter
Erwinia
Kosakonia
Mangrovibacter

marina
gergoviae
ferrihydriticus
montiporae
enterica
aquatica
praecaptivus
aerosaccus
coli
gamma proteobacterium HTCC2143
fontium
sp. TF
fonticola
bacterium B14
blattae
antarctica
agrestis
formigenes
mallotivora
radicincitans
sp. MFB070

x
x
x
x
x
x
x
x
x
x
x
x
x
x
x
x
x
x
x
x
x

x
x
x
x
x
x
x
x
x
x
x
x
x
x
x
x
x
x
x
x
x

Gordonia

aichiensis
alkanivorans
amicalis
namibiensis
otitidis
polyisoprenivorans
rubripertincta
sp. SGD-V-85
terrae

x
x
x
x
x
x
x
x
x

x
x
x
x
x
x
x
x
x

Actinobacteria

No. of Species#

12
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Domain

Phylum/Kingdom/
Genus
Group
Rubrobacter
Conexibacter
Corynebacterium

Family
I-P

Species#

Family
I-E

x
x
x

xylanophilus
woesei
durum

Family
II

No. of Species#

x
x
x

Firmicutes

9
desmolans
sp. ER2
Dehalobacter
sp. FTH1
Pontibacillus
marinus
Aneurinibacillus
terranovensis
Erysipelotrichaceae
bacterium NK3D112
Butyricicoccus
pullicaecorum
[Ruminococcus]
torques
Candidatus Desulforudis audaxviator

x
x
x
x
x
x
x
x
x

x
x
x
x
x
x
x
x
x

Rhodopirellula

baltica
maiorica

x
x

x
x

Fibrobacter

succinogenes

x

x

Eubacterium

Planctomycetes

2

Fibrobacteres

1

Eukaryota

10
Viridiplantae

3
Bathycoccus
Ostreococcus
Micromonas

prasinos
tauri
sp. RCC299

x
x
x

x
x
x

Sphaeroforma
Capsaspora

arctica JP610
owczarzaki ATCC 30864

x
x

x
x

Thecamonas

trahens ATCC 50062

Salpingoeca

rosetta

Ichthyosporea

2

Apusozoa

1
x

x

Choanoflagellida

1
x

Stramenopiles

x
1

134

Domain

Phylum/Kingdom/
Genus
Group

Family
I-P

Species#

Thalassiosira

pseudonana CCMP1335

Guillardia

theta CCMP2712

Family
I-E

Family
II

x

x

Cryptophyta

No. of Species#
1

x

x

Haptophyceae

1
Emiliania

x

huxleyi CCMP1516

x

Archaea

5
5

Euryarchaeota
Natrialba
Haladaptatus
Natronococcus
Halobacteriaceae
Halogeometricum

x
x
x
x
x

magadii
cibarius
amylolyticus
archaeon SB9
pallidum

x
x
x
x
x
Total

#

Species include distinct species, strains and subspecies
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Phylum Proteobacteria, which includes previously identified V. cholerae, is the
most pronounced phylum here with 110 species containing both families of IPPases.
Interestingly, 107 of them belong to class Gammaproteobacteria. Phylum Actinobacteria
is the second major contributor with 12 species, of which 10 species belong to class
Corynebacteriales. Among 9 species in phylum Firmicutes, 6 species belong to class
Clostridia. Six genera of bacteria contribute at least four species: Vibrio (33 species),
Photobacterium (16), Gordonia (9), Aeromonas (8), Citrobacter (7) and Klebsiella (4).
Together, these six genera contribute to about half of all the species that contain both
families of IPPases, and this demonstrates the prevalence of closely related species with
both family of IPPases. Vibrio being the largest Genus here is not surprisingly the first
genera of bacteria that was discovered to contain both families. Among the six genera
listed above, genus Gordonia belongs to class Corynebacteriales of phylum
Actinobacteria, whereas remaining five genera belong to class Gammaproteobacteria of
phylum Proteobacteria.
Interestingly, habitat of about 65 % of prokaryotic and eukaryotic species with
both Family I and II IPPases are marine or other water related sources. Other major
habitats include Humans, animals (mammals), plants and soil (Table 3.9). When oxygen
requirement of bacterial species was probed, >69 % were found to be facultative
anaerobic and >17 % to be aerobic (Table 3.9). It remains to be studied whether such
correlation of habitat and oxygen requirement to species having both Family I and II
IPPases is of any significance to those species.
Furthermore, interestingly, 31 species that have both families of IPPases are
pathogenic, opportunistic or otherwise (Table 3.9). Among them, 19 species are
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pathogenic to Humans, and others can affect fish, shrimp, animals or land plants. Few
notable Human pathogen among them are V. cholerae, Vibrio vulnificus, Klebsiella
pneumoniae, Klebsiella oxytoca, Salmonella enterica and Aeromonas hydrophila.
E. coli is known to have only Family I-P IPPase among soluble IPPases [20].
Surprisingly, E. coli was found to contain both Family I-P and Family II IPPases (Table
3.8). However, it still stands true that commensal E. coli contains only the former, but
the latter is found to be present in a strain of extraintestinal pathogenic E. coli (ExPEC).
ExPEC is the most common gram negative bacterial pathogen in Humans capable of
causing urinary tract infections, adult bacteremia and neonatal meningitis [142, 143]. A
putative Family II IPPase gene (34 % identical to B. subtilis IPPase with 98 % query
coverage) is located in pAPEC-O103-ColBM, a hybrid RepFIIA/FIB mobilizable
plasmid in ExPEC. This plasmid confers ExPEC the ability to cause septicemia in
chickens and meningitis in rats [142]. Commensal E. coli strains contain just Family I-P
IPPases, but certain ExPEC strains have a Family II IPPase due to this plasmid. It is not
known if or when Family II IPPase from this plasmid gets expressed at protein level, or if
this provides any advantage to ExPEC for its virulence.
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Table 3.9. Habitat, pathogenicity and O2 requirement nature of species that has both active site conserved Family I and II IPPases.

Domain

Phylum/
Kingdom/
Group

Genus

Species#

Habitat

Pathogenic to

Source

Vibriof

alginolyticus
azureus
campbellii
cholerae
cholerae O1 biovar El Tor str. N16961
coralliilyticus
diazotrophicus
furnissii
genomosp. F10
harveyi
harveyi group
hepatarius
ichthyoenteri
litoralis
maritimus
mytili
nereis
nigripulchritudo
ordalii
owensii
parahaemolyticus
parahaemolyticus RIMD 2210633
proteolyticus
rumoiensis
sagamiensis
scophthalmi

Marine
Marine
Marine
WEM
WEM
Marine
Marine
Marine
Marine
Marine
Marine
Marine
WEM
WEM
Marine
WEM
Marine
Marine
Marine
WEM
Marine
Marine
Marine
WEM
Marine
WEM

Fish

[144]
[145]
[146]
[147]
[148]
[149]
[150]
[151]
[152]
[153]
[153]
[154]
[155]
[156]
[157]
[158]
[159]
[160]
[161, 162]
[163]
[164]
[164]
[165]
[166]
[167]
[168]

Bacteria
Proteobacteria
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Human
Human
Coral

Fish

Shrimp
Fish
Human
Human

Domain

Phylum/
Kingdom/
Group

Species#

Genus

Photobacteriumf

Aeromonasf

f

Citrobacter

Habitat

sinaloensis
Marine
sp. 16
sp. AND4
Marine
sp. CAIM 1540
WEM
sp. N418
sp. ZOR0018
WEM
vulnificus
Marine
angustum
Marine
aphoticum
Marine
aquae
Marine
aquimaris
Marine
damselae
Marine
gaetbulicola
WEM
ganghwense
Marine
iliopiscarium
Marine
kishitanii
Marine
leiognathi
Marine
marinum
Marine
phosphoreum
Marine
profundum
Marine
sanctipauli
WEM
sp. JCM 19050
swingsii
Marine
allosaccharophila
Human, WEM, Animal
bivalvium
WEM
enteropelogenes
Human
hydrophila
WEM
hydrophila subsp. hydrophila ATCC 7966 Milk
molluscorum
WEM
rivuli
WEM
sobria
Human, WEM
amalonaticus
Human
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Pathogenic to

Human

Human

Fish

Human, Fish

Humanop, Fish
Human

Source
[169]
[148]
[170]
[171]
[152]
[172]
[173]
[174]
[175]
[176]
[177]
[178]
[179]
[180]
[181]
[182]
[183]
[184]
[185]
[186]
[187]
[188]
[189]
[190]
[191, 192]
[193]
[194]
[195]
[196, 197]
[198]

Domain

Phylum/
Kingdom/
Group

Genus

Klebsiellaf

Moraxellaae

Edwardsiellaf

Enterobacterf

Colwellia
Pantoeaf
Marinomonasae
Thalassomonasae
Ferrimonasf
Thioalkalivibrio

Species#

Habitat

freundii
koseri
pasteurii
sp. MGH 55
sp. MGH100
werkmanii
michiganensis
oxytoca
pneumoniae
variicola
boevrei
bovoculi
caprae
hoshinae
ictaluri
tarda
aerogenes
cloacae
cloacae subsp. cloacae ATCC 13047
psychrerythraea
sp. TT2012
ananatis
sp. At-9b
sp. MED121
sp. S3726
actiniarum
viridans
futtsuensis
kyonanensis
sp. AKL11
sulfidiphilus
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Soil, WEM, Food
Human
Human
Human
Human
Animal
Tooth brush
Human
Plants (Land), Human
Animal
Animal
Animal
Birds, reptiles, WEM
WEM
WEM
Human
Human
Human
Marine
Marine
Plants (Land)
Plants (Land)
Marine
Marine
Marine
Marine
Beach
WEM
WEM
Bioreactor

Pathogenic to

Source

Humanop, Animalop,
Fish
[199, 200]
Humanop
[201]
[202]
[148]
[148]
[203]
[204]
Human
[205]
Humanop
[206]
[207]
[208]
[209]
[210]
[211]
Fish
[212]
Fish
[213]
Human
[214]
Humanop
[215]
Humanop
[216]
[217]
[148]
Plant
[218]
Plant
[219]
[152]
[148]
[220]
[221]
[222]
[222]
[148]
[223]

Domain

Phylum/
Kingdom/
Group

Genus

Species#

Habitat

Shewanellaf
Pluralibacterf
Geoalkalibacteran
Endozoicomonas
Salmonellaf
Budviciaf
Sodalisae
Enhydrobacterf
Escherichiaf
marine
Pragiaf
Desulfuromonas
Serratiaf
Enterobacteriaceaef
Shimwelliaf
Oleispiraae
Buttiauxellaf
Oxalobacteran
Erwiniaf
Kosakoniaf
Mangrovibacterf

marina
gergoviae
ferrihydriticus
montiporae
enterica
aquatica
praecaptivus
aerosaccus
coli
gamma proteobacterium HTCC2143
fontium
sp. TF
fonticola
bacterium B14
blattae
antarctica
agrestis
formigenes
mallotivora
radicincitans
sp. MFB070

Marine
Plants (Land), Human
WEM
Marine
Animal
WEM
Human
WEM
Human, Animal
Marine
WEM
Marine
WEM, Soil
Insect
Insect
Marine
WEM
Human, Animal
Plants
Plants
WEM

Gordoniaae

aichiensis
alkanivorans
amicalis
namibiensis
otitidis
polyisoprenivorans
rubripertincta
sp. SGD-V-85
terrae
xylanophilus

Human
WEM
Soil
Soil
Human
WEM
Plants (Land)

[244]
[245]
[246]
[247]
[248]
[249]
[250]

Human
WEM

[251]
[252]

Pathogenic to

Human

Human

Humanop

Plant

Source
[224]
[225]
[226]
[227]
[228]
[229]
[230]
[231]
[232]
[233]
[234]
[152]
[235]
[236]
[237]
[238]
[239]
[240]
[241]
[225, 242]
[243]

Actinobacteria

Rubrobacterae
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Domain

Phylum/
Kingdom/
Group

Genus

Species#

Habitat

Conexibacterae
Corynebacteriumf

woesei
durum

Soil
Human

[253]
[254]

desmolans
sp. ER2
Dehalobacterae
sp. FTH1
Pontibacillusae
marinus
Aneurinibacillus
terranovensis
Erysipelotrichaceae
bacterium NK3D112
Butyricicoccusan
pullicaecorum
[Ruminococcus]
torques
Candidatus Desulforudis audaxviator

Animal
Human
Soil
Saltern
Soil
Animal
Animal
Human
WEM

[255]
[256]
[152]
[257]
[258]
[152]
[259]
[260]
[261]

Rhodopirellulaae

baltica
maiorica

Marine
Marine

[262]
[263]

Fibrobacteran

succinogenes

Human

[264, 265]

Bathycoccus
Ostreococcus
Micromonas

prasinos
tauri
sp. RCC299

Marine
Marine
Marine

[266]
[267]
[268]

Sphaeroforma
Capsaspora

arctica JP610
owczarzaki ATCC 30864

Marine
WEM

[269, 270]
[269]

Thecamonas

trahens ATCC 50062

Marine

[271, 272]

Salpingoeca

rosetta

Marine, WEM

[273]

Thalassiosira

pseudonana CCMP1335

Marine

[274]

Pathogenic to

Source

Firmicutes
Eubacteriuman

Planctomycetes

Fibrobacteres
Eukaryota
Viridiplantae

Ichthyosporea

Apusozoa
Choanoflagellida
Stramenopiles
Cryptophyta
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Domain

Phylum/
Kingdom/
Group

Genus

Species#

Habitat

Guillardia

theta CCMP2712

Marine

[275, 276]

Emiliania

huxleyi CCMP1516

Marine

[277]

Pathogenic to

Source

Haptophyceae
Archaea
Euryarchaeota
Natrialba
magadii
WEM
Haladaptatus
cibarius
Marine
Natronococcus
amylolyticus
WEM
Halobacteriaceae
archaeon SB9
Marine
Halogeometricum
pallidum
WEM
f
Facultative anaerobes; anAnaerobes; aeAerobes [152, 220-222, 224-226, 230, 237, 238, 243, 257, 259, 262, 283, 284]
op

Opportunistic pathogen.

WEM – Water related habitat other than seawater.
#

Species include distinct species, strains and subspecies.
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[278]
[279]
[280]
[152]
[281, 282]

So far, Family II IPPases are known to be present only in bacteria and archaea
[20]. However, in our analysis, 12 eukaryotic species were found to have active site
conserved Family II IPPases (Table 3.6), and 10 of those species also have Family I-P or
Family I-E IPPases (Table 3.8). All of those 10 eukaryotic species are unicellular, and
their habitat is either marine or other water related sources. Six of these species are algae
and the remaining are amoeba, ichthyosporean or flagellate.
3.2.5.2 Species with both Family I-P and I-E IPPases:
There are 63 species that contained both types of Family I IPPases (i.e. Family I-P
and Family I-E) and all of them are eukaryotic (Table 3.10). Not surprisingly, most of
them are in kingdom Viridiplantae (55 species) as they are known to have both Family
I-P and I-E IPPases in cytoplasm, chrloroplast and/or mitochondria [31, 33]. Of those
55 species, 50 are from class Streptophyta and the remaining 5 are from phylum
Chlorophyta.
Among the remaining species, seven are from kingdom Metazoa and are
multicellular organisms. They range from Trichoplax adhaerens (the structurally
simplest metazoan), worm, insects to aquatic or land mammals. Besides these, Naegleria
gruberi strain NEG-M, a unicellular protest, contains both types of Family I IPPases.
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Table 3.10. Species that share active site conserved Family I-P and I-E IPPases.
Domain

Kingdom

Genus

Species#

Amborella
Arabidopsis

trichopoda
lyrata subsp. lyrata
thaliana
protothecoides
vulgaris subsp. vulgaris
distachyon
napus
oleracea var. oleracea
rapa
sativa
rubella
reinhardtii
variabilis
arietinum
clementina
sinensis
subellipsoidea C-169
melo
sativus
guineensis
guttata
grandis
salsugineum
vesca subsp. vesca
max
raimondii
curcas
domestica
truncatula
notabilis
acuminata subsp. malaccensis
nucifera
sylvestris
tomentosiformis
brachyantha
vulgaris
dactylifera
patens
euphratica
trichocarpa
mume
persica
x bretschneideri
communis
indicum

Eukaryota Viridiplantae

No. of Species#
55

Auxenochlorella
Beta
Brachypodium
Brassica

Camelina
Capsella
Chlamydomonas
Chlorella
Cicer
Citrus
Coccomyxa
Cucumis
Elaeis
Erythranthe
Eucalyptus
Eutrema
Fragaria
Glycine
Gossypium
Jatropha
Malus
Medicago
Morus
Musa
Nelumbo
Nicotiana
Oryza
Phaseolus
Phoenix
Physcomitrella
Populus
Prunus
Pyrus
Ricinus
Sesamum
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Domain

Kingdom

Genus

Species#

Setaria
Solanum

Sorghum
Tarenaya
Theobroma
Vigna
Volvox
Zea

italica
lycopersicum
pennellii
tuberosum
bicolor
hassleriana
cacao
radiata var. radiata
carteri f. nagariensis
mays

Bombus
Caenorhabditis
Lipotes
Monomorium
Pantholops
Plutella
Trichoplax

impatiens
remanei
vexillifer
pharaonis
hodgsonii
xylostella
adhaerens

No. of Species#

Metazoa

7

Heterolobosea1

1
Naegleria

gruberi strain NEG-M
Total

1

Class

#

Species include distinct species, strains and subspecies.

63

3.2.5.3 Lateral gene transfer
When sequenced genes in eukaryotic organisms are found to be of prokaryotic
origin rather than eukaryotic origin, there is a need for probing them in order to ascertain
that they actually belong to the said species. There is a possibility that such prokaryotic
origin genes might be a byproduct of bacterial DNA contamination occurred during
sample preparation for sequencing, or they were from bacteria that were associated with
the eukaryotic cells, either environmentally or symbiotically. Besides these, those
sequences may indeed be a part of the eukaryotic species’ genome and this may have
occurred due to lateral gene transfer from prokaryotes to eukaryotes [285]. Lateral gene
transfer plays a significant role in evolution among prokaryotes but more and more
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evidence are increasingly available about later gene transfer from prokaryotes to
eukaryotes – both vertebrates and invertebrates [286, 287].
In contrast to current knowledge available in literature, Family I-P IPPases were
found to be present in multicellular metazoans (Table 3.10) and Family II IPPases in
unicellular eukaryotes (Table 3.8). The possibility that Family I-P IPPases are actually
present in those metazoans’ genome, and they were acquired due to lateral gene transfer
from prokaryotes cannot be ignored. Indeed, recently, it was found that amoebozoan
Mastigamoeba balamuthi, an invertebrate eukaryote, contains one Family I-E IPPase and
two Family I-P IPPases, and it was suggested that the M. balamuthi may have acquired
the latter by lateral gene transfer from prokaryotes [288]. Mastigamoeba balamuthi is
noted not to be found in our analysis (Table 3.8) as IPPase sequences from this species
was not available as part of RefSeq protein database. Eukaryotic species Trichoplax
Adhaerens (a primitive animal) and Plutella xylostella (diamondback moth), both of
which contain Family I-P as well as Family I-E IPPases, were suggested to have acquired
certain genes from prokaryotes [285, 289].
Similarly, same argument can be made for presence of Family II IPPases, which
were identified only in prokaryotes so far, in eukaryotes. Indeed, eukaryotes Emiliania
huxleyi and Thalassiosira pseudonana – which have both Family II and Family I-E
IPPases (Table 3.8) – were suggested to have acquired certain genes by lateral gene
transfer from bacteria or viruses [290, 291]. As few of the eukaryotic species, which
were identified to have more than one family of IPPases, are suggested to have obtained
certain genes (though not IPPase gene) from prokaryotes or viruses, it is possible that the
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eukaryotic species – some if not all –identified here do indeed have more than one family
of soluble IPPases in their genome.
3.2.6

Signature sequence analysis
Primary sequence motifs, also called as signature sequences, are used to great

extent in bioinformatics sequence analysis for protein. They may represent highly
conserved active sites in enzymes, binding sites in proteins and can also be used to
determine family of proteins [292]. Signature sequence for Family I IPPases (Families
I-P and I-E combined) had been analyzed as part of PROSITE database and its regular
expression has been defined as ‘D-[SGDN]-D-[PE]-[LIVMF]-D-[LIVMGAC]’
(corresponding to residues 65-71 for E. coli IPPase and residues 115-121 for S. cerevisiae
IPPase). Such detailed regular expression is not available yet for Family II IPPases but
sequence ‘SRKKQxxP’ (residues 294-301 for B. subtilis IPPase) at their C-terminal was
proposed to be their signature sequence [293-295].
In both cases, three residues of their signature sequence are part of their respective
active site (by reference sequence numbering - 65D, 67D and 70D for E. coli IPPase,
residues 115D, 117D and 120D for S. cerevisiae IPPases and residues 294S, 295R and
S296K for B. subtilis IPPases). The mass investigation of all soluble Family I and II
IPPases from RefSeq database provides a unique opportunity to analyze the extent of
conservation of their signature sequences. Here, for both families of IPPases, respective
signature sequences were studied by considering only those sequences that have active
site completely conserved, and their regular expressions were constructed (Figure 3.20,
Table 3.11). Furthermore, Families I-P and I-E IPPases were studied separately in order
to spot differences, if any present.
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Family I-P

Family I-E

Family II

Family I-P – Mismatch groups
Group A

Group B

Group C

Group D

Figure 3.20. Sequence logos of signature sequences. Only the sequences that have active site
completely conserved were utilized to obtain sequence logos for Family I and Family II IPPases
(top row). Signature sequences of Groups A-D of Family I-P IPPases mismatches are also shown
(bottom row). Amino acids are colored by their charge: Yellow- non polar; Green- polar,
uncharged; Red- polar, acidic; Blue- polar, basic.

Table 3.11. Regular expression patterns of signature sequence for Family I and II IPPases.
IPPase family
I-P

Signature sequence
D-[GNSEHKDQLRATC]-D-[PEAHSG]-[LVIAMCFTSQ]-D-[VAIGCMTSLF]*
D-[GNSEHKD]-D-[PEA]-[LVIAMCFT]-D-[VAIGC]#
D-[NGDSQTK]-D-P-[ILVTM]-D-[VIACLGRF] *

I-E

II

D-[NGDS]-D-P-[ILV]-D-[VIACLG] #
S-R-K-[KSRNQLT]-[QEDVNLG]-[VILGMFTAYC]-[VILWAGMFTSQ]-[PATNSG] *
S-R-K-[KSRN]-[QED]-[VILGMF]-[VILWAGM]-[PAT] #

*

If all residues were considered irrespective of their frequency.

#

If only residues that have frequency >0.5 % were considered.
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3.2.6.1 Signature sequence in Family I IPPases:
E. coli IPPase numbering is used here to describe signature sequence of both
Family I-P and I-E IPPases. Comparison of signature sequences of Family I-P IPPases
and Family I-E IPPases reveal that besides aspartates at active site positions 65, 67 and
70, proline is heavily conserved at position 68 (95.7% for Family I-P and 100% for
Family I-E IPPases). Interestingly, though amino acids at positions 69 and 71 are not as
conserved as proline at position 68, amino acids at these positions are predominantly
non-polar (Figure 3.20). Therefore, it is possible that non-polar nature of these residues
at these positions may play a role structurally or functionally in Family I IPPases. This is
not the case at position 66 though where, strikingly, amino acid glycine is predominantly
present in Family I-P IPPases (83.6%) whereas polar asparagine is primarily present at
this position in Family I-E IPPases (93.5%).
However, it is interesting to note that cytoplasmic IPPases in plants of phyla
Streptophyta, which are of type Family I-P unlike their chloroplastic counterpart,
predominantly (~89%) contain polar amino acids Asn or Ser at this poition similar to
Family I-E IPPases. This is shown as Group C of Figure 3.20 – though this is sequence
logo of sequences with mismatches, this is true even for sequences without mismatches.
Groups A and B of Family I-P IPPases with active site mismatches have or likely to have
mismatch at Asp67 where Group D of same family, despite having 6-8 active site
mismatches, have conserved active site residues in the signature sequences. This might
be the reason why sequences in Group D were categorized as Family I IPPases as despite
the sequence similarity, signature sequences are also used to categorize protein
sequences.

150

3.2.6.2 Signature sequences in Family II IPPases:
In addition to conserved active site residues at positions 294, 295 and 296
(B. subtilis IPPase numbering) in Family II IPPase’s signature sequence, residues lysine,
glutamine and proline are heavily conserved at positions 297 (92.2%), 298 (95.8%) and
301 (98%), respectively. Beside active site residue positions, polar amino acids are
pronounced at positions 297 and 298 whereas non-polar amino acids are pronounced at
positions 299, 300 and 301.
3.2.7

UniProtKB/Swiss-Prot
UniProtKB/Swiss-Prot database contains high quality, manually curated protein

sequences [54]. Mass analysis of IPPases obtained from RefSeq protein database
contained a small number of manually curated protein sequences whereas for the most
sequences, annotations were automatically generated by annotation programs. Here,
IPPase sequences from UniProtKB/Swiss-Prot database were analyzed to demonstrate
sequence analysis by Scheme A (Figure 3.15) and to determine the presence of
mismatching active site residues among high quality, manually curated IPPase sequences.
There were 341 sequence hits obtained from UniProtKB/Swiss-Prot database and
they were converted to FASTA format using ResCon. A neighbor-joining phylogenetic
tree was constructed using Clustal Omega and clades containing Family I-P, I-E and II
IPPases were identified (Figure 3.21) and their sequences were isolated using ResCon.
Remaining clade (branch length – 0.431663) was verified not to have any Family I-P, I-E
or II IPPases as sequences in it did not have bit score greater than 50 to the reference
sequences (Table 2.2). Then, Family I-P, I-E and II IPPases were analyzed for
mismatches at their active site using ResCon with respective reference sequences.
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109 Sequences belonged to Family I-P IPPases, 28 to Family I-E IPPases and 98 to
Family II IPPases (Figure 3.21). Only one Family I-P IPPase and one Family II IPPase
had mismatches at the active site. In both cases, mismatches were due to those sequences
being incomplete – one sequences was 25 aa long and the other was 16 aa long.
In terms of taxonomy domain and phyla/kingdom, results obtained here
corresponded to conventional knowledge about soluble IPPases (Table 3.12). Family I-P
IPPases were present in bacteria, archaea, and only in kingdom Viridiplantae in
eukaryotes; Family I-E IPPases were present only in eukaryotes; Family II present
predominantly in phylum Firmicutes along with three other phyla of bacteria and archaea.

Figure 3.21. Phylogenetic tree of IPPase sequences from UniProtKB/Swiss-Prot database. An
unrooted neighbor-joining phylogenetic tree was built using Clustal Omega to separate each family
of IPPases. Numbers above branches refer to the branch length of clades. Total number of
sequences and number of sequences with mismatches at active site in respective clades of Family
I and II IPPases are shown.
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Table 3.12. Summary of sequences by taxonomy ranks for Family I-P, I-E and II IPPases from UniProtKB/Swiss-Prot database.
Family I-P
Domain

Phylum/Kingdom/Group

Family I-E

Without
With
mismatches mismatches

Bacteria

79
3
47
8
7
5
4
2
2
1

Firmicutes
Proteobacteria
Actinobacteria
Chlamydiae
Tenericutes
Cyanobacteria
Spirochaetes
Aquificae
Deinococcus-Thermus
Thermotogae
Eukaryota

1

Metazoa

11

1

Amoebozoa

5

Alveolata5
Archaea
Euryarchaeota
Crenarchaeota
Nanoarchaeota
Total

18
13
4
1
108

94
92

1
1

28
15

15

2

13

9

9

1

1

1

1
21
16
4
1
235

3
3

1

No. of
sequences
175
96
47
8
7
5
5
2
2
2
1
39

1
1

Fungi1
Viridiplantae

Without
With
mismatches mismatches

1

11
1

Without
With
mismatches mismatches

Family II

28

1

Kingdom, 2Class, 3Order, 4Genus, 5Unranked.
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97

1

No. of
sequences
with
mismatches
2

1

1

2

3.2.8

Limitations and assumptions
Two major assumptions have been made in the active site conservation analysis of

Family I and II IPPases:
1. If active site is completely conserved, then those IPPase sequences are
considered to be functional enzymes. However, this might not be true for all
sequences because not all of those sequences may get expressed at protein level,
or they may have mutation at non-active site residue(s) that are necessary for
their structural or functional stability.
2. If a sequence does not have any mismatches at the active site, then that sequence
would be considered to have completely conserved active site. While this would
be true for most sequences, there is a possibility that a small number of
sequences turned out not to have mismatches due to multiple sequence alignment
being not completely accurate, and neighboring residues were aligned instead to
reference sequence’s active site residue position. While the same could be said
for those sequences identified to have mismatches, it was ensured that they
actually do have mismatches by manually probing them.

3.3

Residue conservation in Family I and II IPPases
Among the Family I and II IPPase sequences with completely conserved active

site, overall conservation of residues across the reference sequence was analyzed. Such
analysis could potentially result in identifying structurally and functionally important
residues, besides the active site and oligomeric interface residues. For example, if a
residue is a highly conserved and surface exposed but is not involved in active site or

154

oligomeric interface, they could potentially be involved in protein-protein interaction or
binding of ligands, effectors, etc. As redundant sequences may introduce significant bias
if closely related sequences are over-represented in the data, sequences were clustered to
remove redundant sequences that had >90 % identity. This resulted in the removal of
44 % - 57 % of sequences (Table 3.13). Evolutionary conservation of all residues in each
family of IPPases, with respect to their reference sequence, was performed using ConSurf
from the non-redundant sequences [87]. ConSurf assigns conservation score ranging
from 1 to 9 depending on the extent of evolutionary rate of conservation. Highest grade
of 9, doesn’t necessarily mean residues are 100 % conserved; it instead suggests that the
position is evolutionarily conserved.

Table 3.13. Sequence clustering with 90 % identity as threshold.

3.3.1

IPPase
Family

No. of sequences with
conserved active site

No. of non-redundant
sequences

I-P
I-E
II

5126
860
2454

2179
456
1366

Family I IPPases
Among Family I IPPases, residues of Family I-E IPPases tend to be more

conserved than that of Family I-P IPPases (Figure 3.22). If a residue in Family I-P
IPPase is highly conserved, its equivalent residue in Family I-E IPPase is also highly
conserved in similar fashion. Exception is Glu187 (ConSurf grade – 6) of S. cerevisiae
IPPase, which is not as highly conserved as its equivalent residue His136 (ConSurf
grade – 9) of E. coli IPPase.
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Figure 3.22. Residue conservation in Family I-P and I-E IPPase sequences. E. coli IPPase (PDB:
2au6) and S. cerevisiae IPPase (PDB: 2ihp) were used as reference sequences and aligned based on
their structural homology using PDBeFold [296]. Colors highlighting the amino acids represent
evolutionary amino acid conservation grade, as shown in legend, determined by ConSurf [87]. Red
arrow below and above the sequences represent active site residues, which are 100 % conserved.
Green and red circles represent residues with ≥91 % identity, as shown in legend, with respect to
residues of reference sequences. Secondary structure (from PDB: 2au6 and 2ihp) is depicted above
the sequences (squiggles - α-helices, arrows – β-strands, TT – strict β-turns and TTT – strict
α-turns). Colored rectangular bar below sequence depicts relative solvent accessibility of residues
as determined from PDB: 2au6 and 2ihp (blue – accessible, cyan – intermediate and white – buried).
Orange boxed residues are part of structurally conserved OB fold, and B, M and T refer to stacked
bottom, middle and top residues of the OB fold. Residues in black dashed box represent the
signature sequence. Secondary structure and relative solvent accessibility were obtained using
ESPript 3.0 [297].
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Besides active site residues, which are 100 % conserved, significant number of
residues in Family I-P (14 residues) and I-E (40 residues) IPPases are highly conserved
with ≥91 % identity (Figure 3.22, Figure 3.23, Figure 3.24). Interestingly, three and
seven residues of Family I-P and I-E IPPases, respectively, are either 100 % or almost
100 % conserved (Table 3.14). Structurally, these residues are very close to active site
pocket, or they are in the layer surrounding the active site pocket. Asp42, which has been
proposed to be necessary to coordinate active site residues involved in substrate and
inhibitory Mg2+ ion binding in E. coli IPPase [298], is heavily conserved in both Family
I-P and I-E IPPases (Table 3.14).
Certain major differences can be seen between Family I-P and I-E IPPases among
these ultra-high conserved residues. For example, Gly114 of Family I-E IPPase is 100 %
conserved, but its equivalent residue in Family I-P IPPase is not as well conserved with
ConSurf grade of only 4. Pro52 of Family I-P IPPase is 100 % conserved, but just 5.9 %
of sequences have Proline at its equivalent position in Family I-E IPPase. Furthermore,
while residues at most of those positions are the same in both families, residues of
different charge or size are present at equivalent positions of Pro52 of Family I-P and
Glu101 and Gly114 of Family I-E IPPases.
Sequence of S. cerevisiae IPPase is 111 aa longer than E. coli IPPase, and those
additional amino acids are present as extensions in the former’s N- and C-terminals, and
as insertions (Figure 3.22). Most residues in those terminal extensions of Family I-E
IPPase are poorly conserved. However, the additional residues present as insertions
display varying levels of conservation. In the order of residues from N- to C-terminal,
while the first two insertions display moderate to high conservation, the last two
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insertions have poor to moderate conservation. The third insert, which is the longest
insertion with 12 aa, has varying levels of conservation with residues in its N-terminal
edge showing very high conservation (Pro103 – 95.8 % identity).
Interestingly, residues just prior to those terminal extensions in Family I-E
IPPases are highly conserved (Ser27 – 98 % and Leu229 – 93.2 % identity),
predominantly better than their equivalent residues in Family I-P IPPases (Figure 3.22).
Similarly, residues in one or both sides of the insertions in Family I-E tend to be well
conserved. Strikingly, longest insert sequence is present between residues Glu101 and
Gly114, and both these residues are almost 100 % conserved (Figure 3.22, Table 3.14).
Thus, in general, while additional amino acids, except a small fraction of them, present in
Family I-E IPPases tend to be poorly conserved, residues that are present at the edges of
these extensions/insertions tend to be highly conserved.
Most bacterial and archaeal Family I IPPases are believed to have homohexameric quaternary structure, assembled as dimer of trimers, and eukaryotic IPPases as
homodimer. Here, oligomeric interface interactions were analyzed using crystal
structures of reference proteins (Table 3.15, Table 3.16). In Family I-P IPPases,
conservation of residues involved in intra-trimeric interactions range from low to high,
with just 7 of 18 residues having ConSurf grade of 7 or higher. While Tyr30 and Val41
have ConSurf grade 9, residue Tyr is highly conserved at position 30 with 97.1 %
identity. However, Tyr30’s pairing residue Gln80 is poorly conserved. Though Tyr30’s
equivalent position is well conserved in Family I-E IPPases, they instead have Met as the
highly conserved residue (67.8 % identity) at that position. Unlike intra-trimeric
interactions, inter-trimeric interactions are better conserved with 5 of 8 residues having
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ConSurf grade of 7 or higher (Table 3.15). Many Family I-E IPPases are believed to
form homodimer as the quaternary structure. While none of the residues here show
>90 %identity as Tyr30 of Family I-P IPPases, Arg51 shows high conservation followed
by Trp52 and His87 (Table 3.16).
Family I-P IPPases are well conserved around active site pocket and are
reasonably conserved in the region that forms inter-trimeric interactions (Figure 3.23).
Besides these surface exposed residues, other surface exposed residues show low to
medium conservation. However, the interior of Family I-P IPPases show medium to high
conservation. In Family I-E IPPases, among surface exposed residues, besides active site
pocket, higher conservation is seen around the surface of dimer interface (Figure 3.24).
Compared to Family I-P IPPases, Family I-E has lower conservation on the surface but
its core interior shows medium to high conservation (Figure 3.24).
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Figure 3.23. Residue conservation in structure of Family I-P IPPases. A) Stereo diagram of E. coli
IPPase colored on the basis of evolutionary conservation of residues (determined using ConSurf)
in Family I-P IPPases. Substrate pyrophosphate (yellow colored) is shown at the active site.
B) Colored surface representation of E. coli IPPase with the leftmost structure oriented in the same
orientation as that in A. Subsequent images are rotated 90° around its y-axis. C) Stereo diagram
of E. coli IPPase colored on the basis of %Identity of residues in Family I-P IPPases. Active site
residues, which are of 100 % identity, are colored red. Residues with 91–98.9 % identity are
highlighted in green, and those with ≥99 % identity are highlighted in orange. Substrate and
product in the active site are shown in blue.
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Figure 3.24. Residue conservation in structure of Family I- E IPPases. A) Stereo diagram of
S. cerevisiae IPPase colored on the basis of evolutionary conservation of residues (determined
using ConSurf) in Family I-E IPPases. Substrate phosphate (yellow colored) is shown at the active
site. B) Colored surface representation of S. cerevisiae IPPase with the leftmost structure oriented
in the same orientation as that in A. Subsequent images are rotated 90° around its y-axis. C) Stereo
diagram of S. cerevisiae IPPase colored on the basis of %Identity of residues in Family I-E IPPases.
Active site residues, which are of 100 % identity, are colored red. Residues with 91–98.9 % identity
are highlighted in green, and those with ≥99 % identity are highlighted in orange. Product
phosphate in the active site is shown in blue.
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Table 3.14. Residues of Family I IPPases with ≥99 % identity. Residues with 91–98.9 %
identity are highlighted in green, and those with ≥99 % identity are highlighted in orange.
Active site residues, which are of 100 % identity, are not shown.
Family I-P
Family I-E
Residue
Residue
ConSurf
ConSurf
#
#
Residue % Identity
Residue % Identity
*
*
Grade
Grade
No.
No.
42
D
99.6
9
71
D
98.9
9
52
P
100
9
90
I
61.4
8
56
G
99.9
9
94
G
99.8
9
59
P
71.0
8
97
P
99.6
9
61
T
93.6
9
99
T
99.6
9
63
S
27.7
7
101
E
99.8
9
64
E
32.0
4
114
G
100
9
68
P
94
9
118
P
100
9
82
G
83.3
8
132
G
99.6
9
*
E. coli (Fam. I-P) or S. cerevisiae IPPase (Fam. I-E) numbering.
#
Residue with highest %Identity at that position.

Table 3.15. Oligomeric contacts in E. coli IPPase [299].
Intra-trimeric contacts
Inter-trimeric contacts
Residue
ConSurf Residue
ConSurf
Residue % Identity
Residue % Identity
No.
Grade
No.
Grade
1
S
13.8
6
26
D
11.7
3
26
D
11.7
3
46
S
11
5
27
P
35.6
7
48
A
25.3
7
28
I
25.1
8
50
F
15.1
5
30
Y
97.1
9
133
Q
27.4
8
36
S
35.2
6
136
H
75.2
9
39
L
36.4
5
140
H
39.1
7
40
F
28.3
3
143
D
59.2
7
41
V
53.1
9
44
F
33.8
7
75
T
27.9
6
76
P
31.7
5
77
Y
12.2
4
79
L
30.4
7
80
Q
6.9
1
84
V
51.3
5
85
I
43.2
7
113
L
23
5
Note: Residues with ≥ 91 % identity are highlighted in green.
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Table 3.16. Oligomeric contacts in S. cerevisiae IPPase [300].
Residue
No.
51
52
87
277
279

Residue

% Identity

R
W
H
D
W

80.3
73.9
25.2
28.9
62.1

ConSurf
Grade
9
7
7
3
2

3.3.1.1 OB-fold
Family I IPPases are classified as OB (oligonucleotide/oligosaccharide binding)
fold proteins. The core structure of family I IPPases is made of two α-helices and eight
β-strands where five of those β-strands form a β-barrel [301, 302]. OB fold was first
identified in oligonucleotide or oligosaccharide binding proteins, and it currently has
16 superfamilies and 36 families in SCOP database [302, 303]. Superfamily ‘nucleic
acid-binding proteins’ is the largest among them with 16 families. Theobald et al.
analyzed four families of this superfamily in 2001 and identified common structural
elements, despite lack of similarity among those sequences [304].
E. coli IPPase and S. cerevisiae IPPase of Family I IPPases superfamily were
compared to six other superfamilies of OB-fold (Table 3.17) in order to study the
relationship between conservation of their residues to their structural fold. There was no
significant sequence similarity between these superfamilies. These 7 superfamilies share
a common core of 32 residues aligning with an average RMSD of 2.60 Å, and they
(OB1 – OB4) primarily include four β-stands that are part of the OB-fold’s β-barrel
(Figure 3.25, Figure 3.26).
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Similar to analysis by Theobald et al. [304], stacking layers of residues
(designated as top, middle and bottom layers) are present in the interior of OB-fold, and
residues in these are primarily hydrophobic, especially in the middle layer (Figure 3.25).
While nucleic acid-binding proteins have two conserved glycine residues – one in OB1
and the other in OB4, IPPases have glycine residue conserved only in OB4 but not in
OB1. This glycine (Gly82 of E. coli IPPase) in OB4 block contributes to the tight β-turn
(Figure 3.25, Figure 3.26). Such tight turn appears to be highly significant for the proper
structural fold of OB-fold as they are highly conserved across several superfamilies of
OB-fold. This glycine residue is conserved in 83.3 % of Family I-P IPPase sequences
and in 99.6 % of Family I-E IPPase sequences (Figure 3.22).
Residue conservation in OB1-OB4 in Family I IPPases
In Family I IPPases, OB4 is partly exposed to solvent whereas OB1, OB2 and
OB3 are mostly well buried (Figure 3.22). OB2 and OB3 are heavily conserved,
followed by OB1 and OB4. OB1, OB2 and OB3 each have an active site residue in them.
Furthermore, OB3 contains the well-conserved signature sequence of Family-I IPPases
(Figure 3.22). In summary, Family I IPPases share four regions of OB-fold with seven
other OB-fold superfamilies, though they do not share any function and sequence
similarity with them.
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Table 3.17. OB-fold proteins used for structural analysis.
Protein
Ec-IPP

PDB ID
2au6-A

Protein name
Inorganic pyrophosphatase

Organism
Escherichia coli

Sc-IPP

2ihp-B

Inorganic pyrophosphatase

S17

1j5e-Q

Ribosomal protein S17

Saccharomyces
cerevisiae
Thermus thermophilus

HypC

2z1c-A

Hydrogenase assembly
chaperone (HypC)
EutN
2hd3-A
Ethanolamine utilization
(1-95)
protein (EutN)
GP5
1k28-A
Tail-associated lysozyme
(6-129)
gp5, N-terminal domain
PHO471 2exd-A*
Hypothetical protein
(72-143) PH0471 (NfeD homolog)
Ifi-16
2oq0-A
Gamma-interferon(115-202) inducible protein (Ifi-16)
*NMR structure

Thermococcus
kodakarensis
Escherichia coli

SCOP- Superfamily
Inorganic
pyrophosphatase
Inorganic
pyrophosphatase
Nucleic acid-binding
proteins
HupF/HypC-like

Source
[305]
[306]
[307]
[308]

EutN/CcmL-like

[309]

Enterobacteria phage
t4 sensu lato
Pyrococcus horikoshii

gp5 N-terminal
domain-like
NfeD domain-like

[310]

Homo sapiens

HIN-2000 domain-like

Unpublished

[311]

Figure 3.25. Partial order alignment of OB-fold protein superfamilies with secondary structures.
Structural-based sequence alignment was obtained using POSA (Partial Order Structure
Alignment) server in rigid mode [312]. Only the residues in common core are shown here.
Numbers in braces represent the number of amino acids that do not align. The conserved blocks
are labelled as OB1-4, with respective RMSD in parenthesis. Average RMSD of the common core
is 2.60 Å. Labels B, M and T refer to stacked bottom, middle and top residues in the OB fold.
Gly82 is completely conserved in OB4 (marked by asterisk) and is involved in tight beta-turn.
Secondary structures corresponding to the conserved OB blocks are shown above the sequence
(arrows or lines – β-strands, TT – strict β-turns and TTT – strict α-turns). Residues are highlighted
on the basis of their physiochemical characteristics (green – polar, blue – basic, red – acidic, yellow
– non-polar). Partial order alignment was highlighted based on physio-chemistry of residues using
Geneious, and secondary structures were depicted using ESPript 3.0 [127, 297].
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Figure 3.26. Structural-based sequence alignment of OB-fold proteins. Structural-based sequence
alignment was obtained using POSA (Partial Order Structure Alignment) server in rigid mode
[312]. A) Colored part in grey-colored monomeric fold of E. coli IPPase represent the structurally
conserved region of OB-fold among all superfamilies. Stacked bottom (B), middle (M) and top (T)
residues of OB-fold are shaded in yellow, cyan and pink, respectively. Highly conserved Gly82
that forms beta-turn is shown in green. B) Ribbon representation of multiple protein structure
alignment sharing complete monomeric structure of E. coli IPPase (light grey and blue)
superimposed with just the common core from other OB-fold structures (red – Sc-IPPase, green –
S17, yellow – HypC, dark grey – EutN, cyan – GP5, purple – PHO471, pink – Ifi-16). E. coli
IPPase in A and B are in same orientation. C is rotated form of B to clearly view OB1-4 blocks.

3.3.2

Family II IPPases
Besides active site residues, Family II IPPases have 22 residues with sequence

identity ≥91 % (Figure 3.27), and 17 of them are in the N-terminal domain (Figure 3.28).
Five of above 22 residues have ≥99 % identity, and all of those are present in N-terminal
domain either in the active site pocket or close to it (Figure 3.28, Table 3.18). It is highly
likely that that these residues are involved in the binding of ligands and their function. In
general, N-terminal domain is more conserved than C-terminal, both in the interior and
surface of the protein. Besides the active site pocket, dimeric interface region is medium
to high level of conservation but the other surface exposed regions are mostly poor to
medium level of conservation (Figure 3.28, Figure 3.27). Most of the residues involved
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in dimeric interface interactions are reasonably well conserved (Table 3.19). In
particular, threonine residues at 105 and 159 are heavily conserved.

Figure 3.27. Residue conservation in Family II IPPase sequences. B. subtilis IPPase (PDB: 2haw)
was used as reference sequence. Colors highlighting the amino acids represent evolutionary amino
acid conservation grade, as shown in legend, determined by ConSurf [87]. Red arrow below the
sequence represent active site residues, which are 100 % conserved. Green and red circles represent
residues with ≥91 % identity, as shown in legend, with respect to residues of reference sequence.
Secondary structure (from PDB: 2haw) is depicted above the sequence
(squiggles - α-helices, arrows – β-strands, TT – strict β-turns and TTT – strict α-turns). Colored
rectangular bar below sequence depicts relative solvent accessibility of residues as determined from
PDB: 2haw (blue – accessible, cyan – intermediate and white – buried). Residues in black dashed
box represent the signature sequence. Secondary structure and relative solvent accessibility were
obtained using ESPript 3.0 [297].
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Figure 3.28. Residue conservation in structure of Family II IPPases. A) Stereo diagram of
B. subtilis IPPase colored on the basis of evolutionary conservation of residues (determined using
ConSurf) in Family II IPPases. Substrate analog PNP (yellow colored) is shown at the active site.
B) Colored surface representation of B. subtilis IPPase with the leftmost structure oriented in the
same orientation as that in A. Subsequent images are rotated 90° around its y-axis. C) Stereo
diagram of B. subtilis IPPase colored on the basis of %Identity of residues in Family II IPPases.
Active site residues, which are of 100 % identity, are colored red. Residues with 91–98.9 % identity
are highlighted in green, and those with ≥99 % identity are highlighted in orange. Substrate analog
PNP in the active site is shown in blue.
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Table 3.18. Residues of Family II IPPases with ≥99 % identity (highlighted in orange).
Active site residues, which are of 100 % identity, are not shown.
Residue
No.
8
12
96
157
162

B. subtilis
Residue
G
P
D
T
D

% Identity
99.9
99.4
99.8
99.7
99.6

ConSurf
Grade
9
9
9
9
9

Table 3.19. Oligomeric contacts in B. subtilis IPPase.
Residue B. subtilis
ConSurf
% Identity
No.
Grade
Residue
99
R
70.8
9
100
I
47.8
7
105
T
93.3
9
106
A
24.1
3
110
Y
41
3
111
Y
28.2
7
113
A
34
7
159
T
96.3
9
Note: Interface interactions were obtained for S. gordonii IPPase (PDB ID: 1k20) using PISA
[313]. Residues of B. subtilis IPPase corresponding to those residues were obtained by sequence
alignment, and their conservation is shown above. Residues with ≥ 91 % identity are highlighted
in green.

3.4

Crystal structure of St-IPPase
The St-IPPase structure has two copies of polypeptide chains (A and B) per

asymmetric unit. Of the 175 residues of St-IPPase (excluding 6-His tag and fMet at
N-terminal, Appendix D), all were modelled in chain A, but residues 98-102 (which is
involved in β-turn motif in chain A) of chain B could not be modelled due to poor
electron density in that region. Similar poor electron density around same residues were
observed in crystal structures of E. coli IPPase [26, 299]. A summary of the model
statistics for the crystal structure of St-IPPase is shown in Table 3.20.
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Table 3.20. X-ray data collection and refinement statistics for St-IPPase crystal.
Data Collection
Wavelength (Å)
Temperature (K)
Resolution range (Å)
Space group

0.98
100
24.37 - 1.954 (2.024 - 1.954)
I23

Unit cell dimensions

a = b = c = 142.076 Å
α = β = γ = 90°

Total reflections
Unique reflections
Multiplicity
Completeness (%)
Redundancy

758926 (74771)
34517 (3428)
22.0 (21.8)
97.0 (100.0)
22.2
55.09 (11.33)
17.6

Mean I/sigma(I)
Wilson B-factor
Rmerge (%)

9.964 (47.16)

Rmeas (%)

10.21 (48.28)

Refinement
Reflections used in refinement
Reflections used for R-free

33465 (3238)
1934 (186)

Rwork (%)

18.26 (21.71)

Rfree (%)

20.89 (27.58)

Molecules per A.U.

2

Number of non-hydrogen atoms
macromolecules
Protein residues
RMS(bonds) (Å)
RMS(angles) (°)
Ramachandran plot
Favored (%)
Allowed (%)
Outliers (%)
Rotamer outliers (%)
Clashscore

3049
2751
345
0.01
1.1
98
1.7
0
1.3
6.18

Average B-factor (Å2)
32.76
macromolecules
31.75
ligands
44.71
solvent
42.04
Number of TLS groups
15
Note: Statistics for the highest-resolution shell are shown in parentheses.
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3.4.1

Monomeric fold
Similar to E. coli IPPases [26], St-IPPase is a single domain protein with OB fold

and is made of four α-helices and eight β-sheets with topology: α1-β1-β2-β3-β4-β5-β6β7- α2- α3-β8-α4 (Figure 3.29, Figure 3.30). Strands β1-β4-β5-β7-β6 forms a barrel,
which is the core of OB fold.
St-IPPase shares 94 % sequence similarity to E. coli IPPase (bacterial) and 42 %
to T. thioreducens IPPase (archaeal). Despite these differences in similarity, St-IPPase
has high structural similarity to both E. coli IPPase and T. thioreducens IPPase
(Tt-IPPase), as demonstrated by their average polypeptide backbone RMSD (root mean
square deviation) (Figure 3.30). Secondary structures and structural motifs of St-IPPase
were highly similar to that of E. coli IPPase, due to the high sequence similarity.
However, minor differences were seen between St-IPPase and Tt-IPPase including the
presence of β-turn and α-helix in the latter between β7 and α2. Though St-IPPase is
about 110 residues shorter and has lower sequence similarity (31 %) to S. cerevisiae
IPPase (eukaryotic), its core three dimensional structure has high structural similarity
with average RMSD 1.51 Å (Figure 3.30) [296].
Active site residues are well conserved in St-IPPase, both in sequence and in their
three-dimensional orientation (Figure 3.31, Figure 3.30C). These residues are present in
a cavity formed by strands β1, β2, β3, β4, β5, β6, β7, loop between β4 and β5 and another
loop between β8 and α3.
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B

C

Figure 3.29. Crystal structure of St-IPPase subunit and its secondary structure. A) Secondary
structures in crystal structure of St-IPPase (chain A) subunit are labelled showing its architecture.
N- and C-terminals are labelled. B) Two dimensional topology representation of St-IPPase subunit
with cylinders representing α-helices and block arrows representing β-sheets. C) Amino acid
sequence of St-IPPase is shown with corresponding secondary structure elements (α-helices and
β-sheets) and structural motifs (β-hairpin, β-turn and γ-turn).
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Figure 3.30. Structural alignment of St-IPPases with bacterial, archaeal and eukaryotic IPPases.
A) St-IPPase (pink) is superimposed with IPPases of E. coli (cyan, PDB ID: 2au7) and
T. thermoreducens (red, PDB ID: 3r5u). B) St-IPPase (pink) is superimposed with S. cerevisiae
IPPase (blue, PDB ID: 2ihp). St-IPPase shares high topology similarity with IPPases of E. coli,
T. thermoreducens and S. cerevisiae with average RMSD of 0.58 Å, 1.00 Å and 1.51 Å, respectively
[296]. Structural alignment was obtained and rendered using Pymol [28]. C) Secondary structure
observed in St-IPPase is highly similar to that of E. coli (bacterial) and
T. thioreducens (archaeal) IPPase. Secondary structure is depicted above the sequence
(squiggles - α-helices, arrows – β-strands, TT – strict β-turns and TTT – strict α-turns). Identical
residues are highlighted in bold. Structure driven sequence alignment was obtained using
PDBeFold, and figure was rendered using ESPript [296, 297].
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B

Figure 3.31. Active site of St-IPPase. A) Cartoon representation of St-IPPase monomer with active
site residues shown as sticks. B) Superimposition of active site residues of St-IPPase, E. coli IPPase
(PDB ID: 2au9) and Tt-IPPase (PDB ID: 3q9m). Orientation of St-IPPase in B is same as that in
A. Substrate pyrophosphate modelled in E. coli IPPase and Tt-IPPase is labelled as POP.

3.4.2

Oligomeric Contacts
The asymmetric unit of crystal structure of St-IPPase contained two monomers.

The PISA (Proteins, Interfaces, Structures and Assemblies) server was utilized to
determine the probable biologically-relevant quaternary structure of St-IPPase, by
analyzing interactions at probable interface between monomeric subunits and their
chemical thermodynamics [313]. This analysis predicted hexamer as the quaternary
structure of St-IPPase with solvent-accessible surface area as 40,000 Å2 and solventaccessible surface area of monomeric units buried upon assembly formation as
14,840 Å2. Hexameric St-IPPase is made of six identical monomeric subunits, arranged
as dimer of trimers (Figure 3.32). This is in line with quaternary structure of E. coli
IPPase and T. thioreducens IPPase, both in solution and crystal [20, 68, 299]. Each
monomeric subunit of hexameric has a solvent-exposed active site pocket.
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A

B

Figure 3.32. Oligomer of St-IPPase. St-IPPase forms a hexamer – dimer of trimers. Both A and
B show hexameric form of St-IPPase formed by two trimers (1st trimer subunits: Magenta + Pink
+ Red; 2nd trimer subunits: Green + Pale green + Cyan). B is 180° rotated form of A in its Y-axis.

Table 3.21. Oligomeric contacts of St-IPPase hexamer determined using PISA [313].
Intra-trimeric contacts
Hydrogen bonds
Hydrophobic bonds
Ser 1
Asp 26
Tyr 30
Pro 27
Ser 36
Ile 28
Leu 39
Phe 40
Val 41
Val 41
Phe 44
Phe 44
Gln 80
Thr 75
Pro 81
Pro 76
Val 84
Tyr 77
Leu 113
Leu 79
Val 84
Ile 85
Inter-trimeric contacts
Hydrogen bonds
Salt bridges
Asn 24
His 136
Asp 26
His 140
Ser 46
Asp 143
Ala 48
Phe 50
Gln 133
His 136
His 140
Asp 143
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Hexameric form of St-IPPase consists of inter-trimeric and intra-trimeric
interactions (Figure 3.32, Table 3.21). Inter-trimeric interactions mostly involve sidechain hydrogen bonds and salt bridges, contributed by nine residues. These residues are
present in the helix α3, excursions between α3 and β8, between β3 and β4, and between
β1 and β2. In contrast to inter-trimeric interactions, intra-trimeric interactions mostly
involve main-chain hydrogen bonds and hydrophobic side-chain bonds at the interface.
Residues contributing to these interactions are present in strands β2, β3, excursions
between β1 and β2, between β2 and β3, between β5 and β6, and between β7 and α2.
Hexameric E. coli IPPase involve same inter-trimeric and intra-trimeric
interactions as St-IPPase, except that inter-trimeric side-chain hydrogen bond between
Asn24 and Asp26, and intra-trimeric hydrogen bond between Pro81 and Gln80 are not
present in the E. coli IPPase [299].
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3.5

Cloning, purification, characterization and crystallization of Human IPPase

3.5.1

Gene synthesis, protein expression and purification
The sequence containing Human IPPase gene (ppa1), with hexahistdine tag and

thrombin cleavage site at its N-terminal (Appendix D), was codon-optimized using
DNAWorks [314], and oligonucleotide sequences for gene synthesis were designed
(Table 2.3). Using PCR-based SeqTBIO method, this sequence, with pET3a vector
specific sequences flanking at both the edges, was assembled in an inside-out manner
from oligonucleotides (Figure 3.33B) [117]. The synthesized gene was then inserted in
to linearized pET3a plasmid by in vivo homologous recombination in E. coli
(Figure 3.33A). After verifying five recombinant plasmids for successful gene insertion
(Figure 3.33C), only two (P2 and P3) out of those five resulted in successful overexpression of recombinant Human IPPase in E. coli Rosetta (Figure 3.33D).
Recombinant plasmid P2 was verified by sequencing to have error-free Human IPPase
gene, and hence it was used for subsequent experiments.
Similarly, C-terminal hexahistidine tagged Human IPPase (Appendix D) was
obtained by gene synthesis but when sequenced, it was found to be missing two
nucleotides – G438 and A439. Site directed mutagenesis employed to correct those
errors in the sequence failed to produce an error-free C-terminal his-tagged Human
IPPase. Hence, subsequent experiments were carried out only using N-terminal Histagged Human IPPase, and, from hereon, the term ‘Human IPPase’ refers to the Nterminal his-tagged protein.
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Figure 3.33. N-terminal hexahistidine tagged Human IPPase gene synthesis. A) Schema of Human
IPPase gene insertion in to pET3a plasmid via in vivo homologous recombination in E. coli.
B) Synthesis of sequence fragment containing recombinant Human IPPase gene, with vectorspecific sequences flanking at its edges, visualized using 1 % agarose gel electrophoresis. Lanes 1
through 12 show stepwise increase of size of synthesized sequence and lane 12 contains completely
synthesized sequence. Lane C has 60 bp oligonucleotide loaded as control. C) Insertion of
recombinant gene in pET3a plasmids P1 to P5 from five E. coli colonies was verified by PCR with
T7 forward and reverse primers. Band of size 1074 bp corresponds to the gene insert. D) After
transformation of plasmids P1 to P5 in to E. coli Rosetta, only cells with plasmids P2(1-3) and
P3(3) over-expressed recombinant Human IPPase (34 kDa, arrow-marked). E. coli cells
transformed with native pET3a plasmid without recombinant gene in it was used as negative
control. Label ‘UnIn’ represents samples that were not induced with IPTG.
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A.

pET3a w/o gene insert

B.

pET3a w/ P2 plasmid

Figure 3.34. Small scale purification test for Human IPPase. Ni-NTA agarose beads were used to
test for their binding to his-tagged Human IPPase and evaluated using 12 % SDS-PAGE. Purified
Human IPPase (34 kDa) can be seen in with E. coli transformed with pET3a containing P2 plasmid
(B) unlike those cells with native pET3a plasmid (A). Lane FT shows protein in clarified lysate
that did not bind with Ni-NTA beads, and lane Beads has beads resuspended after second elution.

Human IPPase was recombinantly expressed in E. coli Rosetta using T7
expression system. As Human IPPase has hexa-histidine tag, its nickel affinity was used
to purify the protein. Small scale protein purification with Ni-NTA agarose beads
confirmed the affinity of recombinant Human IPPase to nickel resin (Figure 3.34).
Following lysis of E. coli cells, Human IPPase was purified to >95 % homogeneity using
nickel affinity chromatography and size exclusion chromatography (Figure 3.35). Protein
yield typically obtained was about 60 mg of purified protein (by Bradford assay with
BSA as standard) from 5 g E. coli cells (wet-cell weight) grown in LB medium.
SDS-PAGE revealed Human IPPase (308 amino acids) to have molecular weight of
34 kDa, which corresponds to ProtParam estimated molecular weight of 34.7 kDa [315].
Its molecular weight in solution at pH 8.0 was determined to be 64.5 kDa corresponding
to homo-dimeric form as their quaternary structure, which is in agreement with
eukaryotic yeast IPPase [300].
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Figure 3.35. Purification of Human IPPase. After cell lysis, Human IPPase was purified using
nickel affinity chromatography (A) and size exclusion chromatography (B). Fractions
corresponding to the major peaks in chromatograms (A, B) contained Human IPPase. Purity of
fractions in the major peak of size exclusion chromatography (C), and its purity as a function of
purification steps (D) were evaluated using 12 % SDS-PAGE (C). Crude lysate shows strong
expression of Human IPPase (D). Nickel affinity and size exclusion chromatography results in
further purification of Human IPPase to greater than 95% homogeneity. Approximately 10 μg of
protein was loaded in each lane (D), stained with Coomassie brilliant blue and visualized with white
light illumination.
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3.5.2

Enzyme activity analysis
Human IPPase was assayed using ammonium molybdate based assay to determine

optimal conditions for pyrophosphate hydrolysis (Figure 3.36). It has highest activity at
37 °C, which is same as Human body temperature. It is inactive at 4 °C and has about
52 % activity at 25 °C. Highest activity was observed around neutral pH with optimal
activity at pH 7, and it has <10 % activity for pH<6 and pH≥9.5. Cytoplasmic pH of
Human cells range from 7.1 – 7.4 [316], and Human IPPase shows high hydrolysis
activity at this pH range.
Among the divalent cations, magnesium ions provide the highest activity, similar
to other Family I IPPases including S. cerevisiae IPPase [20, 301]. Its activity decreases
in the order of Mg2+ > Mn2+ > Zn2+ > Co2+ for Human IPPase, in contrast to the order
Mg2+ > Zn2+ > Co2+ > Mn2+ of IPPases from S. cerevisiae, an eukaryote [317] and
Pyrococcus horikoshii OT3, an archaeon [318]. Human IPPase had ~7 % activity in
presence of calcium ions, though they are known to inhibit S. cerevisiae and E. coli
IPPase [317, 319]. Human IPPase has >50 % activity at broad range of magnesium
chloride concentration [5 mM – 52.5 mM] with maximum activity at 10 mM (Figure
3.36). Mammalian cells have 0.5-1.0 mM free [Mg2+] in cytosol, and about 4-5 mM of
[Mg2+] in cytosol as a complex with as a complex with adenine trisphosphate and other
phosphometabolites in cytosol [320]. Human IPPase has just 2.3 % and 3.1 % of optimal
activity at 0.75 mM and 1.5 mM [Mg2+] in vitro.
Human IPPase has specific activity of 10,170 micromoles of phosphate produced
per milligram of IPPase per minute, when assayed in presence of Tris pH 7.0 and 7.5 mM
magnesium chloride at 37 °C.
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Figure 3.36. Enzyme activity assay on Human IPPase. A) Human IPPase has highest activity at
37 °C in presence of magnesium chloride and at pH 7.0. B) pH 7 is the optimal pH in presence of
magnesium chloride at 37 °C. pH of buffers were adjusted in above experiments (A and B) for
drift in pH to temperature change. C) Among divalent cations of chloride salts at 7.5 mM
concentration, magnesium shows highest activity at pH 7.0 and 37 °C. D) Effect of magnesium
chloride on Human IPPase at pH 7 and 37 °C. Error bars represent standard deviation where n = 6
(B, C) or n = 3 (A, D).
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3.5.3

Crystallization screening
Recombinant Human IPPase purified in presence of Tris pH 8.0 as buffer was

used. It was tagged with carboxyrhodamine, a fluorescent dye (excitation: 528 nm and
emission: 551 nm) and then subjected to preliminary crystallization screening by vapor
diffusion [111]. Dendrite crystalline form were observed in two precipitant conditions –
(1) 0.2 M MgCl2, 0.1 M Tris pH 8.5, 3.4 M 1,6-Hexanediol and (2) 0.1 M MES pH 6.5,
1.6 M MgSO4. However, optimization of these crystallization conditions, using sitting
drop vapor diffusion and capillary counter diffusion, did not improve crystal quality.
Using the crystalline material obtained in above conditions, seed stocks were prepared,
and random microseed matrix screening was performed with sitting drop vapor diffusion
[128]. This resulted in dendrite crystalline form appearing in more than 10 conditions but
all were similar to initial crystalline morphology without any qualitative improvement.
However, random microseed matrix using capillary counter diffusion [321]
resulted in three dimensional crystal (Figure 3.37). Crystals grew when 8.5 mg/ml
Human IPPase with seed stock, obtained in presence of 160 mM magnesium sulfate and
5 mM sodium pyrophosphate, was subjected to capillary counter diffusion with
precipitant 0.1 M HEPES pH 7.5, 0.2 M calcium chloride and 28% polyethylene glycol
400. Despite multiple attempts and efforts, crystals of Human IPPase could not be
obtained by means of vapor diffusion using above precipitant. Crystals grown by
capillary counter diffusion were confirmed as protein crystals by use of CrystalX2, a
fluorescent microscopy imager (Figure 3.37-C, D). Crystals were then subjected to X-ray
diffraction, and diffraction image (Figure 3.37-A, B) obtained verified that this was
indeed protein crystal. Though these crystals diffracted, they were of poor quality and
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further optimization of this crystallization condition failed to improve its quality. In
addition, reproducing crystal growth in above mentioned condition proved difficult, and
thereby not allowing further microseeding experiments.
Besides these in-home experiments, microbatch-under-oil crystallization
screening was performed with 1536 precipitant conditions at HTSlab, HauptmanWoodward Institute, Buffalo. Both trace-fluorescent labelled and unlabeled Human
IPPases, in presence or absence of substrate pyrophosphate, was utilized but they did not
yield any crystallizable conditions or lead.

A

B

C

D

Figure 3.37. (A) X-ray diffraction image of Human IPPase crystal. (B) Blow-up of boxed area in
(A) showing diffraction spots (black dots). White light (C) and fluorescent (D) image of Human
IPPase crystal diffracted confirming it as a protein crystal as the crystal fluoresces because of
fluorescent dye carboxyrhodamine.
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3.5.4

Thermal shift assay
Homogeneity, stability and solubility of proteins correlate strongly to proteins’

crystallization, and, therefore, optimization of these properties can improve their
crystallization [322-324]. Fluorescence-based thermal shift assay, also known as
differential scanning fluorimetry or Thermofluor, can be used to improve the stability of
proteins by measuring their melting temperature in presence of various compounds or
additives [322, 325]. Increase in melting temperature represents potential binding of
compound to the protein and such binding increases the stability of protein. Hydrophobic
sensitive dye, sypro orange for example, is employed in this method, whose fluorescence
increases as protein unfolds as a function of temperature and exposes hydrophobic
patches in soluble proteins [121].
In order to determine melting temperature (Tm) by thermal shift assay, a protein
must produce a sharp sigmoidal denaturation curve, which is the case for Human IPPase
(Figure 3.38). Stability of Human IPPase is enhanced at lower pH and is less pronounced
at higher pH (Figure 3.39). At 50 mM concentration of buffering component, Tm in
presence of sodium acetate pH 5.0 is 9 Tm greater than that in presence of Tris pH 8.0.
Furthermore, choice of buffering component slightly affects Tm as can be seen for sodium
acetate and sodium citrate, and for Tris and HEPES (Figure 3.39).
Among the salts tested, all except ammonium phosphate have comparable Tm to
that for sodium chloride, and concentrations (50, 100 and 200 mM) did not affect Tm
(Figure 3.40A). Potassium phosphate and sodium phosphate slightly increases the
stability of Human IPPase, possibly due to binding of phosphate to Human IPPase at its
active site. Intriguingly, while ammonium phosphate significantly lowers the stability of
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Human IPPase, other ammonium or phosphate salts tested did not have similar effect on
Human IPPase.
In most cases, varying concentration of divalent metal ions affects the stability of
Human IPPase, positively or negatively, unlike the salts (Figure 3.40B). Mg2+ and Cs2+
does not affect the stability of Human IPPase as they result in similar Tm compared to the
control where divalent metal ions were absent. As concentration of divalent metal
increases, Mn2+ and Ca2+ increases stability of Human IPPase in contrast to Co2+, Zn2+,
Cd2+ and Ni2+, which negatively affects its stability. Cd2+ heavily reduces the stability at
50 mM compared to that at 5 mM or 10 mM.
Though magnesium chloride contributes to the optimal pyrophosphate hydrolysis
activity of Human IPPase, and manganese chloride contributes just ~18% of such activity
(Figure 3.36C), contrastingly, the latter significantly increases the stability of Human
IPPase whereas the former does not have any effect (Figure 3.40B). Among the
compounds tested, 10 mM of manganese chloride and calcium acetate, have the highest
effect on increasing the stability of Human IPPase by 4.9Tm and 7.2 Tm, respectively.
Glycerol, which has been reported to stabilize many proteins [322], moderately increases
the stability of Human IPPases by ~2Tm(Figure 3.41).

186

A

B

Figure 3.38. Thermal shift assay of Human IPPase. Raw melting curve (A) of Human IPPase in
presence of 25 mM buffer and 50 mM sodium chloride, and its normalized curve (B). Human
IPPase has higher stability in presence of sodium acetate pH 4.5 compared to Tris and HEPES.

Figure 3.39. Effect of pH on stability of Human IPPase. Melting temperature of Human IPPase
in presence of 25 mM (solid lines) or 50 mM (dashed lines) buffer and 50 mM sodium chloride
was determined using thermal shift assay. Effect of pH on pyrophosphate hydrolysis activity of
Human IPPase (dotted lines) is also shown. Error bars represent standard deviation where n = 2.
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B

Figure 3.40. Effect of salts and divalent metals on stability of Human IPPase. Melting temperature
of Human IPPase at varying concentrations of salts (A) in presence of 50 mM sodium acetate pH
5.0 and divalent metal ions (B) in presence of 50 mM sodium acetate pH 5.0 and 50 mM NaCl were
determined using thermal shift assay. Control did not have any metal added (B). Error bars
represent standard deviation where n = 3 (A) and n = 3(B – 5 mM and 10 mM) or n = 2
(B – 50 mM).
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Figure 3.41. Effect of more additives on stability of Human IPPase. Melting temperature of Human
IPPase was determined with additives in the presence of 50 mM sodium acetate pH 5.0 and 50 mM
NaCl. Control did not have any additive added. Error bars represent standard deviation where
n = 3.

3.5.4.1 Crystallization screening
Based on thermal shift assay, Human IPPase was purified using buffer containing
sodium acetate pH 5.0 or sodium citrate pH 5.0, and was then subjected to crystallization
screening. Screening was performed as before, i.e., when Tris pH 8.0 was used as
purification buffer. In addition to those trials, 10 mM manganese chloride and 20 mM or
50 mM calcium acetate was used as additives in crystallization screening, as they
considerably increase Tm of Human IPPase (Figure 3.40). Also, random microseed
matrix screening was performed as earlier but they did not result in any hits.
Furthermore, crystal growth could not be reproduced when using the precipitant that
resulted in crystals in earlier experiments.
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3.5.5

Rational engineering of Human IPPase
Structure of Human IPPase has been modeled (predicted) by an automated

structure modeling pipeline called ModPipe, using crystallographic structure of yeast
IPPase (PDB: 1E9Q, 54% sequence homology to Human IPPase) as a template structure.
This predicted structure (Figure 3.42) is considered to have reliable folding with GA341
(score system to discriminate between correct and incorrect folding models) score of
1.0 [326]. The folding in structure of yeast IPPase and predicted structure of Human
IPPase matches well globally (Figure 3.42). In order to overcome poor crystallization of
Human IPPases, they were engineered using four different rationales.
B

A

Figure 3.42. Predicted structure of Human IPPase. A) Structure of Human IPPase predicted using
crystallographic structure of yeast IPPase (PDB: 1E9Q) as template. B) Predicted structure of
Human IPPase (orange) superimposed with crystallographic structure of yeast IPPase (cyan).

3.5.5.1 Crystal contact engineering:
Yeast IPPase is the only protein molecule whose structure has been determined
among eukaryotic IPPases. Here, the knowledge of crystal contacts in available structure
of yeast IPPase was utilized to optimize crystallization of Human IPPase. Intermolecular
crystal contacts present in the crystallographic structure of yeast IPPase (PDB id: 1e6a)
were analyzed (Figure 3.43A) using CONTACT [327]. These residues were compared to
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Human IPPase using sequence alignment for corresponding residues and their potential
location in three dimensions were examined using predicted structure of Human IPPase.
Results of this comparison, their effects on such probable crystal contacts in Human
IPPase and mutations that were proposed to rectify them are listed in Table 3.22.
Among 16 crystal contact sets observed in yeast IPPase crystals, five are
completely conserved in Human IPPase, and three sets have one residue conserved but
the other residue is substituted with similarly charged residues (Arg for Lys and Asp for
Glu) in Human IPPase. Remaining 8 crystal contact sets would potentially have negative
effect on crystallization of Human IPPase as they are either missing a residue in the set,
replaced with residues of opposite polarity, hydrophobic nature or having varying lengths
of side chain. For example, in yeast IPPase crystal, Lys214 forms salt bridge with Thr73
of neighboring IPPase molecule (Figure 3.43B) whereas, Asp214 and Val73 are present
in those equivalent positions in Human IPPase, thus removing the possibility of salt
bridge formation at that site in Human IPPase crystals.
In order to improve or introduce crystal contacts in Human IPPase, ten mutants
were designed (Table 3.22, Table 3.23). Five of those mutations (K195E, Q306S, S241E,
N187K, Mut5) target only one specific site and two of them (Mut6, Mut7) target two
different sites. Remaining three mutations (ccVar1-3) were designed to introduce all or
most of crystal-contact based mutations. ccVar1 contains all 7 mutations described in
mentioned in Table 3.22. ccVar2 is a variant of ccVar1 where last 5 residues in
C-terminal are removed due to their disordered nature. ccVar3 is a variant of ccVar1
where last 5 residues in C-terminal are substituted with 9 aa long, predominantly negative
charged sequence (Table 3.23).
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A

B

Figure 3.43. Crystallographic structure of yeast IPPase (PDB: 1e6a) showing salt bridges between
a dimeric yeast IPPase (dark salmon colored), which is an asymmetric unit here, and neighboring
dimeric IPPase molecules (green colored) in the crystal (A). Blue colored residues of the
asymmetric unit form crystal contacts with red colored residues of neighboring IPPase molecules
which is essential for ordered protein packing in the crystal. Enlarged image (B) of boxed area in
(A) showing few crystal contacts including K214 and T73.

Table 3.22. Mutation of Human IPPase based on crystal contacts in crystallographic
structure of yeast IPPase (PDB id: 1E6A).
Crystal contact
residues in Yeast
IPPase
Lys 75
Glu 176

Corresponding
residues in Human
IPPase#
Lys 75
Lys 176

Effect

Mutation#

Same polarity

K176E

Lys 214

Thr 73

Asp 214

Val 73

Hydrophobic

D214K + V73T

Ser 284

Lys 77

Gln 287

Lys 77

Gln for Ser

Q287S

Glu 222

Lys 75

Ser 222

Lys 75

Ser for Glu

S222E

Glu 64

Lys 168

Asp 64

Asn 168

Asn for Lys

N168K

Glu 110

Lys 74

†

Lys 74

Missing residue

H110_T111insPE

Lys 75

Glu 110

Lys 75

†

Missing residue

H110_T111insPE

Asn 41

Asp 237

†

Gly 237

Missing residue

D42_V43insNN + G237D

Asp 72

Lys 177

Asp 72

Arg 177

No polarity change

Gly 76

Lys 177

Gly 76

Arg 177

No polarity change

Glu 40

Asn 117

Asp 42

Asn 117

No polarity change

Asp 38

Lys 239

Asp 40

Lys 238

No change

Lys 39

Glu 151

Lys 41

Glu 151

No change

Asp 218

Lys 74

Asp 218

Lys 74

No change

Asp 225

Lys 199

Asp 225

Lys 199

No change

Lys 75
Asp 218
Lys 75
Asp 218
No change
† Residues missing (gap)
#
Residue numbers here correspond to naturally occurring cytosolic Human IPPase PPA1; not recombinant
N-terminal his-tagged Human IPPase.
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Table 3.23. Rational engineering of recombinant Human IPPase for crystallization.
S.
Mutant Mutation(s)a
No.
Based on Crystal contacts
1 K195E K195E

Method*

Success Small scaleLarge
Mutation
rate
expression scale
success?
(a/b)#
success? purified?

QC-S

Yes

5/5

Yes

2

Q306S

Q306S

QC-S

Yes

5/5

Yes

3

S241E

S241E

QC-S

Yes

4/5

Yes

4

N187K

N187K

QC-S

Yes

5/5

Yes

5

Mut5

H129_T130insPE

QC-S

Yes

4/5

Yes

6

Mut6

D233K and V92T

QC-M

Yes

5/7

Yes

7

Mut7

D61_V62insNN and G256D

QC-M

Yes

6/7

Yes

ccVar1

K195E, Q306S, S241E, N187K,
D233K, V92T, G256D,
QC-S, WM Yes
D61_V62insNN and
H129_T130insPE

4/4

†

ccVar2

K195E, S241E, N187K, D233K,
V92T, G256D, D61_V62insNN,
GS
H129_T130insPE and
H304_N308del

4/6

Yes

0/6

n/a

8

9

10 ccVar3

Yes

K195E, S241E, N187K, D233K,
V92T, G256D, D61_V62insNN,
QC-S, WM No
H129_T130insPE,
H304_N308delinsASDAESDAS

Yes

Yes
Yes

Yes

Based on Surface entropy reduction
11 Ser1

K93A, K94A and K96A

QC-S, WM Yes

7/8

Yes

Yes

12 Ser2

E43A and K44A

QC-S

Yes

4/4

Yes

Yes

13 Ser3

K252A and K253A

QC-S

Yes

4/4

Yes

14 Ser4

E26A and E27A

QC-S

Yes

4/4

Yes

Yes
Yes
Yes
(Insoluble)

Based on truncation of disordered regions
15 Trun1

A280_308Ndel

Mak

Yes

3/10

16 Trun2

L249_308Ndel

Mak

Yes

4/16

Based on lysozyme insertion
T4-Lysozyme between 19S &
17 LysIns
Gei
Yes
2/4
Yes
Yes
20M
*
QC-S – QuikChange II SDM; QC-M – QuikChange lightning multi-SDM; WM –Wang & Malcolm
protocol [328]; Mak – Makarova et al. protocol [124]; Gei – Geiser et al. protocol [126]; GS – Gene
Synthesis.
#
a – No. of plasmids with successful mutation; b – No. of colonies or plasmids verified for mutation.
† – Not tested.
a
Numbering based on wild type N-terminal His tagged Human IPPase (Appendix D)
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3.5.5.2 Surface-entropy reduction
In recombinant Human IPPase sequence, four surface-exposed sequence clusters
were found to have increased entropy (Figure 3.44), which could potentially disrupt
crystallization [329]. Four mutations (Ser1-4) were designed where lysine and glutamine
residues contributing to such high entropy in those clusters were substituted with alanine
(Table 3.23).
3.5.5.3 Truncation of disordered regions
DISOPRED2 [83] predicted Human IPPase was predicted to have two major
regions of structural disorder, both in its C-terminus, corresponding to residues 230-242
and residues 261-277 (Figure 3.45) [83]. Comparative analysis of sequences of yeast,
E. coli and Human IPPases, and analysis of their structures (predicted structure in case of
Human IPPase) shows that these residues primarily constitute loop in the surface of
protein. Strikingly, these regions are absent in C-terminus of E. coli IPPase whose
sequence ends just before this disordered region (Figure 3.45). This suggested that
truncation of these residues in Human IPPase may not affect protein stability, solubility
or activity, and these constructs might have a higher probability for success in
crystallization. Two mutants – Trun1 [Δ(261-289)] and Trun2 [Δ(230-289)] – were
designed to have those disordered regions removed from C-terminus of WT Human
IPPase..
3.5.5.4 Fusion-protein crystallization
Mutant LysIns was designed to have T4-Lysozyme (160 aa) inserted after
thrombin cleavage site in WT-Human IPPase (Table 3.23, Appendix D).
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A

S. No.

Residue range

1

93-96

2

43-44

3

252-253

4

26-27

B

Cluster

SERp score

KQDVKKGK

5.53

EKGQ

4.89

KK

4.74

EERAA

4.52

C
3
2

4
1
Figure 3.44. Surface entropy reduction. A) Surface-exposed sequence patches or clusters with
residues having high entropy as predicted by Surface Entropy Reduction prediction (SERp) server
[329]. Lysine and glutamate residues that contribute to such high entropy are underlined. B and
C) Lysine (red) and glutamate (yellow) in high-entropy sequence clusters are highlighted in the
predicted structure of Human IPPase, and the sequence clusters are labelled. C is 180° rotated form
of B in its y-axis.

Figure 3.45. Truncation of disordered regions in Human IPPase. Superimposition of E. coli IPPase
(Blue) and predicted structure of Human IPPase (cyan and red). Region highlighted in red
corresponds to sequence with predicted structural disorder in C-terminal of Human IPPase. Black
arrow indicate C-terminus of E. coli IPPase where disorder of Human IPPase begins.
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3.5.6

Construction of mutants
Table 3.23 summarizes the mutagenesis methodology used to obtain the mutants

of Human IPPase. Constructs that involved mutation at only one site (i.e. needs only one
set of forward and reverse primers) were obtained using Quikchange II SDM-based
protocol [123]. However, if such mutations involved insertion of more than 4 aa or
substitution of more than 2 aa at the site of mutation, then Wang and Malcolm’s modified
Quikchange II SDM protocol was done, in addition, as such mutations cannot always be
obtained easily the former methodology [328]. Constructs that involved mutation at two
different sites were obtained using Quikchange lightning multi-SDM [125]. Constructs
Trun1 and Trun2 that involved deletion of >28 aa were obtained using modified
QuikChange protocol described by Makarova et al. [124]. For each of these truncation
constructs, two primers were designed, instead of just one, to improve mutation success
probability. Construct ccVar2 was obtained using PCR-based SeqTBIO gene synthesis
method as it required mutation at more than seven different sites [117]. Finally, construct
LysIns (Appendix D) was obtained using a complex protocol. First, T4 lysozyme
sequence flanked by sequences corresponding to WT-Human IPPase was obtained using
PCR-based SeqTBIO gene synthesis [117]. Then, using this assembled sequence as
primer, mutant LysIns was constructed using modified QuikChange described by Geiser
et al [126].
3.5.7

Small scale protein expression and purification of mutants
All mutants, except ccVar3 that failed despite multiple attempts, were

successfully obtained and verified by sequencing (Table 3.23). Rate of successful
mutation was 80% or more in most cases, but it was 50 % for LysIns and just

196

25 % – 30 % for Trun1 and Trun2 where large fragment of sequences needed to be
removed (Table 3.23). Among the mutants that were tested for over-expression in E.
coli, all were producing soluble protein of interest, except Trun2 that was instead
insoluble (Figure 3.46, Table 3.23). In WT-Human IPPase, 29 aa can be removed
without affecting its solubility (Trun1) but removal of 31 furthermore amino acids in Cterminus (Figure 3.45) affects its solubility (Trun2).
For each rationale of mutagenesis, few mutants were prioritized for purification
depending on their potential effect on their crystallization. Among the mutants based on
crystal-contact engineering, K195E, Mut5 and Mut7 were chosen as they could
potentially remove charge repulsion or introduce residues capable of forming crystal
contacts that were otherwise missing (Table 3.22). Furthermore, ccVar2 was chosen as it
has most of crystal contact based mutations in one construct. Among the mutants
designed based on surface entropy reduction, Ser1 and Ser2 were chosen as they had
higher SERp score than Ser3 and Ser4 (Figure 3.44). Among the mutants based on
truncation of disordered regions and lysozyme insertion, Trun1 and LysIns were chosen
as they were the only constructs successfully obtained. Purification of these mutants
were carried out using the same protocol used for WT-Human IPPase (Figure 3.47 to
Figure 3.50). As use of low pH buffers during protein purification did not improve
crystallization or provide new leads, Tris pH 8.0 buffer was used for purification of all
mutants, except Mut7, Ser1 and Trun2, which were also purified with sodium citrate pH
5.0 buffer.
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E

Figure 3.46. Small scale protein expression of Human IPPase mutants. Mutants were verified for
their overexpression in E. coli using SDS-PAGE. A, B, C and D contain sample from soluble
fraction after cell lysis, and D contains sample from insoluble fraction, which was then solubilized
using 8 M urea. Among the mutants tested, all except Trun2 were overexpressed in E. coli and
were soluble (A, B, C and D). Trun2, whose predicted MW is 28 kDa [120], was found to be
overexpressing in E. coli though it was insoluble (E). LysIns (predicted MW - 53 kDa) is
arrowmarked (D). E. coli cells transformed with native pET3a plasmid without any gene inserted
in it was used as negative control. Label ‘UnIn’ represents samples that were not induced with
IPTG. Sample loaded in lane X (A) is not discussed here and can be ignored.
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ccVar2
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K195E

B

C

A

C

Figure 3.47. Purification of Human IPPase mutants ccVar2 and K195E. Following cell lysis,
ccVar2 and K195E were purified by nickel affinity (A) and size exclusion chromatography (B).
Fractions from size exclusion column were analyzed by 12 % SDS-PAGE (C).
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Mut5
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Mut7
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A
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Figure 3.48. Purification of Human IPPase mutants Mut5 and Mut7. Following cell lysis, Mut5
and Mut7 were purified by nickel affinity (A) and size exclusion chromatography (B). Fractions
from size exclusion column were analyzed by 12 % SDS-PAGE (C).
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A1

Ser1

B1

C1

A2

B2

Ser2

Figure 3.49. Purification of Human IPPase mutants Ser1 and Ser2. Following cell lysis, Ser1 and
Ser2 were purified by nickel affinity (A1, A2) and size exclusion chromatography (B1). Fractions
from size exclusion column were analyzed by 12 % SDS-PAGE (C1, B2).
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Trun1
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Figure 3.50. Purification of Human IPPase mutants Trun1 and Trun2. Following cell lysis, Trun1
and Trun2 were purified by nickel affinity (A) and size exclusion chromatography (B). Fractions
from size exclusion column were analyzed by 12 % SDS-PAGE (C).
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3.5.7.1 Crystallization screening
In addition to crystallization screening techniques utilized for WT-Human IPPase,
in-situ proteolysis using thrombin or trypsin and addition of heterogeneous nucleants
(mix of seaweed, horse hair and cellulose) were also utilized for Human IPPase mutants
during crystallization screening. Among the mutants tested, K195E, Mut5, Mut7, Ser1
and Ser2 produced dendrite crystalline forms but only in the presence of pyrophosphate
or phosphate as additives. Mutants ccVar2, Trun1 and LysIns did not yield any
crystallization leads. Most of the mutants that were designed to improve crystal contacts
or to reduce surface entropy resulted in dendrite crystalline forms, similar to WT-Human
IPPase, albeit in different precipitant conditions. However, the mutants that were
designed using terminal truncation and fusion protein engineering did not yield any
crystallization leads. The precipitant conditions that resulted in such dendrite forms
predominantly had magnesium chloride or ammonium sulfate as part of the precipitant
(Table 3.24). Unlike WT-Human IPPase for which dendrite morphology could be
improved using random microseeding matrix-screening, crystalline morphology could
not be improved for Human IPPase mutants.
Despite several advances in the last decade, protein crystallization remains the
bottleneck step to successfully determine three dimensional atomic structure by X-ray
crystallography. In general, less than 10% of targeted proteins can be purified to
homogeneity and then result in diffraction quality crystals [330]. Success rate gets
affected even further if proteins targeted are mammalian proteins. Human IPPase can be
purified to high purity (Figure 3.35) and is found to be monodisperse (Figure 3.51),
which is necessary for successful crystallization [331]. Despite several attempts to
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Table 3.24. Precipitant conditions that produced dendrite forms of Human IPPase mutants
Mutant
K195E

A

Precipitant
0.2 M Magnesium formate
0.2 M Magnesium chloride , 0.1 M TRIS HCl pH 8.5, 30 % w/v PEG 4,000

Mut5

0.2 M Magnesium chloride , 0.1 M HEPES sodium pH 7.5, 30 % v/v 2-Propanol
0.2 M Magnesium acetate, 0.1 M Sodium cacodylate pH 6.5, 30 % v/v MPD
0.1 M HEPES sodium pH 7.5, 10 % v/v 2-Propanol, 20 % w/v PEG 4,000
0.2 M Magnesium chloride , 0.1 M HEPES sodium pH 7.5, 30 % v/v PEG 400
0.2 M Magnesium chloride , 0.1 M Tris pH 8.5, 3.4 M 1,6-Hexanediol

Mut7

0.2 M Ammonium sulfate, 0.1 M Sodium cacodylate pH 6.5, 30 % w/v PEG 8,000
0.2 M Magnesium chloride , 0.1 M Tris pH 8.5, 3.4 M 1,6-Hexanediol
0.2 M Magnesium formate
0.2 M Magnesium chloride , 0.1 M HEPES sodium pH 7.5, 30 % v/v PEG 400
0.2 M Magnesium acetate, 0.1 M Sodium cacodylate pH 6.5, 30 % v/v MPD

Ser1

0.1 M MES pH 6.5, 1.6 M Magnesium sulfate
0.2 M Magnesium chloride , 0.1 M Tris pH 8.5, 3.4 M 1,6-Hexanediol

Ser2

0.2 M Magnesium chloride , 0.1 M Tris pH 8.5, 3.4 M 1,6-Hexanediol
0.2 M Ammonium sulfate, 0.1 M Sodium acetate pH 4.6, 25 % w/v PEG 4,000

B

Figure 3.51. Dynamic light scattering of WT-Human IPPase. Experimental correlation function
and the best calculated fit (A) and the corresponding calculated histogram of particle sizes (B) for
Human IPPase (in presence of 50 mM Tris at pH 8.0, 50 mM NaCl) show monomodal distribution
of particle sizes.
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improve crystallization of Human IPPase using thermal stability assays and protein
engineering, dendrites were the only crystalline morphology obtained. As protein can be
purified to high homogeneity and is stable, it is likely that possible lack of rigidity in
human IPPase is causing the disruption in its crystallization. Though attempts were made
to reduce its disorder using surface entropy reduction and terminal truncation
engineering, crystallization leads were not obtained.

3.6

Purification and characterization of Tt-IPPase
Tt-IPPase is a soluble Family I IPPase obtained from Thermococcus thioreducens,

a hyperthermophilic, sulfur-reducing archaeon isolated from Rainbow hydrothermal vent
site on the Mid-Atlantic Ridge [66]. Its 178 amino acid sequence (Appendix D) shares
high 88 % sequence identity to IPPase of Pyrococcus horikoshii, a hyperthermophilic
archaeon and just 41 % to that of E. coli, a bacterium. It has all 13 active site residues
conserved, both in sequence and in their orientation in quaternary structure [68].
3.6.1

Purification of Tt-IPPase
Tt-IPPase was recombinantly expressed in E. coli Rosetta cells using T7

expression system. As Tt-IPPase is a hyperthermophilic protein, heat precipitation at
75 ºC removed most of E. coli’s proteins, and they were then further purified to >95 %
homogeneity using anion exchange chromatography and size exclusion chromatography
(Figure 3.52, Figure 3.53A). Sample requirement for QENS studies is rather high as
250-300 mg of protein sample is required for one complete set of measurements. About
one gram of Tt-IPPase was purified in total with regular yield of 80-100 mg of purified
protein (by Bradford assay with BSA as standard) per one liter of culture (or ~1.8 g wet-

205

cell weight). Its molecular weight in solution at pH 7.8 was determined to be 128 kDa
(Figure 3.53B), which corresponds to homo-hexamer as its quaternary structure, similar
to bacterial Family-I IPPases [20].
A.

B.

Figure 3.52. Purification of Tt-IPPase by chromatography. After initial purification by heat
precipitation, Tt-IPPase was further purified using anion exchange chromatography (A) and size
exclusion chromatography (B). Fractions that contained Tt-IPPase are highlighted in the
chromatograms, and their purity was evaluated using 12 % SDS-PAGE. 21 kDa band correspond
to monomeric subunit of Tt-IPPase and the higher band at ~60 kDa correspond to its trimeric form.
Incomplete heating of sample for SDS-PAGE resulted in that higher band.
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A

B

Figure 3.53. Purification and molecular weight determination of Tt-IPPase. A) The production of
recombinant Tt-IPPase was evaluated on a 12% SDS-PAGE as a function of purification steps.
Crude lysate showed strong expression of the Tt-IPPase corresponding to a molecular size of
21 kDa when compared to molecular weight standards (lane 1). Heat treatment at 75°C removed
most temperature labile protein contaminants. Anion exchange and size exclusion chromatography
results in further purification of Tt-IPPase to greater than 95% homogeneity. Approximately 10 μg
of protein was loaded in each lane, stained with Coomassie brilliant blue and visualized with white
light illumination. B) Molecular weight of Tt-IPPase in solution (50mM Tris pH 7.8, 50mM NaCl)
was determined to be 128 kDa using size exclusion chromatography at room temperature. Modelprotein used as markers are shown with their molecular weight in parentheses.

3.6.2

Enzyme activity analysis
As Tt-IPPase is a hyperthermophilic protein, appropriate buffer selection

presented a challenge when measuring their enzyme activity. Temperature plays a major
role on pKa of buffers and such effect varies depending on the buffer component used
[332]. For commonly used buffers in biological labs, temperature coefficient (ΔpKa/°C)
has been defined to estimate/predict pH of buffers as temperature changes. For example,
for Tris, which has temperature coefficient -0.028 ΔpKa/°C, the buffer adjusted to pH 8.0
at 25 °C would theoretically be pH 7.66 at 37 °C [333]. Such temperature coefficients
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were experimentally determined for most of common buffers by measuring their pKa at
three different temperatures (0 °C, 20 °C and 37 °C) [332].
When assaying Tt-IPPase to determine optimal temperature, we opted to
experimentally verify the correctness of Tris’ temperature coefficient (-0.028 ΔpKa/°C).
While experimentally measured Tris’ pH up to 37 °C agreed well with pH estimated
using theoretical temperature coefficient, experimentally measured pH beyond 37 °C was
not linear as estimated by temperature coefficient (Figure 3.54A). Instead, Tris’ pH
begins to slowly stabilize as temperature increases beyond 50 °C. The experimental data
up to 37 °C match well with pH estimated using temperature coefficient, as the latter was
indeed defined by measuring pKa of buffers only at three different temperatures up to
37 °C [332]. It is not clear at this point why Tris’s pKa starts to slowly stabilize beyond
37 °C. While other buffers were not tested, it is possible that effect of temperature on
them may follow a similar trend beyond 37 °C or at least at higher temperatures.
Tt-IPPase displays maximum pyrophosphate hydrolysis activity at 85 °C
(Figure 3.54B), which is in line with optimum temperature for growth of T. thioreducens
[334]. It holds 88 % activity even at 95 °C, and, surprisingly, it still held measurable
activity even after autoclaving at 121 °C for 15 min. As it is a hyperthermophilic protein,
its activity is only about 6 % at 37 °C and about 1 % at 25 °C. Beyond 37 °C, increase in
their activity is almost linear to increase in temperature up to 85 °C.
Tt-IPPase shows significant activity (at least 76% of optimal activity) at broad pH
range from pH 6 to 9 (Figure 3.54C) at 85 °C. It has optimal activity in presence of
CAPS buffer at pH 8.05 and has approximately 97% of optimal activity with Tris buffer
at pH 7.5. Besides pH, the choice of buffering component also affects Tt-IPPase’s
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activity as can be seen from varying level of activity at same pH and differing buffer
components. The dependency of stability of Tt-IPPase on pH have certain correlation to
their enzymatic activity (Figure 3.55), unlike Human IPPase (Figure 3.39). The stability
of Tt-IPPase increases steadily from pH 5 to pH 8.8 but effect of lower pH could not be
reliably measured. For buffers sodium acetate at pH 4.0 and sodium citrate at pH 4.5,
only partial melting curves that never flatten out were obtained. This suggests that
Tt-IPPase probably has higher stability at these buffer conditions when compared to Tris
at higher pH. While one would expect the stability of protein to be lower around its
predicted isoelectric point [315], intriguingly, such effect was not observed for Tt-IPPase
(pI - 4.76 [315], Figure 3.55) or for Human IPPase (pI - 6.05 [315], Figure 3.39). Similar
effect can be seen in Human protein c-FMS kinase domain (pI – 5.77 [315]) as well
[335], but the reason for such effect is not noted in literature to the best of our
knowledge.
Among the divalent cations, Tt-IPPase shows highest activity in the presence of
magnesium ions and gets inhibited in the presence of calcium ions (Figure 3.54D),
similar to other soluble Family I IPPases [317, 319]. They did not have any measurable
activity in presence of nickel, whereas it barely had any measurable activity in presence
of cadmium and cesium ions. The activity decreases in the order of Mg2+ > Mn2+ > Co2+
> Zn2+ for Tt-IPPase, in contrast to the order Mg2+ > Zn2+ > Co2+ > Mn2+ of IPPases from
S. cerevisiae, an eukaryote [317] and Pyrococcus horikoshii OT3, an archaeon [318].
Tt-IPPase has specific activity of 16,600 micromoles of phosphate produced per
milligram of IPPase per minute, when assayed in presence of Tris pH 8.0 and 1.5 mM
magnesium chloride at 85 °C.
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A

B

C

D

Figure 3.54. Effect of temperature on Tris and enzyme activity assay on Tt-IPPase. A) pH
estimated by theoretical temperature coefficient and experimentally measured pH for buffer
50 mM Tris at pH 9 (at 21 °C) matches only up to 37 °C, and then as temperature increases, pH
change is not linear as theoretically predicted. B) When pH was maintained at pH 8.0 using
experimentally measured Tris buffers across the temperature range of 25 – 95 °C in presence of
MgCl, Tt-IPPase shows highest activity at 85 °C. C) When assayed at 85 °C in presence of MgCl,
it has highest activity in presence of CAPS buffer at pH 8.05. D) Among divalent cations at
1.5 mM concentration, magnesium shows highest activity at pH 7.5 and 85 °C. Error bars represent
standard deviation where n = 4, except for temperature assay where n = 6.
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Figure 3.55. Stability of Tt-IPPase as a function of pH. Thermal shift assay was carried out using
200 µg/ml Tt-IPPase and 5x sypro orange in presence of 50 mM buffer as additive and
50 mM sodium chloride. The melting temperature at certain pH (sodium acetate pH 4.0 and sodium
citrate pH 4.5) could not be measured as their melting curve never flattened out. Both higher and
lower pH seem to provide higher thermal stability for Tt-IPPase. Enzyme activity of Tt-IPPase
have certain correlation to its thermal stability.

3.6.3

Tt-IPPase sample preparation for QENS
In a collaborative study with Biophysicists at Oak Ridge National Laboratory

(ORNL), Tt-IPPase samples were prepared for the QENS study on whether a large
oligomeric protein, Tt-IPPase with quaternary structural complexity, would have
distinguishable dynamic characteristics compared to that of the small simple monomeric
model protein, Lysozyme [336]. Sample requirement for QENS studies is rather high as
250-300 mg of protein sample is required for one complete set of measurements. One
gram of Tt-IPPase was purified, as described earlier.
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Ideal sample for QENS study would be the lyophilized protein hydrated with D2O
without any other additives added. If any other component has to be present, ideally they
should not have hydrogen atoms or should have only very few, in order to eliminate or
reduce background noise produced during QENS. However, most proteins require
certain additives for their stability and for retaining their native oligomeric form.
Tt-IPPase is a homohexamer in solution (Figure 3.53B), and hence it must be ensured
that such oligomeric form is preserved during sample preparation for QENS study.
Dynamic light scattering (DLS) provides information on oligomeric nature of
protein by means of their radius of gyration when the protein sample used has low
polydispersity [334]. When water is the only solvent and no other additive is present,
oligomeric form of Tt-IPPase varies (Figure 3.56A, B) when compared to Tt-IPPase in
the presence of buffer solution (50mM Tris pH 7.8, 50 mM NaCl). However, Tt-IPPase
could be reverted to their native oligomeric form when buffer was added to the sample
that contained only water as solvent (Figure 3.56C). Among the components present in
buffer solution, either Tris or sodium chloride could be used to retain the native
oligomeric form of Tt-IPPase (Figure 3.56D,E). Sodium chloride at 10 mM
concentration was chosen to be added for QENS sample preparation as Tris, unlike
sodium chloride, has several hydrogen atoms and would contribute to background noise
during QENS data collection. Moreover, the addition of 10 mM NaCl provided the
advantage of heavily reducing protein aggregation when Tt-IPPase was lyophilized only
in the presence of D2O.
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A

B

Buffer (Tris + NaCl)

Water

4.2 nm
0.8 nm

C

Buffer readded

4.1 nm

D

10 mM NaCl

3.7 nm

E

10 mM Tris

4.1 nm

Figure 3.56. Dynamic light scattering analysis of Tt-IPPase in presence of different solvents.
When Tt-IPPase in buffer (50mM Tris pH 7.8, 50 mM NaCl) (A) was exchanged to just water (B),
Tt-IPPase lost its native oligomeric state. Addition of buffer components to the same sample
reverts Tt-IPPase to its native oligomeric state (C). Addition of either 10 mM NaCl (D) or
10 mM Tris (E) could cause such reversion. NaCl was chosen to retain oligomeric state as it offers
advantage in neutron scattering experiment.

Thus, Tt-IPPase protein sample that retains its native oligomeric form was
successfully prepared and utilized for QENS study. Detailed description of results of this
study [336] is beyond the scope of this dissertation and its summary is provided here.
The β-relaxational dynamics of the two proteins, IPPase and lysozyme, were compared in
the 10 ps to 0.5 ns time interval using QENS [336]. Both of the protein dynamics
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showed a characteristic logarithmic-like decay in the intermediate scattering function
(ISF) of the hydrogen atoms. Both hexameric Tt-IPPase and monomeric lysozyme had
similar characteristic glass transition temperature at 220 K (Figure 3.57). Distinguishable
dynamical behavior found between two proteins revealed local ﬂexibility and
conformational substates unique to oligomeric structures. Moreover, the temperature
dependence of the mean square displacement (MSD) of the hydrogen atoms in protein
molecules, which is a traditional way to determine the softness of the protein molecule,
was measured and showed no diﬀerence for the two proteins [336].

Figure 3.57. The mean square displacement (MSD), <x2>, of D2O hydrated IPPase is compared to
that of lysozyme. A transition temperature of ~220K (-53ºC) is common for both enzymes. The
dashed lines indicate the slope of the MSD vs T curve, which is a qualitative indicator of the
softness of the protein.
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3.7

Conserved binding pockets as potential drug targets in St-IPPase
The objective of the research reported in this dissertation is to provide a platform

for future drug-design studies that targets IPPases. This was achieved by studying
evolutionary conservation of residues in Family I and Family II IPPases through
bioinformatics analyses, and biochemical and structural analysis of Family I IPPases
from Human and S. typhi, a pathogen.
While the core of prokaryotic-origin (Family I-P) and mammalian (Family I-E)
IPPases share high structural similarity, they vary in oligomerization and oligomer
interactions, with the former typically forming homohexamers and the latter forming
homodimers. While both these IPPases have highly conserved active site, their oligomer
interaction sites could be targeted for drug-binding in order to inhibit its activity.
Cooperativity between subunits in hexameric E. coli IPPase is required to hold complete
pyrophosphate hydrolysis activity, and disruption of such oligomerization severely
affects their activity [51, 52]. As St-IPPase shares 94 % sequence identity to E. coli
IPPase, it is likely that disruption of former’s oligomerization would result in reduced
activity. Human IPPases are homo-dimers, and they do not share same oligomeric
interactions as St-IPPase. Hence, targeting oligomeric interface of St-IPPase, intertrimeric or intra-trimeric, for drug binding to inhibit its activity is a viable approach.
Conserved residues on the surface of protein are potential drug target sites [337].
Here, evolutionary residue conservation data obtained for Family I-P IPPases
(Figure 3.22) was applied to the solved crystal structure of St-IPPase, which is from
S. typhi, a Human pathogen. This shows the extent of conservation of surface-exposed
residues that are involved in the intra-trimeric and inter-trimeric oligomer interaction
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sites (Figure 3.58). Three well conserved surface-exposed pockets have been identified –
two of them are involved in inter-trimeric interactions, whereas the third is part of intratrimeric interactions. We predict that these surface-exposed pockets are potential drug
target sites, and such binding of drug would result in interfering oligomerization thereby
affecting its activity. This predicted target sites lay the foundation for future drug-design
studies using Family I IPPases. Similarly, evolutionary conservation data obtained for
Family II IPPases (Figure 3.27) could be used for prediction of conserved pockets on
surface of protein.
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A

B

C

Figure 3.58. Conserved pockets in St-IPPase as potential drug target. Ribbon (left) and surface
(right) representation of crystal structure of St-IPPase colored on the basis of evolutionary
conservation of residues (color code shown at the bottom). Residues involved in intra-trimeric (A)
and inter-trimeric (B, C) oligomeric interactions are rendered as sticks. Conserved pockets in
oligomeric interaction sites on the surface of St-IPPase are highlighted in blue circles.

217

Chapter 4

CONCLUSION AND PROSPECTIVE

IPPases are essential for life in both prokaryotes and eukaryotes, and they are
potential drug targets. Family I and Family II IPPases were studied, using a combination
of bioinformatics, molecular biology, biochemistry and structural biology, in order to
provide platform for future drug-designing studies. ResCon, a standalone, cross
OS-platform, software suite with easy-to-use graphical user interface was developed in
Python. It aids in isolation of homologous sequences from noisy sequences dataset and
allows analysis of conservation of residues, just at positions of interest, based on their
multiple sequence alignment. Family I-P, I-E and II IPPase sequences were successfully
isolated using ResCon from sequences retrieved from NCBI RefSeq Protein database,
with combination of homologous sequence filtering using BLAST’s bit-score and
neighbor-joining phylogenetic tree. Active site residues are well conserved in Family II
IPPases (98.7 %) compared to that in Family I-P (95.2 %) and I-E (86.3 %) IPPases. In
general, sequences from prokaryotes show higher conservation than eukaryotes, and
relative higher fraction of active site mismatches in the latter are primarily due to
alternative splicing isoform sequences. Certain active-site mismatching sequences could
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be grouped together on the basis of active site residue affected by mismatch and their
sequence similarity. Active site residue Asp67 (E. coli IPPase numbering) of Family I-P
IPPases is the most affected among their 13 active site residues. However, its equivalent
residue in Family I-E IPPases is likely to be unaffected. Certain active site residues are
more likely to be affected than the others, and location of active site residues in three
dimensional structure of Family I IPPases appear to play a role in selection for their
conservation.
In 149 species, including 10 eukaryotes and a pathogenic strain of Escherichia
coli, both Family I and II IPPases were found to be present. Out of those species, 31 are
bacterial pathogens, opportunistic or otherwise, to Humans, fish, shrimp, animals or land
plants. Notable Human pathogens to them are Vibrio cholerae, Vibrio vulnificus,
Klebsiella pneumoniae and Klebsiella oxytoca. Furthermore, seven metazoans were
found to contain both Family I-P and I-E IPPases, in contrast to conventional knowledge.
Lateral gene transfer appears to be the potential source of these prokaryotic-origin genes
in eukaryotes. Besides active site residues, several other residue positions are well
conserved with ≥ 91 % identity. Interestingly, significant number of residues are
conserved with ≥ 99 % identity in both Family I and Family II IPPases, and they are
located either in the active site pocket or in the concentric layer to active site pocket.
Interior of Family I and Family II IPPases’ structure are conserved better than the surface
exposed residues. A glycine residue is found to be essential for OB-fold proteins as it
facilitates, potentially, structurally significant tight β-turn.
Crystals of Family I IPPase from Salmonella typhi, a bacterial pathogen,
diffracted X-ray to a maximum resolution of 1.95 Å and belonged to space group I23
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with unit cell parameter a = 142.0 Å. Its structure was solved using molecular
replacement using E. coli IPPase as the search model. Its crystal structure, solved using
molecular replacement, has OB-fold, and it shares high structural homology to E. coli
IPPase and T. thioreducens IPPase. They are homohexamers in quaternary structure, and
their oligomeric contacts are similar to that of E. coli IPPase.
Recombinant Human IPPase gene was assembled by PCR-based gene synthesis
and cloned in to pET3a vector. Then, Human IPPase was over-expressed in E. coli and
protein was purified to >95 % homogeneity. It has optimal pyrophosphate hydrolysis
activity at 37 °C and pH 7 in the presence of magnesium ions. Crystals were obtained by
random microseed matrix and capillary counter-diffusion, but they poorly diffracted
X-ray. Thermal shift assay was employed to identify buffer and additives that could
increase the stability of protein, in order to improve their crystallization. Human IPPase
displayed higher stability at low pH buffers and in presence of additives – manganese
chloride and calcium acetate, but usage of these components did not improve crystal
quality or provide newer leads. Besides in situ trypsin and thrombin proteolysis, protein
engineering by means of four different rationales was employed to improve crystal
contact points and to reduce disorder, but crystal quality could not be improved.
About one gram of T. thioreducens IPPase was purified, and they were
characterized to ensure that its native oligomeric state remains intact during sample
preparation for QENS experiment. It is a homo-hexamer in solution, and has optimal
pyrophosphate hydrolysis at 85 °C and around pH 8. They show highly stability at basic
pH, which is in contrast to that of Human IPPase.
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To complete the objective of this investigation, evolutionary residue conservation
data obtained for Family I-P IPPases was combined with structural information obtained
for St-IPPases (from Human pathogen S. typhi). Based on the findings of this study,
three conserved pockets were observed on the surface of St-IPPase, and those pockets are
predicted to be potential drug-target sites to selectively affect just the prokaryotic Family
I-P IPPases but not mammalian Family I-E IPPases. Hence, this predicted target sites lay
the foundation for future drug-design studies using Family I IPPases. Similarly,
evolutionary conservation data obtained in our study for Family II IPPases could be used
for prediction of conserved pockets on surface of protein.
The results shown here presents multiple opportunities for future studies
involving Family I and Family II IPPases. The sites predicted to be target for drug
binding could be validated using in silico studies before proceeding to drug screening.
Among the sequences with completely conserved active site, three, seven and five
residues of Family I-P, I-E and II IPPases, respectively, are almost completely conserved
with >99 % identity, and these residues are present in or in vicinity of active site. These
residues are potentially necessary for ligand binding or shaping active site pocket.
Probing of these residues could assist in understanding of their structural role and
function. While evolutionary residue conservation analysis was carried out for Family I
and Family II IPPases, study of their phylogenetic analysis would allow us to understand
the relationship between active site conserved and non-conserved sequences.
Furthermore, it would assist us in understanding of the potential lateral gene transfer
observed in this study.
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Appendix A
Modified Liu08 Similarity Matrix SM

Figure A.1. Modified Liu08 Similarity Matrix SM. The matrix to the left of and above red lines
represent the Liu08 Similarity Matrix S obtained by normalizing BLOSUM62 substitution matrix.
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Appendix B
Clustal Omega Parameters

Table B.1. Command line parameters of Clustal Omega and their equivalent to use with ResCon in local ClustalO mode.
Clustal Omega Parameters
Command line

Description

For ResCon (BioPython)

Options

# Sequence Input
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-i, --in, --infile

infile

Multiple sequence input file

Filename with path

--hmm-in

HMM input, hmm_input

HMM input files

Filename with path

--dealign

dealign

Dealign input sequences

True or False

--profile1, --p1

profile1

Pre-aligned multiple sequence file (aligned columns
will be kept fix).

Filename with path

--profile2, --p2

profile2

Pre-aligned multiple sequence file (aligned columns
will be kept fix).

Filename with path

-t, --seqtype

seqtype

Force a sequence type (default: auto).

protein, rna, dna,Protein, RNA, DNA,
PROTEIN

--is-profile

isprofile

Disable check if profile, force profile (default no)

True or False

--infmt

infmt

Forced sequence input file format (default: auto)

a2m, fa, fasta,clu, clustal,msf,phy,
phylip,selex,st, stockholm,vie, vienna

Clustal Omega Parameters
Command line

For ResCon (BioPython)

Description

Options

# Clustering
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--distmat-in

distmat_in

Pairwise distance matrix input file (skips distance
computation)

Filename with path

--distmat-out

distmat_out

Pairwise distance matrix output file.

Filename with path

--guidetree-in

guidetree_in

Guide tree input file (skips distance computation
and guide-tree clustering step).

Filename with path

--guidetree-out

guidetree_out

Guide tree output file.

Filename with path

--full

distmat_full

Use full distance matrix for guide-tree calculation
(slow; mBed is default)

True or False

--full-iter

distmat_full_iter

Use full distance matrix for guide-tree calculation
during iteration (mBed is default)

True or False

--cluster-size

clustersize

soft maximum of sequences in sub-clusters

integer

--clustering-out

clusteringout

Clustering output file

Filename with path

--use-kimura

usekimura

use Kimura distance correction for aligned
sequences (default no)

True or False

--percent-id

percentid

convert distances into percent identities (default no)

True or False

-o, --out, --outfile

outfile

Multiple sequence alignment output file (default:
stdout).

Filename with path

--outfmt

outfmt

MSA output file format

a2m, fa, fasta,clu, clustal ,phy, phylip
,vie, vienna

# Alignment Output

Clustal Omega Parameters
Description

Options

Command line

For ResCon (BioPython)

--residuenumber, --resno

residuenumber

in Clustal format print residue numbers (default no)

True or False

--wrap

wrap

number of residues before line-wrap in output

integer

--output-order

outputorder

MSA output order like in input/guide-tree

input-order, tree-order

--iterations, --iter

iterations

Number of (combined guide-tree/HMM) iterations

Integer

--max-guidetree-iterations

max_guidetree_iterations

Maximum number of guidetree iterations

Integer

--max-hmm-iterations

max_hmm_iterations

Maximum number of HMM iterations

Integer

--maxnumseq,

maxnumseq

Maximum allowed number of sequences

Integer

--maxseqlen

maxseqlen

Maximum allowed sequence length

Integer

--auto

auto

Set options automatically (might overwrite some of
your options)

True or False

--threads

threads

Number of processors to use

Integer

-l, --log

log

Log all non-essential output to this file.

Filename?

-h, --help,

help

Print help and exit.

True or False

-v, --verbose

verbose

Verbose output

True or False

# Iteration
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# Limits (will exit early, if
exceeded)

# Miscellaneous

Clustal Omega Parameters
Description

Options

Command line

For ResCon (BioPython)

--version

version

Print version information and exit

True or False

--long-version

long_version

Print long version information and exit

True or False

--force

force

Force file overwriting

True or False

Table B.2. Parameters of Clustal Omega to use with ResCon in Clustal Omega webserver mode
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Parameter

Function

Value

Usage - Example

--mbed

Mbed-like clustering guide-tree

None

--mbed

--nombed

No Mbed-like clustering guide-tree

None

--nombed

--mbediteration

Mbed-like clustering iteration

None

--mbediteration

--nombediteration

No Mbed-like clustering iteration

None

--nombediteration

--iterations

Number of iterations

integer

--iterations 2

--gtiterations

Maximum guild tree iterations

integer

--gtiterations 3

--hmmiterations

Maximum HMM iterations

integer

--hmmiterations 2

--stype

Input sequence type

protein, dna, rna

--stype dna

--email

e-mail address

--email string

--email demo@email.com

Appendix C
IPPases with Active Site Mismatches

Table C.1. Mismatching sequences in Family I-P IPPases and their taxonomy information.
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S. No. Accession ID

Domain

Phylum

Class

Species

Group A
1 WP 043368586.1
2 WP 011128629.1
3 WP 009789251.1
4 WP 010307330.1
5 WP 010316670.1
6 WP 011619933.1
7 WP 011363697.1
8 WP 028951460.1
9 WP 011360432.1
10 WP 048017973.1
11 WP 038543655.1
12 WP 043695633.1
13 WP 038556297.1
14 WP 011935290.1
15 WP 007097364.1
16 WP 007101918.1
17 WP 006171226.1
18 WP 011932536.1
19 WP 006043594.1
20 WP 006853397.1
21 WP 048346929.1

Bacteria
Bacteria
Bacteria
Bacteria
Bacteria
Bacteria
Bacteria
Bacteria
Bacteria
Bacteria
Bacteria
Bacteria
Bacteria
Bacteria
Bacteria
Bacteria
Bacteria
Bacteria
Bacteria
Bacteria
Bacteria

Cyanobacteria
Cyanobacteria
Cyanobacteria
Cyanobacteria
Cyanobacteria
Cyanobacteria
Cyanobacteria
Cyanobacteria
Cyanobacteria
Cyanobacteria
Cyanobacteria
Cyanobacteria
Cyanobacteria
Cyanobacteria
Cyanobacteria
Cyanobacteria
Cyanobacteria
Cyanobacteria
Cyanobacteria
Cyanobacteria
Cyanobacteria

Oscillatoriophycideae
Oscillatoriophycideae
Oscillatoriophycideae
Oscillatoriophycideae
Oscillatoriophycideae
Oscillatoriophycideae
Oscillatoriophycideae
Oscillatoriophycideae
Oscillatoriophycideae
Oscillatoriophycideae
Oscillatoriophycideae
Oscillatoriophycideae
Oscillatoriophycideae
Oscillatoriophycideae
Oscillatoriophycideae
Oscillatoriophycideae
Oscillatoriophycideae
Oscillatoriophycideae
Oscillatoriophycideae
Oscillatoriophycideae
Oscillatoriophycideae

Cyanobium sp. PCC 7001
Synechococcus NA
Synechococcus sp. BL107
Synechococcus sp. CB0101
Synechococcus sp. CB0205
Synechococcus sp. CC9311
Synechococcus sp. CC9605
Synechococcus sp. CC9616
Synechococcus sp. CC9902
Synechococcus sp. GFB01
Synechococcus sp. KORDI-100
Synechococcus sp. KORDI-49
Synechococcus sp. KORDI-52
Synechococcus sp. RCC307
Synechococcus sp. RS9916
Synechococcus sp. RS9917
Synechococcus sp. WH 5701
Synechococcus sp. WH 7803
Synechococcus sp. WH 7805
Synechococcus sp. WH 8016
Synechococcus sp. WH 8020

Sequence
No. of
Length Mismatches
180
169
169
171
171
170
169
169
169
179
169
171
169
186
170
170
181
170
170
170
170

1
4
2
1
1
1
2
3
2
1
2
1
2
3
1
1
1
1
1
1
1

S. No. Accession ID
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Domain

Phylum

Class

Species
Prochlorococcus marinus
Prochlorococcus marinus
Prochlorococcus marinus
Prochlorococcus marinus
Prochlorococcus marinus
Prochlorococcus marinus
Prochlorococcus marinus
Prochlorococcus marinus
Prochlorococcus marinus
Prochlorococcus marinus
Prochlorococcus marinus
Prochlorococcus marinus
Prochlorococcus marinus
Prochlorococcus marinus
Prochlorococcus marinus
Prochlorococcus marinus subsp. marinus str.
CCMP1375
Prochlorococcus NA
Prochlorococcus NA
Prochlorococcus sp. MIT 0601
Prochlorococcus sp. MIT 0604
Prochlorococcus sp. MIT 0801
Prochlorococcus sp. scB241 527L22
Prochlorococcus sp. scB241 527N11
Prochlorococcus sp. scB241 528J8
Prochlorococcus sp. scB241 528O2
Prochlorococcus sp. scB243 495L20
Prochlorococcus sp. scB243 495N3
Prochlorococcus sp. scB243 496M6
Prochlorococcus sp. scB243 497N18
Prochlorococcus sp. scB245a 518O7
Prochlorococcus sp. scB245a 519G16

22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37

WP 012195066.1
WP 011294476.1
WP 011130626.1
WP 032526815.1
WP 032524695.1
WP 032522498.1
WP 032519407.1
WP 032517787.1
WP 032513915.1
WP 002805942.1
WP 011862531.1
WP 011819891.1
WP 011818020.1
WP 011376071.1
WP 011132146.1
NP 874903.1

Bacteria
Bacteria
Bacteria
Bacteria
Bacteria
Bacteria
Bacteria
Bacteria
Bacteria
Bacteria
Bacteria
Bacteria
Bacteria
Bacteria
Bacteria
Bacteria

Cyanobacteria
Cyanobacteria
Cyanobacteria
Cyanobacteria
Cyanobacteria
Cyanobacteria
Cyanobacteria
Cyanobacteria
Cyanobacteria
Cyanobacteria
Cyanobacteria
Cyanobacteria
Cyanobacteria
Cyanobacteria
Cyanobacteria
Cyanobacteria

Prochlorales
Prochlorales
Prochlorales
Prochlorales
Prochlorales
Prochlorales
Prochlorales
Prochlorales
Prochlorales
Prochlorales
Prochlorales
Prochlorales
Prochlorales
Prochlorales
Prochlorales
Prochlorales

38
39
40
41
42
43
44
45
46
47
48
49
50
51
52

WP 036917053.1
WP 025955351.1
WP 036901187.1
WP 042849971.1
WP 038651679.1
WP 025971850.1
WP 025892912.1
WP 025926151.1
WP 025929939.1
WP 025924270.1
WP 025975748.1
WP 025965434.1
WP 025953551.1
WP 025941431.1
WP 025969094.1

Bacteria
Bacteria
Bacteria
Bacteria
Bacteria
Bacteria
Bacteria
Bacteria
Bacteria
Bacteria
Bacteria
Bacteria
Bacteria
Bacteria
Bacteria

Cyanobacteria
Cyanobacteria
Cyanobacteria
Cyanobacteria
Cyanobacteria
Cyanobacteria
Cyanobacteria
Cyanobacteria
Cyanobacteria
Cyanobacteria
Cyanobacteria
Cyanobacteria
Cyanobacteria
Cyanobacteria
Cyanobacteria

Prochlorales
Prochlorales
Prochlorales
Prochlorales
Prochlorales
Prochlorales
Prochlorales
Prochlorales
Prochlorales
Prochlorales
Prochlorales
Prochlorales
Prochlorales
Prochlorales
Prochlorales

Sequence
No. of
Length Mismatches
175
1
175
1
174
1
184
2
184
2
184
2
184
2
184
2
184
2
184
2
184
2
182
2
184
2
184
2
182
2
176
1
176
184
173
184
175
184
166
184
184
184
184
184
184
184
184

1
2
1
2
1
2
2
2
2
2
2
2
2
2
2

S. No. Accession ID
53
54
55

Domain

WP 025914330.1 Bacteria
WP 019474049.1 Bacteria
WP 019478425.1 Bacteria
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Group B
1 WP 051450398.1
2 WP 041542133.1
3 WP 048893630.1
4 WP 057003462.1
5 WP 020823986.1
6 WP 003921656.1
7 WP 012948686.1
8 WP 015621649.1
9 WP 027944868.1
10 WP 049652137.1
11 WP 042424779.1
12 WP 042415340.1
13 WP 042388310.1
14 WP 042365301.1
15 WP 037606825.1
16 WP 033351763.1
17 WP 049714356.1
18 WP 030421777.1
19 WP 051829822.1
20 WP 030367711.1
21 WP 045696511.1
22 WP 020554529.1
23 WP 030354645.1
24 WP 058927454.1
25 WP 058042586.1
26 WP 045932882.1

Bacteria
Bacteria
Bacteria
Bacteria
Bacteria
Bacteria
Bacteria
Bacteria
Bacteria
Bacteria
Bacteria
Bacteria
Bacteria
Bacteria
Bacteria
Bacteria
Bacteria
Bacteria
Bacteria
Bacteria
Bacteria
Bacteria
Bacteria
Bacteria
Bacteria
Bacteria

Phylum

Class

Species

Cyanobacteria
Cyanobacteria
Cyanobacteria

Prochlorales
Prochlorales
Prochlorales

Prochlorococcus sp. scB245a 520K10
Prochlorococcus sp. W2
Prochlorococcus sp. W8

Actinobacteria
Actinobacteria
Actinobacteria
Actinobacteria
Actinobacteria
Actinobacteria
Actinobacteria
Actinobacteria
Actinobacteria
Actinobacteria
Actinobacteria
Actinobacteria
Actinobacteria
Actinobacteria
Actinobacteria
Actinobacteria
Actinobacteria
Actinobacteria
Actinobacteria
Actinobacteria
Actinobacteria
Actinobacteria
Actinobacteria
Actinobacteria
Actinobacteria
Actinobacteria

Catenulisporales
Catenulisporales
Corynebacteriales
Corynebacteriales
Corynebacteriales
Corynebacteriales
Geodermatophilales
Micromonosporales
Pseudonocardiales
Streptomycetales
Streptomycetales
Streptomycetales
Streptomycetales
Streptomycetales
Streptomycetales
Streptomycetales
Streptomycetales
Streptomycetales
Streptomycetales
Streptomycetales
Streptomycetales
Streptomycetales
Streptomycetales
Streptomycetales
Streptomycetales
Streptomycetales

Actinospica robiniae
Catenulispora acidiphila
Mycobacterium heckeshornense
Mycobacterium kyorinense
Mycobacterium NA
Mycobacterium xenopi
Geodermatophilus obscurus
Actinoplanes sp. N902-109
Amycolatopsis taiwanensis
Kitasatospora sp. MY 5-36
Streptacidiphilus anmyonensis
Streptacidiphilus anmyonensis
Streptacidiphilus melanogenes
Streptacidiphilus neutrinimicus
Streptacidiphilus rugosus
Streptomyces aureofaciens
Streptomyces caatingaensis
Streptomyces NA
Streptomyces NA
Streptomyces roseoverticillatus
Streptomyces rubellomurinus
Streptomyces scabrisporus
Streptomyces scopuliridis
Streptomyces sp. CdTB01
Streptomyces sp. MBT76
Streptomyces sp. NRRL B-1568

Sequence
No. of
Length Mismatches
184
2
182
2
182
2

173
165
162
162
162
162
164
161
162
166
174
162
185
174
174
161
159
164
172
167
166
169
167
165
180
163

1
1
1
1
1
1
3
2
1
2
1
1
2
1
1
2
1
1
2
1
2
1
1
1
1
1

S. No. Accession ID
27
28
29

Domain

WP 037901266.1 Bacteria
WP 037973866.1 Bacteria
WP 040275884.1 Bacteria
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Group C
1 XP 010905721.1
2 XP 014626017.1
3 XP 008781015.1
4 XP 010930986.1
5 XP 009371641.1
6 XP 010325309.1
7 XP 010489523.1
8 XP 010462897.1
9 XP 010482434.1
10 XP 006429017.1
11 XP 006418371.1
12 XP 013444528.1
13 XP 010113422.1
14 XP 009405327.1
15 XP 007144464.1
16 XP 012701719.1
17 XP 007046886.1
18 XP 010263621.1
19 XP 010254786.1
20 XP 010489935.1
21 XP 014627990.1
22 XP 008781409.1
23 XP 008648631.1

Eukaryota
Eukaryota
Eukaryota
Eukaryota
Eukaryota
Eukaryota
Eukaryota
Eukaryota
Eukaryota
Eukaryota
Eukaryota
Eukaryota
Eukaryota
Eukaryota
Eukaryota
Eukaryota
Eukaryota
Eukaryota
Eukaryota
Eukaryota
Eukaryota
Eukaryota
Eukaryota

Group D
1 WP 026387513.1 Bacteria

Sequence
No. of
Length Mismatches
176
2
172
2
175
1

Phylum

Class

Species

Actinobacteria
Actinobacteria
Actinobacteria

Streptomycetales
Streptomycetales
Streptosporangiales

Streptomyces sp. NRRL S-350
Streptomyces sp. NRRL WC-3742
Streptomonospora alba

Viridiplantae
Viridiplantae
Viridiplantae
Viridiplantae
Viridiplantae
Viridiplantae
Viridiplantae
Viridiplantae
Viridiplantae
Viridiplantae
Viridiplantae
Viridiplantae
Viridiplantae
Viridiplantae
Viridiplantae
Viridiplantae
Viridiplantae
Viridiplantae
Viridiplantae
Viridiplantae
Viridiplantae
Viridiplantae
Viridiplantae

Streptophyta
Streptophyta
Streptophyta
Streptophyta
Streptophyta
Streptophyta
Streptophyta
Streptophyta
Streptophyta
Streptophyta
Streptophyta
Streptophyta
Streptophyta
Streptophyta
Streptophyta
Streptophyta
Streptophyta
Streptophyta
Streptophyta
Streptophyta
Streptophyta
Streptophyta
Streptophyta

Elaeis guineensis
Glycine max
Phoenix dactylifera
Elaeis guineensis
Pyrus x bretschneideri
Solanum lycopersicum
Camelina sativa
Camelina sativa
Camelina sativa
Citrus clementina
Eutrema salsugineum
Medicago truncatula
Morus notabilis
Musa acuminata subsp. malaccensis
Phaseolus vulgaris
Setaria italica
Theobroma cacao
Nelumbo nucifera
Nelumbo nucifera
Camelina sativa
Glycine max
Phoenix dactylifera
Zea mays

215
142
204
190
201
183
250
172
205
203
190
198
227
237
196
244
211
192
167
110
115
111
105

2
4
5
1
2
1
2
3
4
2
2
2
2
2
2
1
2
3
4
5
5
7
8

Acidobacteria

Acidobacteriales

Acidobacteria bacterium KBS 146

180

7

S. No. Accession ID
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2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32

WP 020708296.1
WP 022841761.1
WP 044934140.1
WP 035349492.1
WP 011684777.1
WP 011684752.1
WP 025225334.1
WP 026462441.1
WP 041932228.1
WP 044511184.1
WP 022831749.1
WP 014219371.1
WP 015807556.1
WP 021070780.1
WP 034360154.1
WP 052214706.1
WP 039184858.1
NP 774287.1
WP 028352275.1
WP 038387024.1
WP 028162302.1
WP 016841006.1
WP 039146731.1
WP 014493256.1
WP 038959825.1
WP 038958321.1
WP 018645210.1
WP 057752922.1
WP 027561371.1
WP 050385533.1
WP 050420915.1

Domain

Phylum

Class

Species

Bacteria
Bacteria
Bacteria
Bacteria
Bacteria
Bacteria
Bacteria
Bacteria
Bacteria
Bacteria
Bacteria
Bacteria
Bacteria
Bacteria
Bacteria
Bacteria
Bacteria
Bacteria
Bacteria
Bacteria
Bacteria
Bacteria
Bacteria
Bacteria
Bacteria
Bacteria
Bacteria
Bacteria
Bacteria
Bacteria
Bacteria

Acidobacteria
Acidobacteria
Acidobacteria
Acidobacteria
Acidobacteria
Acidobacteria
Armatimonadetes
Bacteroidetes
Bacteroidetes
Bacteroidetes
Bacteroidetes
Bacteroidetes
Bacteroidetes
Bacteroidetes
Deinococcus-Thermus
Proteobacteria
Proteobacteria
Proteobacteria
Proteobacteria
Proteobacteria
Proteobacteria
Proteobacteria
Proteobacteria
Proteobacteria
Proteobacteria
Proteobacteria
Proteobacteria
Proteobacteria
Proteobacteria
Proteobacteria
Proteobacteria

Acidobacteriales
Acidobacteriales
Acidobacteriales
Acidobacteriales
Solibacteres
Solibacteres
Fimbriimonadia
Cytophagia
Cytophagia
Cytophagia
NA
Sphingobacteriia
Sphingobacteriia
Sphingobacteriia
Deinococci
Alphaproteobacteria
Alphaproteobacteria
Alphaproteobacteria
Alphaproteobacteria
Alphaproteobacteria
Alphaproteobacteria
Alphaproteobacteria
Alphaproteobacteria
Alphaproteobacteria
Alphaproteobacteria
Alphaproteobacteria
Alphaproteobacteria
Alphaproteobacteria
Alphaproteobacteria
Alphaproteobacteria
Alphaproteobacteria

Acidobacteriaceae bacterium KBS 83
Acidobacteriaceae bacterium TAA166
Acidobacterium sp. PMMR2
Edaphobacter aggregans
Candidatus Solibacter usitatus
Candidatus Solibacter usitatus
Fimbriimonas ginsengisoli
Adhaeribacter aquaticus
Cytophaga hutchinsonii
Hymenobacter sp. DG25B
Cytophagales bacterium B6
Niastella koreensis
Pedobacter heparinus
Sphingobacterium paucimobilis
Deinococcus phoenicis
Belnapia sp. F-4-1
Bradyrhizobium diazoefficiens
Bradyrhizobium diazoefficiens USDA 110
Bradyrhizobium elkanii
Bradyrhizobium elkanii
Bradyrhizobium elkanii
Bradyrhizobium elkanii
Bradyrhizobium japonicum
Bradyrhizobium japonicum
Bradyrhizobium japonicum
Bradyrhizobium japonicum
Bradyrhizobium japonicum
Bradyrhizobium manausense
Bradyrhizobium NA
Bradyrhizobium pachyrhizi
Bradyrhizobium sp. SEMIA 6148

Sequence
No. of
Length Mismatches
186
7
177
7
178
7
165
7
180
7
192
8
174
7
182
7
170
7
175
7
167
7
160
6
266
7
269
7
182
7
182
7
171
8
171
8
171
7
171
8
171
8
171
8
171
7
171
7
171
8
171
8
171
8
171
8
171
7
171
7
178
8

S. No. Accession ID
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33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63

WP 050401574.1
WP 036174138.1
WP 029351027.1
WP 027054444.1
WP 038646356.1
WP 027029348.1
WP 019857724.1
WP 032929992.1
WP 041009554.1
WP 023804020.1
WP 056568384.1
WP 027168587.1
WP 048463263.1
WP 015932235.1
WP 018263385.1
WP 043839886.1
WP 022688735.1
WP 027102232.1
WP 011423145.1
WP 041448770.1
WP 012528180.1
WP 059438257.1
WP 047855092.1
WP 044243203.1
WP 014393600.1
WP 043403906.1
WP 044182939.1
WP 013935980.1
WP 046710998.1
WP 002635613.1
WP 015346479.1

Domain

Phylum

Class

Species

Bacteria
Bacteria
Bacteria
Bacteria
Bacteria
Bacteria
Bacteria
Bacteria
Bacteria
Bacteria
Bacteria
Bacteria
Bacteria
Bacteria
Bacteria
Bacteria
Bacteria
Bacteria
Bacteria
Bacteria
Bacteria
Bacteria
Bacteria
Bacteria
Bacteria
Bacteria
Bacteria
Bacteria
Bacteria
Bacteria
Bacteria

Proteobacteria
Proteobacteria
Proteobacteria
Proteobacteria
Proteobacteria
Proteobacteria
Proteobacteria
Proteobacteria
Proteobacteria
Proteobacteria
Proteobacteria
Proteobacteria
Proteobacteria
Proteobacteria
Proteobacteria
Proteobacteria
Proteobacteria
Proteobacteria
Proteobacteria
Proteobacteria
Proteobacteria
Proteobacteria
Proteobacteria
Proteobacteria
Proteobacteria
Proteobacteria
Proteobacteria
Proteobacteria
Proteobacteria
Proteobacteria
Proteobacteria

Alphaproteobacteria
Alphaproteobacteria
Alphaproteobacteria
Alphaproteobacteria
Alphaproteobacteria
Alphaproteobacteria
Alphaproteobacteria
Alphaproteobacteria
Alphaproteobacteria
Alphaproteobacteria
Alphaproteobacteria
Alphaproteobacteria
Alphaproteobacteria
Alphaproteobacteria
Alphaproteobacteria
Alphaproteobacteria
Alphaproteobacteria
Betaproteobacteria
Deltaproteobacteria
Deltaproteobacteria
Deltaproteobacteria
Deltaproteobacteria
Deltaproteobacteria
Deltaproteobacteria
Deltaproteobacteria
Deltaproteobacteria
Deltaproteobacteria
Deltaproteobacteria
Deltaproteobacteria
Deltaproteobacteria
Deltaproteobacteria

Bradyrhizobium sp. SEMIA 6208
Maribius sp. MOLA 401
Mesorhizobium ciceri
Mesorhizobium erdmanii
Mesorhizobium huakuii
Mesorhizobium loti
Mesorhizobium loti
Mesorhizobium loti
Mesorhizobium plurifarium
Mesorhizobium sp. L48C026A00
Mesorhizobium sp. Root172
Mesorhizobium sp. WSM3224
Methylobacterium aquaticum
Methylobacterium nodulans
Methylobacterium sp. WSM2598
Roseomonas aerilata
Sphingomonas-like bacterium B12
Comamonadaceae bacterium URHA0028
Anaeromyxobacter dehalogenans
Anaeromyxobacter sp. Fw109-5
Anaeromyxobacter sp. K
Anaeromyxobacter sp. PSR-1
Archangium gephyra
Chondromyces apiculatus
Corallococcus coralloides
Cystobacter violaceus
Hyalangium minutum
Myxococcus fulvus
Myxococcus fulvus
Myxococcus sp. mixupus
Myxococcus stipitatus

Sequence
No. of
Length Mismatches
171
8
177
7
182
7
179
7
178
7
177
7
178
7
178
7
179
7
182
7
183
7
178
7
182
7
182
7
180
6
185
7
175
7
183
7
182
7
167
7
182
7
182
7
182
7
211
7
179
7
181
7
175
7
176
7
179
7
176
7
176
7

S. No. Accession ID
64
65
66

Domain

WP 011550983.1 Bacteria
WP 002611555.1 Bacteria
WP 040549275.1 Bacteria

Group E
1 WP 013062410.1 Bacteria

Sequence
No. of
Length Mismatches
176
7
175
7
176
7

234

Phylum

Class

Species

Proteobacteria
Proteobacteria
Verrucomicrobia

Deltaproteobacteria
Deltaproteobacteria
Verrucomicrobiae

Myxococcus xanthus
Stigmatella aurantiaca
Pedosphaera parvula

Bacteroidetes

Bacteroidetes Order II.
Incertae sedis
Bacteroidetes Order II.
Incertae sedis
Bacteroidetes Order II.
Incertae sedis
Flavobacteriia
Flavobacteriia
Flavobacteriia
Flavobacteriia
Flavobacteriia
Flavobacteriia
Flavobacteriia
Flavobacteriia
Flavobacteriia
Flavobacteriia
Sphingobacteriia
Sphingobacteriia
Sphingobacteriia
Sphingobacteriia
Chlorobia
Prochlorales
Alphaproteobacteria
Deltaproteobacteria
Gammaproteobacteria
Gammaproteobacteria
Gammaproteobacteria
Gammaproteobacteria

Salinibacter ruber

246

2

Salinibacter ruber

223

2

Salinibacter ruber DSM 13855

223

2

Altibacter lentus
Gramella echinicola
Gramella forsetii
Gramella portivictoriae
Leeuwenhoekiella blandensis
Maribacter sp. Hel I 7
Salegentibacter mishustinae
Salegentibacter sp. Hel I 6
Salegentibacter sp. Hel I 6
Zunongwangia profunda
Haliscomenobacter hydrossis
Lewinella cohaerens
Lewinella persica
Phaeodactylibacter xiamenensis
Chlorobium phaeobacteroides
Prochlorococcus marinus
alpha proteobacterium HIMB5
Desulfovibrio desulfuricans
Halomonas alkaliantarctica
Halomonas campaniensis
Halomonas salina
Halomonas sp. HAL1

229
198
198
198
204
230
201
228
201
201
204
201
206
199
237
231
202
251
235
235
235
235

1
2
2
2
1
1
2
1
2
2
2
1
1
2
1
1
1
1
1
1
1
1

2

WP 011404754.1 Bacteria

Bacteroidetes

3

YP 446130.1

Bacteria

Bacteroidetes

4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25

WP 034257663.1
WP 026933612.1
WP 011710619.1
WP 026915214.1
WP 009780237.1
WP 027065459.1
WP 057482175.1
WP 037319789.1
WP 037319374.1
WP 013073192.1
WP 013768185.1
WP 020539118.1
WP 020571882.1
WP 044228174.1
WP 012474940.1
WP 032526634.1
WP 014953602.1
WP 012625475.1
WP 030073894.1
WP 038477742.1
WP 035599143.1
WP 008956972.1

Bacteria
Bacteria
Bacteria
Bacteria
Bacteria
Bacteria
Bacteria
Bacteria
Bacteria
Bacteria
Bacteria
Bacteria
Bacteria
Bacteria
Bacteria
Bacteria
Bacteria
Bacteria
Bacteria
Bacteria
Bacteria
Bacteria

Bacteroidetes
Bacteroidetes
Bacteroidetes
Bacteroidetes
Bacteroidetes
Bacteroidetes
Bacteroidetes
Bacteroidetes
Bacteroidetes
Bacteroidetes
Bacteroidetes
Bacteroidetes
Bacteroidetes
Bacteroidetes
Chlorobi
Cyanobacteria
Proteobacteria
Proteobacteria
Proteobacteria
Proteobacteria
Proteobacteria
Proteobacteria

S. No. Accession ID
26
27
28
29
30
31
32
33
34
35
36

WP 018916403.1
WP 014291612.1
WP 047874896.1
WP 045045090.1
WP 045028211.1
WP 036791911.1
WP 038139208.1
WP 038192711.1
WP 005471144.1
WP 009388256.1
WP 053438794.1

235

Group F
1 WP 042507785.1
2 WP 051127291.1
3 WP 010932504.1
4 NP 661717.1
5 WP 007306938.1
6 WP 004879422.1
7 WP 007778286.1
8 WP 038989274.1
9 WP 037468281.1
10 XP 005968954.1
11 WP 051072622.1
12 WP 032968426.1
13 WP 044594794.1
14 WP 037468284.1

Sequence
No. of
Length Mismatches
234
1
235
1
218
1
217
1
219
1
219
1
217
1
217
1
217
1
218
1
216
1

Domain

Phylum

Class

Species

Bacteria
Bacteria
Bacteria
Bacteria
Bacteria
Bacteria
Bacteria
Bacteria
Bacteria
Bacteria
Bacteria

Proteobacteria
Proteobacteria
Proteobacteria
Proteobacteria
Proteobacteria
Proteobacteria
Proteobacteria
Proteobacteria
Proteobacteria
Proteobacteria
Proteobacteria

Gammaproteobacteria
Gammaproteobacteria
Gammaproteobacteria
Gammaproteobacteria
Gammaproteobacteria
Gammaproteobacteria
Gammaproteobacteria
Gammaproteobacteria
Gammaproteobacteria
Gammaproteobacteria
Gammaproteobacteria

Halomonas zhanjiangensis
Oceanimonas sp. GK1
Photobacterium aphoticum
Photobacterium kishitanii
Photobacterium phosphoreum
Photobacterium phosphoreum
Vibrio caribbeanicus
Vibrio sinaloensis
Vibrio sp. 16
Vibrio sp. N418
Vibrio xuii

Bacteria
Bacteria
Bacteria
Bacteria
Bacteria
Bacteria
Bacteria
Bacteria
Bacteria
Eukaryota
Bacteria
Bacteria
Bacteria
Bacteria

Actinobacteria
Actinobacteria
Chlorobi
Chlorobi
Cyanobacteria
Proteobacteria
Proteobacteria
Proteobacteria
Proteobacteria
Metazoa
Actinobacteria
Proteobacteria
Proteobacteria
Proteobacteria

Streptomycetales
Streptomycetales
Chlorobia
Chlorobia
Oscillatoriophycideae
Gammaproteobacteria
Gammaproteobacteria
Gammaproteobacteria
Gammaproteobacteria
Chordata
Streptomycetales
Gammaproteobacteria
Gammaproteobacteria
Gammaproteobacteria

Streptomyces cattleya
Streptomyces sp. HmicA12
Chlorobaculum tepidum
Chlorobium tepidum TLS
Crocosphaera watsonii
Acinetobacter venetianus
Cronobacter NA
Salmonella enterica
Shewanella haliotis
Pantholops hodgsonii
Streptomyces mobaraensis
Cronobacter malonaticus
Cronobacter sakazakii
Shewanella haliotis

145
152
137
137
136
58
52
46
52
145
148
121
113
123

3
3
3
3
3
11
11
11
11
3
4
2
2
3

Actinobacteria
Proteobacteria

Frankiales
Gammaproteobacteria

Frankia sp. CeD
Escherichia coli

179
172

1
1

Group G
1 WP 035908648.1 Bacteria
2 WP 044708262.1 Bacteria

S. No. Accession ID
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3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33

WP 038471911.1
WP 020717964.1
WP 029337941.1
WP 012947940.1
WP 010311975.1
WP 055721937.1
WP 013444283.1
WP 029981239.1
WP 052456751.1
WP 023790767.1
WP 012953793.1
WP 007597438.1
WP 017968915.1
WP 028227131.1
WP 007420790.1
WP 008489581.1
XP 001442714.1
XP 005973273.1
XP 001327291.1
WP 009687411.1
WP 060175032.1
XP 005977341.1
WP 027341333.1
WP 040666440.1
XP 013227981.1
WP 004030436.1
WP 014727087.1
WP 020797754.1
WP 048085152.1
WP 007657439.1
WP 028528751.1

Domain

Phylum

Class

Species

Bacteria
Bacteria
Bacteria
Bacteria
Bacteria
Bacteria
Bacteria
Bacteria
Bacteria
Bacteria
Bacteria
Bacteria
Bacteria
Bacteria
Bacteria
Bacteria
Eukaryota
Eukaryota
Eukaryota
Bacteria
Bacteria
Eukaryota
Bacteria
Bacteria
Eukaryota
Archaea
Bacteria
Bacteria
Archaea
Bacteria
Bacteria

Proteobacteria
Acidobacteria
Actinobacteria
Actinobacteria
Actinobacteria
Actinobacteria
Bacteroidetes
Cyanobacteria
Proteobacteria
candidate division SR1
Cyanobacteria
Proteobacteria
Proteobacteria
Proteobacteria
Proteobacteria
Proteobacteria
Alveolata
Metazoa
Parabasalia
Proteobacteria
Proteobacteria
Metazoa
Actinobacteria
Chloroflexi
Alveolata
Euryarchaeota
Proteobacteria
Proteobacteria
Euryarchaeota
Bacteroidetes
Firmicutes

Gammaproteobacteria
Acidobacteriales
Geodermatophilales
Geodermatophilales
Pseudonocardiales
Streptomycetales
Bacteroidia
Prochlorales
Gammaproteobacteria
NA
Oscillatoriophycideae
Alphaproteobacteria
Alphaproteobacteria
Betaproteobacteria
Gammaproteobacteria
Gammaproteobacteria
Ciliophora
Chordata
Trichomonadida
Betaproteobacteria
Betaproteobacteria
Chordata
Micromonosporales
Sphaerobacteridae
Apicomplexa
Methanobacteria
Epsilonproteobacteria
Gammaproteobacteria
Methanobacteria
Cytophagia
Clostridia

Acidithiobacillus caldus
Acidobacteriaceae bacterium KBS 96
Geodermatophilaceae bacterium URHB0048
Geodermatophilus obscurus
Saccharopolyspora spinosa
Streptomyces niveiscabiei
Paludibacter propionicigenes
Prochlorococcus sp. scB245a 521M10
Klebsiella pneumoniae
candidate division SR1 bacterium RAAC1 SR1 1
Candidatus Atelocyanobacterium thalassa
Bradyrhizobium sp. WSM1253
Rhizobium leguminosarum
Burkholderia ferrariae
Idiomarina sp. A28L
Idiomarina xiamenensis
Paramecium tetraurelia strain d4-2
Pantholops hodgsonii
Trichomonas vaginalis G3
Burkholderia pseudomultivorans
Burkholderia cepacia
Pantholops hodgsonii
Hamadaea tsunoensis
Nitrolancea hollandica
Eimeria tenella
Methanobacterium formicicum
Helicobacter pylori
Pseudomonas sp. G5 2012
Methanobacterium formicicum
Pontibacter sp. BAB1700
Ruminococcus gauvreauii

Sequence
No. of
Length Mismatches
177
1
178
1
167
1
169
1
185
1
160
1
188
1
189
1
172
1
182
2
168
2
174
2
177
2
181
2
510
2
414
2
260
2
176
2
236
2
181
3
181
4
141
4
173
5
157
5
524
5
182
6
169
6
181
7
179
8
195
9
184
9

Table C.2. Mismatching sequences in Family I-E IPPases and their taxonomy information.
S. No.

237

Group A
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28

Accession ID

Domain

Kingdom

Phylum

Species

XP 008117407.1
XP 011798646.1
XP 013155165.1
XP 011821719.1
XP 010708092.1
XP 012354929.1
XP 010792338.1
XP 008953599.1
XP 009446365.1
XP 010358491.1
NP 001089524.1
XP 012291978.1
XP 005207717.1
XP 007997631.1
XP 006874618.1
XP 011798644.1
XP 012859685.1
XP 008573005.1
XP 004040275.1
NP 008834.3
XP 011821717.1
XP 012634455.1
XP 012634454.1
XP 003257508.1
XP 011474367.1
XP 003830018.1
XP 001170451.1
XP 007567374.1

Eukaryota
Eukaryota
Eukaryota
Eukaryota
Eukaryota
Eukaryota
Eukaryota
Eukaryota
Eukaryota
Eukaryota
Eukaryota
Eukaryota
Eukaryota
Eukaryota
Eukaryota
Eukaryota
Eukaryota
Eukaryota
Eukaryota
Eukaryota
Eukaryota
Eukaryota
Eukaryota
Eukaryota
Eukaryota
Eukaryota
Eukaryota
Eukaryota

Metazoa
Metazoa
Metazoa
Metazoa
Metazoa
Metazoa
Metazoa
Metazoa
Metazoa
Metazoa
Metazoa
Metazoa
Metazoa
Metazoa
Metazoa
Metazoa
Metazoa
Metazoa
Metazoa
Metazoa
Metazoa
Metazoa
Metazoa
Metazoa
Metazoa
Metazoa
Metazoa
Metazoa

Chordata
Chordata
Chordata
Chordata
Chordata
Chordata
Chordata
Chordata
Chordata
Chordata
Chordata
Chordata
Chordata
Chordata
Chordata
Chordata
Chordata
Chordata
Chordata
Chordata
Chordata
Chordata
Chordata
Chordata
Chordata
Chordata
Chordata
Chordata

Anolis carolinensis
Colobus angolensis palliatus
Falco peregrinus
Mandrillus leucophaeus
Meleagris gallopavo
Nomascus leucogenys
Notothenia coriiceps
Pan paniscus
Pan troglodytes
Rhinopithecus roxellana
Xenopus laevis
Aotus nancymaae
Bos taurus
Chlorocebus sabaeus
Chrysochloris asiatica
Colobus angolensis palliatus
Echinops telfairi
Galeopterus variegatus
Gorilla gorilla gorilla
Homo sapiens
Mandrillus leucophaeus
Microcebus murinus
Microcebus murinus
Nomascus leucogenys
Oryzias latipes
Pan paniscus
Pan troglodytes
Poecilia formosa

Seq.
No. of
Length Mismatches
337
281
286
281
132
281
242
281
281
211
204
259
313
305
274
305
244
306
305
305
305
276
293
305
342
305
305
303

2
2
2
2
2
2
2
2
2
2
2
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3

S. No.

238

29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59

Accession ID

Domain

Kingdom

Phylum

Species

XP 010369848.1
XP 006144430.1
XP 007890119.1
XP 012636973.1
XP 014118644.1
XP 013965521.1
XP 004631990.1
XP 012513899.1
XP 002192220.2
XP 006502279.1
XP 013155168.1
XP 006502280.1
XP 011798647.1
XP 004040276.1
XP 004862334.1
NP 789842.2
XP 011821720.1
XP 011238560.1
XP 003257509.1
XP 012392551.1
XP 010369850.1
XP 014065144.1
XP 008589994.1
XP 012963066.1
XP 011798648.1
XP 004040277.1
XP 004049612.1
NP 789843.2
XP 011821721.1
XP 004089091.1
XP 014200198.1

Eukaryota
Eukaryota
Eukaryota
Eukaryota
Eukaryota
Eukaryota
Eukaryota
Eukaryota
Eukaryota
Eukaryota
Eukaryota
Eukaryota
Eukaryota
Eukaryota
Eukaryota
Eukaryota
Eukaryota
Eukaryota
Eukaryota
Eukaryota
Eukaryota
Eukaryota
Eukaryota
Eukaryota
Eukaryota
Eukaryota
Eukaryota
Eukaryota
Eukaryota
Eukaryota
Eukaryota

Metazoa
Metazoa
Metazoa
Metazoa
Metazoa
Metazoa
Metazoa
Metazoa
Metazoa
Metazoa
Metazoa
Metazoa
Metazoa
Metazoa
Metazoa
Metazoa
Metazoa
Metazoa
Metazoa
Metazoa
Metazoa
Metazoa
Metazoa
Metazoa
Metazoa
Metazoa
Metazoa
Metazoa
Metazoa
Metazoa
Metazoa

Chordata
Chordata
Chordata
Chordata
Chordata
Chordata
Chordata
Chordata
Chordata
Chordata
Chordata
Chordata
Chordata
Chordata
Chordata
Chordata
Chordata
Chordata
Chordata
Chordata
Chordata
Chordata
Chordata
Chordata
Chordata
Chordata
Chordata
Chordata
Chordata
Chordata
Chordata

Rhinopithecus roxellana
Tupaia chinensis
Callorhinchus milii
Microcebus murinus
Pseudopodoces humilis
Canis lupus familiaris
Octodon degus
Propithecus coquereli
Taeniopygia guttata
Mus musculus
Falco peregrinus
Mus musculus
Colobus angolensis palliatus
Gorilla gorilla gorilla
Heterocephalus glaber
Homo sapiens
Mandrillus leucophaeus
Mus musculus
Nomascus leucogenys
Orcinus orca
Rhinopithecus roxellana
Salmo salar
Galeopterus variegatus
Anas platyrhynchos
Colobus angolensis palliatus
Gorilla gorilla gorilla
Gorilla gorilla gorilla
Homo sapiens
Mandrillus leucophaeus
Nomascus leucogenys
Pan paniscus

Seq.
No. of
Length Mismatches
305
3
238
3
272
4
276
4
286
4
303
5
282
5
229
5
309
5
272
6
246
7
213
7
232
8
232
8
274
8
232
8
232
8
264
8
232
8
197
8
232
8
161
8
150
10
263
11
168
11
168
11
134
11
168
11
168
11
168
11
168
11

S. No.

Seq.
No. of
Length Mismatches
168
11
216
7
374
3
159
5
259
2

239

Accession ID

Domain

Kingdom

Phylum

Species

60
61
62
63
64

XP 010369851.1
XP 008468490.1
XP 015417589.1
XP 004624420.1
XP 012872515.1

Eukaryota
Eukaryota
Eukaryota
Eukaryota
Eukaryota

Metazoa
Metazoa
Metazoa
Metazoa
Metazoa

Chordata
Ecdysozoa
Chordata
Chordata
Chordata

Rhinopithecus roxellana
Diaphorina citri
Myotis davidii
Octodon degus
Dipodomys ordii

Group B
1
2
3
4
5
6
7
8
9
10
11

XP 006422674.1
XP 006280876.1
XP 010068328.1
XP 002866618.1
XP 013678962.1
XP 008664356.1
XP 006288931.1
XP 013702372.1
XP 013678500.1
XP 009125356.1
XP 002844233.1

Eukaryota
Eukaryota
Eukaryota
Eukaryota
Eukaryota
Eukaryota
Eukaryota
Eukaryota
Eukaryota
Eukaryota
Eukaryota

Viridiplantae
Viridiplantae
Viridiplantae
Viridiplantae
Viridiplantae
Viridiplantae
Viridiplantae
Viridiplantae
Viridiplantae
Viridiplantae
Fungi

Streptophyta
Streptophyta
Streptophyta
Streptophyta
Streptophyta
Streptophyta
Streptophyta
Streptophyta
Streptophyta
Streptophyta
Dikarya

Citrus clementina
Capsella rubella
Eucalyptus grandis
Arabidopsis lyrata subsp. lyrata
Brassica napus
Zea mays
Capsella rubella
Brassica napus
Brassica napus
Brassica rapa
Arthroderma otae CBS 113480

276
238
251
240
130
139
110
241
166
166
187

1
2
2
5
7
7
8
9
12
12
7

Group C
1
2
3
4
5
6

XP 003667355.1
XP 963564.2
XP 009851843.1
XP 001903527.1
XP 003344181.1
XP 002582880.1

Eukaryota
Eukaryota
Eukaryota
Eukaryota
Eukaryota
Eukaryota

Fungi
Fungi
Fungi
Fungi
Fungi
Fungi

Dikarya
Dikarya
Dikarya
Dikarya
Dikarya
Dikarya

Myceliophthora thermophila ATCC 42464
Neurospora crassa OR74A
Neurospora tetrasperma FGSC 2508
Podospora anserina S mat+
Sordaria macrospora k-hell
Uncinocarpus reesii 1704

324
301
405
314
345
412

1
1
1
1
1
1

Alveolata
Alveolata
Apusozoa

Apicomplexa
Perkinsea
Apusomonadidae

Babesia microti strain RI
Perkinsus marinus ATCC 50983
Thecamonas trahens ATCC 50062

302
275
213

1
1
1

Group D
1
XP 012647482.1 Eukaryota
2
XP 002784627.1 Eukaryota
3
XP 013756789.1 Eukaryota

S. No.

240

Accession ID

Domain

Kingdom

Phylum

Species

4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30

XP 011319388.1
XP 013972996.1
XP 012360483.1
XP 012373131.1
XP 008964850.1
XP 009448409.1
XP 007131120.1
XP 008187333.1
XP 011396105.1
XP 001012306.1
XP 002771058.1
XP 002772105.1
XP 002768368.1
XP 009309750.1
XP 008602692.1
XP 007814156.1
XP 006749881.1
XP 008938932.1
XP 014427109.1
XP 009239565.1
XP 006144459.1
XP 001862097.1
XP 009036015.1
XP 013895361.1
XP 001784606.1
XP 001549931.1
XP 006690652.1

Eukaryota
Eukaryota
Eukaryota
Eukaryota
Eukaryota
Eukaryota
Eukaryota
Eukaryota
Eukaryota
Eukaryota
Eukaryota
Eukaryota
Eukaryota
Eukaryota
Eukaryota
Eukaryota
Eukaryota
Eukaryota
Eukaryota
Eukaryota
Eukaryota
Eukaryota
Eukaryota
Eukaryota
Eukaryota
Eukaryota
Eukaryota

Fungi
Metazoa
Metazoa
Metazoa
Metazoa
Metazoa
Metazoa
Metazoa
Viridiplantae
Alveolata
Alveolata
Alveolata
Alveolata
Euglenozoa
Fungi
Fungi
Metazoa
Metazoa
Metazoa
Metazoa
Metazoa
Metazoa
Stramenopiles
Viridiplantae
Viridiplantae
Fungi
Fungi

Dikarya
Chordata
Chordata
Chordata
Chordata
Chordata
Chordata
Ecdysozoa
Chlorophyta
Ciliophora
Perkinsea
Perkinsea
Perkinsea
Kinetoplastida
Dikarya
Dikarya
Chordata
Chordata
Chordata
Chordata
Chordata
Ecdysozoa
Pelagophyceae
Chlorophyta
Streptophyta
Dikarya
Dikarya

31
32
33
34

XP 009158037.1
XP 014349517.1
XP 011855377.1
XP 005070965.1

Eukaryota
Eukaryota
Eukaryota
Eukaryota

Fungi
Metazoa
Metazoa
Metazoa

Dikarya
Chordata
Chordata
Chordata

Fusarium graminearum PH-1
Canis lupus familiaris
Nomascus leucogenys
Octodon degus
Pan paniscus
Pan troglodytes
Physeter catodon
Acyrthosiphon pisum
Auxenochlorella protothecoides
Tetrahymena thermophila SB210
Perkinsus marinus ATCC 50983
Perkinsus marinus ATCC 50983
Perkinsus marinus ATCC 50983
Trypanosoma grayi
Beauveria bassiana ARSEF 2860
Metarhizium acridum CQMa 102
Leptonychotes weddellii
Merops nubicus
Pelodiscus sinensis
Pongo abelii
Tupaia chinensis
Culex quinquefasciatus
Aureococcus anophagefferens
Monoraphidium neglectum
Physcomitrella patens
Botrytis cinerea B05.10
Chaetomium thermophilum var. thermophilum
DSM 1495
Exophiala dermatitidis NIH/UT8656
Latimeria chalumnae
Mandrillus leucophaeus
Mesocricetus auratus

Seq.
No. of
Length Mismatches
317
1
303
1
306
1
289
1
288
1
288
1
287
1
329
1
845
1
261
2
189
2
286
2
288
2
181
2
318
2
335
2
252
2
127
2
330
2
292
2
289
2
260
2
238
2
219
2
244
2
235
3
318
3
228
323
1349
271

3
3
3
3

S. No.

241

35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55

Accession ID

Domain

Kingdom

Phylum

XP 008049277.1
XP 004029796.1
XP 007819550.1
XP 001257965.1
XP 011313464.1
XP 011158238.1
XP 009171673.1
XP 013434616.1
XP 003883129.1
XP 750738.2
XP 003838909.1
XP 013214318.1
XP 009493103.1
XP 007299907.1
XP 011814475.1
XP 002510002.1
XP 012962679.1
XP 007664955.1
XP 008266967.1
XP 010648028.1
XP 009228650.1

Eukaryota
Eukaryota
Eukaryota
Eukaryota
Eukaryota
Eukaryota
Eukaryota
Eukaryota
Eukaryota
Eukaryota
Eukaryota
Eukaryota
Eukaryota
Eukaryota
Eukaryota
Eukaryota
Eukaryota
Eukaryota
Eukaryota
Eukaryota
Eukaryota

Metazoa
Alveolata
Fungi
Fungi
Metazoa
Metazoa
Metazoa
Alveolata
Alveolata
Fungi
Fungi
Metazoa
Nucleariidae and Fonticula group
Fungi
Metazoa
Viridiplantae
Metazoa
Metazoa
Metazoa
Viridiplantae
Fungi

Chordata
Ciliophora
Dikarya
Dikarya
Ecdysozoa
Ecdysozoa
Platyhelminthes
Apicomplexa
Apicomplexa
Dikarya
Dikarya
Chordata
Fonticula
Dikarya
Chordata
Streptophyta
Chordata
Chordata
Chordata
Streptophyta
Dikarya

Seq.
No. of
Length Mismatches
Tarsius syrichta
289
3
Ichthyophthirius multifiliis
734
4
Metarhizium robertsii ARSEF 23
293
4
Neosartorya fischeri NRRL 181
321
4
Fopius arisanus
211
4
Solenopsis invicta
259
4
Opisthorchis viverrini
173
4
Eimeria necatrix
433
5
Neospora caninum Liverpool
507
5
Aspergillus fumigatus Af293
321
5
Leptosphaeria maculans JN3
191
5
Ictidomys tridecemlineatus
222
5
Fonticula alba
152
5
Stereum hirsutum FP-91666 SS1
303
6
Colobus angolensis palliatus
235
6
Ricinus communis
206
6
Anas platyrhynchos
211
8
Ornithorhynchus anatinus
228
8
Oryctolagus cuniculus
295
8
Vitis vinifera
157
10
Gaeumannomyces graminis var. tritici R3-111a-1
172
11

Species

Table C.3. Mismatching sequences in Family II IPPases and their taxonomy information.
S. No.

Seq.
No. of
Length Mismatches
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Accession ID

Domain

Phylum

Class

Species

Group A
1
2
3
4
5
6
7
8
9
10
11
12
13
14

WP 035235538.1
WP 015403837.1
XP 451703.1
XP 011404658.1
XP 011114275.1
XP 008899618.1
WP 022668371.1
WP 020586627.1
XP 003646740.1
XP 001419770.1
XP 002900227.1
WP 044882799.1
WP 039383502.1
XP 008043387.1

Bacteria
Bacteria
Eukaryota
Eukaryota
Eukaryota
Eukaryota
Bacteria
Bacteria
Eukaryota
Eukaryota
Eukaryota
Bacteria
Bacteria
Eukaryota

Proteobacteria
Proteobacteria
Fungi
Metazoa
Fungi
Stramenopiles
Proteobacteria
Proteobacteria
Fungi
Viridiplantae
Stramenopiles
Chlamydiae
Chlamydiae
Fungi

Deltaproteobacteria
Deltaproteobacteria
Dikarya
Porifera
Dikarya
Oomycetes
Deltaproteobacteria
Deltaproteobacteria
Dikarya
Chlorophyta
Oomycetes
Chlamydiales
Chlamydiales
Dikarya

Desulfobacter vibrioformis
Desulfocapsa sulfexigens
Kluyveromyces lactis NRRL Y-1140
Amphimedon queenslandica
Dactylellina haptotyla CBS 200.50
Phytophthora parasitica INRA-310
Desulfospira joergensenii
Desulfobacter curvatus
Eremothecium cymbalariae DBVPG#7215
Ostreococcus lucimarinus CCE9901
Phytophthora infestans T30-4
Neochlamydia sp. EPS4
Neochlamydia sp. TUME1
Trametes versicolor FP-101664 SS1

377
343
383
365
415
425
362
372
380
394
407
375
375
422

1
1
1
1
1
1
1
1
1
1
1
2
2
2

Group B
1
2
3
4
5
6
7

WP 039334432.1
WP 033744377.1
WP 033777924.1
WP 010616472.1
XP 014160407.1
WP 028062319.1
WP 009424027.1

Bacteria
Bacteria
Bacteria
Bacteria
Eukaryota
Bacteria
Bacteria

Proteobacteria
Proteobacteria
Proteobacteria
Proteobacteria
Ichthyosporea
Actinobacteria
Fusobacteria

Gammaproteobacteria
Gammaproteobacteria
Gammaproteobacteria
Gammaproteobacteria
Ichthyophonida
Thermoleophilia
Fusobacteriales

Pantoea rodasii
Enterobacteriaceae NA
Pantoea ananatis
Plautia stali symbiont
Sphaeroforma arctica JP610
Solirubrobacter soli
Fusobacterium sp. oral taxon 370

273
273
273
273
277
514
469

3
3
3
3
3
3
3

Group C
1
2
3
4
5

WP 026660912.1
WP 012875652.1
WP 009102825.1
WP 034497599.1
XP 001709328.1

Bacteria
Bacteria
Bacteria
Bacteria
Eukaryota

Firmicutes
Thermobaculum
Spirochaetes
Proteobacteria
Diplomonadida

Clostridia
NA
Spirochaetales
Gammaproteobacteria
Hexamitidae

Butyrivibrio sp. AC2005
Thermobaculum terrenum
Treponema sp. JC4
Buttiauxella agrestis
Giardia lamblia ATCC 50803

374
542
369
296
695

1
1
1
1
3

S. No.
6
7
8
9
10

Accession ID

Domain

Phylum

Class

Species

WP 008081951.1
WP 033170097.1
WP 052610713.1
WP 011936248.1
WP 003594415.1

Bacteria
Bacteria
Bacteria
Bacteria
Bacteria

Proteobacteria
Firmicutes
Candidatus Berkelbacteria
Cyanobacteria
Firmicutes

Gammaproteobacteria
Negativicutes
NA
Oscillatoriophycideae
Bacilli

Pseudomonas sp. GM80
Selenomonas sp. ND2010
Berkelbacteria bacterium GW2011 GWE1 39 12
Synechococcus sp. RCC307
Lactobacillus NA

No. of
Seq.
Length Mismatches
304
3
354
5
313
5
230
9
189
10
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Appendix D
Nuleotide and Amino Acid Sequences

D.1

Human IPPase

a. N-Terminal 6His-tagged
Nucleotide Sequence (Codon optimized using DNAworks)
Red

– Hexa-histidine tag + Thrombin cleavage sequence

Black – Cytosolic Human IPPase PPA1 gene
Blue
1
61
121
181
241
301
361
421
481
541
601
661
721
781
841
901

– Stop codon

ATGGGCTCCT
TCTGGTTTCT
AAAAACGAAA
GATGTCTTTC
ACCAAGGACC
GCGAACCTGT
GAAGACCCAG
GTTTGCGAGA
GGTATCCTGG
GACGACCCTG
TATCTCGAAG
AACGAGTTCG
TCTACCCACG
TGTATGAACA
ATCGTTGACG
AAATGGTTCC

CTCACCACCA
CTACCGAAGA
AGGGTCAGTA
ACATGGTTGT
CGCTGAACCC
TCCCGTACAA
GTCATAATGA
TTGGCTCTAA
CGATGATCGA
ACGCGGCCAA
CGACCGTTGA
CGTTCAACGC
ACCACTGGAA
CGACGCTGTC
CGCTGCCACC
ATCATCAGAA

CCATCACCAT
ACGTGCAGCG
CATCTCTCCA
TGAAGTTCCT
GATCAAACAA
AGGTTATATC
TAAACACACC
GGTTTGCGCG
CGAAGGTGAG
CTACAACGAC
CTGGTTCCGT
GGAATTCAAG
AGCGCTGGTT
TGAATCCCCG
GCCGTGCGAA
AAACTAA

TCTTCTGGTC
CCGTTCTCTC
TTCCACGACA
CGTTGGTCTA
GACGTTAAGA
TGGAACTACG
GGTTGCTGCG
CGTGGCGAAA
ACGGATTGGA
ATTAACGATG
CGCTACAAGG
GATAAAGACT
ACCAAGAAAA
TTCAAATGCG
TCTGCGTGCA

TGGTGCCGCG
TGGAATATCG
TCCCGATCTA
ATGCGAAAAT
AAGGTAAACT
GCGCGATCCC
GTGACAATGA
TCATCGGTGT
AAGTTATCGC
TTAAACGCCT
TTCCGGACGG
TCGCCATCGA
CCAACGGCAA
ACCCGGATGC
CTGTACCGAC

TGGTTCTATG
TGTTTTCCTG
CGCGGACAAA
GGAAATCGCG
GCGTTACGTT
ACAAACGTGG
CCCGATTGAT
TAAAGTACTC
AATCAACGTG
GAAGCCGGGC
CAAGCCGGAG
CATCATTAAA
AGGTATCTCT
GGCTCGTGCG
GGACGTTGAC

Overlapping sequences from pET3a plasmid for homologous recombination
5’ overlapping sequence (28 bases) – tgtttaactttaagaaggagatatacat
3’ overlapping sequence (27 bases) – gatccggctgctaacaaagcccgaaag
Amino acid sequence

Thrombin cleavage site
1
61
121
181
241
301

MGSSHHHHHH
DVFHMVVEVP
EDPGHNDKHT
DDPDAANYND
STHDHWKALV
KWFHHQKN

SSGLVPRGSM
RWSNAKMEIA
GCCGDNDPID
INDVKRLKPG
TKKTNGKGIS

SGFSTEERAA
TKDPLNPIKQ
VCEIGSKVCA
YLEATVDWFR
CMNTTLSESP

PFSLEYRVFL
DVKKGKLRYV
RGEIIGVKVL
RYKVPDGKPE
FKCDPDAARA

KNEKGQYISP
ANLFPYKGYI
GILAMIDEGE
NEFAFNAEFK
IVDALPPPCE

FHDIPIYADK
WNYGAIPQTW
TDWKVIAINV
DKDFAIDIIK
SACTVPTDVD

Recombinant Human IPPase is of size 308 aa (289 aa PPA1 + 19 aa tag).
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b. C-Terminal 6His-tagged
Nucleotide Sequence (Codon optimized using DNAworks)
Red

– Hexa-histidine tag + Thrombin cleavage sequence

Black – Cytosolic Human IPPase PPA1 gene
Blue
1
61
121
181
241
301
361
421
481
541
601
661
721
781
841
901

– Stop codon

ATGAGCGGCT
CTGAAAAACG
AAAGACGTTT
GCGACCAAGG
GTTGCGAACC
TGGGAAGACC
GACGTTTGCG
CTGGGTATCC
GTGGACGATC
GGCTACCTGG
GAGAACGAGT
AAATCTACCC
TCTTGCATGA
GCTATCGTAG
GACAAGTGGT
CACTAA

TCTCTACCGA
AAAAAGGCCA
TCCACATGGT
ACCCGCTGAA
TGTTCCCGTA
CTGGTCACAA
AAATCGGTTC
TGGCGATGAT
CTGACGCGGC
AAGCGACCGT
TCGCCTTTAA
ACGATCATTG
ACACCACCCT
ACGCGCTGCC
TCCATCACCA

AGAACGTGCG
GTACATTTCT
TGTTGAGGTC
CCCGATCAAA
CAAAGGTTAC
CGACAAGCAC
TAAAGTTTGC
CGACGAAGGT
CAACTACAAC
TGACTGGTTC
CGCCGAATTT
GAAAGCGCTC
GTCTGAATCC
GCCTCCTTGC
AAAAAACCTG

GCTCCGTTCT
CCTTTCCACG
CCGCGTTGGT
CAGGATGTTA
ATCTGGAACT
ACCGGTTGCT
GCGCGTGGTG
GAAACGGACT
GATATTAACG
CGCCGTTATA
AAGGACAAAG
GTCACGAAGA
CCGTTCAAAT
GAATCTGCTT
GTGCCGCGTG

CTCTGGAATA
ACATCCCGAT
CTAACGCGAA
AAAAGGGTAA
ACGGTGCGAT
GCGGTGATAA
AAATCATCGG
GGAAAGTGAT
ACGTTAAGCG
AAGTTCCTGA
ACTTCGCGAT
AAACCAACGG
GCGACCCGGA
GCACCGTGCC
GCAGCCACCA

CCGTGTTTTC
CTACGCGGAT
AATGGAGATC
ACTGCGTTAC
CCCGCAGACC
TGATCCAATC
TGTTAAGGTT
TGCGATTAAC
CCTGAAACCG
TGGCAAACCG
TGACATCATT
TAAAGGTATC
CGCTGCGCGT
GACGGACGTT
CCATCATCAC

Overlapping sequences from pET3a plasmid for homologous recombination
5’ overlapping sequence (28 bases) – tgtttaactttaagaaggagatatacat
3’ overlapping sequence (27 bases) – gatccggctgctaacaaagcccgaaag
Amino acid sequence
1
61
121
181
241
301

MSGFSTEERA
ATKDPLNPIK
DVCEIGSKVC
GYLEATVDWF
SCMNTTLSES
H

APFSLEYRVF
QDVKKGKLRY
ARGEIIGVKV
RRYKVPDGKP
PFKCDPDAAR

LKNEKGQYIS
VANLFPYKGY
LGILAMIDEG
ENEFAFNAEF
AIVDALPPPC

PFHDIPIYAD
IWNYGAIPQT
ETDWKVIAIN
KDKDFAIDII
ESACTVPTDV

KDVFHMVVEV
WEDPGHNDKH
VDDPDAANYN
KSTHDHWKAL
DKWFHHQKNL

PRWSNAKMEI
TGCCGDNDPI
DINDVKRLKP
VTKKTNGKGI
VPRGSHHHHH

Thrombin cleavage site

Recombinant Human IPPase is of size 301 aa (289 aa PPA1 + 12 aa tag).
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c. LysIns – a mutant of Human IPPase
It is a mutant of Human IPPase. Sequence of T4 lysozyme (160 aa) was inserted
in to WT-Human IPPase (between His tag+Thrombin recognition sequence and Human
IPPase PPA1 gene).

Amino acid sequence
Total Length
Red colored
1
51
101
151
201
251
301
351
401

MGSSHHHHHH
LTKSPSLNAA
KLKPVYDSLD
LAKSRWYNQT
KNEKGQYISP
DVKKGKLRYV
VCEIGSKVCA
INDVKRLKPG
STHDHWKALV

D.2

St-IPPase

– 468 aa
- Lysozyme sequence

SSGLVPRGSN IFEMLRIDEG LRLKIYKDTE
KSELDKAIGR NTNGVITKDE AEKLFNQDVD
AVRRAALINM VFQMGETGVA GFTNSLRMLQ
PNRAKRVITT FRTGTWDAYM SGFSTEERAA
FHDIPIYADK DVFHMVVEVP RWSNAKMEIA
ANLFPYKGYI WNYGAIPQTW EDPGHNDKHT
RGEIIGVKVL GILAMIDEGE TDWKVIAINV
YLEATVDWFR RYKVPDGKPE NEFAFNAEFK
TKKTNGKGIS CMNTTLSESP FKCDPDAARA
451 ACTVPTDVD KWFHHQKN

GYYTIGIGHL
AAVRGILRNA
QKRWDEAAVN
PFSLEYRVFL
TKDPLNPIKQ
GCCGDNDPID
DDPDAANYND
DKDFAIDIIK
IVDALPPPCE

Amino acid sequence (184 amino acids)
MHHHHHHQMSLLNVPAGKELPEDIYVVIEIPANADPIKYEVDKESGALFVDRFMSTAMFY
PCNYGYINHTLSLDGDPVDVLVPTPYPLQPGAVIRCRPVGVLKMTDESGEDAKLVAVPHT
KLSKEYDHIKDVNDLPELLKAQITHFFEHYKDLEKGKWVKVDGWDNAEAAKAEIVASFER
AAKK
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D.3

Tt-IPPase

Nucleotide Sequence
1
51
101
151
201
251
301
351
401
451
501

ATGAACCCGT
TTACGCTCTC
ACAAGAAGAC
TTCTATCCGG
CGACCCCTTC
CCATCATCGA
GATAAGGACT
CGACTGGAAG
CCCACTTCTT
GAGGGCTGGG
CGAGATGTAC

TCCACGAGCT
ATAGAGATAC
TGGTTTACTT
TCGACTACGG
GACATCATGG
GGCCAGGCCG
GGAAGGTTCT
GACATAAGTG
CCAGAGGTAC
GCAACGCCGA
AAGGAGAAGT

TGAGCCCGGA
CGAAGGGGAG
AAGCTCGACC
AATAATCCCG
TCATCATGCG
ATAGGCATCA
CGCCGTTCCG
ATGTTCCCAA
AAGGAGCTGC
GGAGGCCAAG
TCGGCAAGGA

CCGGAGGTTC
CAGGAACAAG
GCGTCCTTTA
CAGACCTGGT
CGAACCTGTC
TGAAGATGGA
GTCGAGGACC
GGCTTTCCTC
AAGGAAAGAC
AGGGAGATAC
GGAGTGA

CAGAGGTCGT
TACGAGCTCG
CAGCCCGTTC
ACGACGACGG
TACCCGCTCA
GGACTCTGGC
CCTACTTCAA
GACGAGATCG
CACCAAGATA
TCAGGGCCAT

Amino acid sequence (178 amino acids)
1
51
101
151

MNPFHELEPG
FYPVDYGIIP
DKDWKVLAVP
EGWGNAEEAK

PEVPEVVYAL
QTWYDDGDPF
VEDPYFNDWK
REILRAIEMY

IEIPKGSRNK YELDKKTGLL KLDRVLYSPF
DIMVIMREPV YPLTIIEARP IGIMKMEDSG
DISDVPKAFL DEIAHFFQRY KELQGKTTKI
KEKFGKEE
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